{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":4230929,"items":[{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:20:27Z","timestamp":1767651627958},"reference-count":7,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":21123,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[1957,11]]},"DOI":"10.1002\/1097-0142(195711\/12)10:6<1153::aid-cncr2820100610>3.0.co;2-j","type":"journal-article","created":{"date-parts":[[2006,6,24]],"date-time":"2006-06-24T21:47:06Z","timestamp":1151185626000},"page":"1153-1156","source":"Crossref","is-referenced-by-count":62,"title":["Spontaneous tumors, including gastrointestinal neoplasms and malignant melanomas, in the syrian hamster"],"prefix":"10.1002","volume":"10","author":[{"given":"Joseph G.","family":"Fortner","sequence":"first","affiliation":[]}],"member":"311","reference":[{"key":"10.1002\/1097-0142(195711\/12)10:6<1153::AID-CNCR2820100610>3.0.CO;2-J-BIB1","author":"Fortner","unstructured":"and : Hitherto unreported malignant melanoma in Syrian hamster; experimental counterpart of human melanoma. Cancer Research. In press."},{"key":"10.1002\/1097-0142(195711\/12)10:6<1153::AID-CNCR2820100610>3.0.CO;2-J-BIB2","first-page":"397","volume":"8","author":"Gardner","year":"1948","journal-title":"Cancer Research"},{"key":"10.1002\/1097-0142(195711\/12)10:6<1153::AID-CNCR2820100610>3.0.CO;2-J-BIB3","first-page":"225","volume-title":"The Physiopathology of Cancer","author":"Gardner","year":"1953","unstructured":"; ; , and : Hormonal factors in experimental carcinogenesis. In and , Eds.: The Physiopathology of Cancer. New York. Paul B. Hoeber, Inc. 1953; pp. 225\u2013297."},{"key":"10.1002\/1097-0142(195711\/12)10:6<1153::AID-CNCR2820100610>3.0.CO;2-J-BIB4","first-page":"122","volume":"10","author":"Kirkman","year":"1950","journal-title":"Cancer Research"},{"key":"10.1002\/1097-0142(195711\/12)10:6<1153::AID-CNCR2820100610>3.0.CO;2-J-BIB5","first-page":"1955","volume-title":"Fifth Annual Report on Stress","author":"Selye","year":"1956","unstructured":"and : Fifth Annual Report on Stress, 1955\u20131956. New York, MD Publications, Inc. 1956."},{"key":"10.1002\/1097-0142(195711\/12)10:6<1153::AID-CNCR2820100610>3.0.CO;2-J-BIB6","first-page":"3","volume-title":"The Physiopathology of Cancer","author":"Stewart","year":"1953","unstructured":": Experimental cancer of alimentary tract. In and , Eds.: The Physiopathology of Cancer. New York, Paul B. Hoeber, Inc. 1953; pp. 3\u201345."},{"key":"10.1002\/1097-0142(195711\/12)10:6<1153::AID-CNCR2820100610>3.0.CO;2-J-BIB7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1749-6632.1949.tb39870.x","volume":"50","author":"Woolley","year":"1949","journal-title":"Ann. New York Acad. Sc."}],"container-title":["Cancer"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2F1097-0142(195711%2F12)10:6%3C1153::AID-CNCR2820100610%3E3.0.CO;2-J","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/1097-0142(195711\/12)10:6%3C1153::AID-CNCR2820100610%3E3.0.CO;2-J","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T11:02:37Z","timestamp":1625137357000},"score":30.256927,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/1097-0142(195711\/12)10:6<1153::AID-CNCR2820100610>3.0.CO;2-J"}},"issued":{"date-parts":[[1957,11]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1957,11]]}},"URL":"https:\/\/doi.org\/10.1002\/1097-0142(195711\/12)10:6<1153::aid-cncr2820100610>3.0.co;2-j","ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"published":{"date-parts":[[1957,11]]}},{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:50:44Z","timestamp":1757613044353,"version":"3.44.0"},"reference-count":5,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780323547635"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/b978-0-323-54763-5.50065-9","type":"book-chapter","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T23:36:32Z","timestamp":1598657792000},"page":"172-173","source":"Crossref","is-referenced-by-count":0,"title":["Spindle Cell Neoplasms of Gastrointestinal Tract, Including Gastrointestinal Stromal Tumors"],"prefix":"10.1016","member":"78","reference":[{"issue":"10","key":"10.1016\/B978-0-323-54763-5.50065-9_bib1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.5858\/arpa.2016-0235-RA","article-title":"Cytologic and immunohistochemical evaluation of low-grade spindle cell lesions of the GI tract","volume":"140","author":"Virani","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/B978-0-323-54763-5.50065-9_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/cncy.21506","article-title":"Cytomorphologic features that distinguish schwannoma from other low-grade spindle cell lesions","volume":"123","author":"Chebib","year":"2015","journal-title":"Cancer Cytopathol"},{"issue":"10","key":"10.1016\/B978-0-323-54763-5.50065-9_bib3","first-page":"13166","article-title":"Immunohistochemical detection of STAT6, CD34, CD99 and BCL-2 for diagnosing solitary fibrous tumors\/hemangiopericytomas","volume":"8","author":"Han","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"10.1016\/B978-0-323-54763-5.50065-9_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.15403\/jgld.2014.1121.234.eug","article-title":"Clinical usefulness of endoscopic ultrasound-guided FNA for gastric subepithelial lesions smaller than 2 cm","volume":"23","author":"Akahoshi","year":"2014","journal-title":"J Gastrointestin Liver Dis"},{"issue":"1","key":"10.1016\/B978-0-323-54763-5.50065-9_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/0970-9371.107505","article-title":"Cytomorphology of gastrointestinal stromal tumors and extra-gastrointestinal stromal tumors: A comprehensive morphologic study","volume":"30","author":"Vij","year":"2013","journal-title":"J Cytol"}],"container-title":["Diagnostic Pathology: Cytopathology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323547635500659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323547635500659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T16:59:24Z","timestamp":1757005164000},"score":27.457981,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780323547635500659"}},"issued":{"date-parts":[[2018]]},"ISBN":["9780323547635"],"references-count":5,"URL":"https:\/\/doi.org\/10.1016\/b978-0-323-54763-5.50065-9","published":{"date-parts":[[2018]]}},{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T03:57:22Z","timestamp":1742961442782,"version":"3.40.3"},"publisher-location":"Cham","reference-count":28,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319172347"},{"type":"electronic","value":"9783319172354"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-17235-4_16","type":"book-chapter","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T11:12:28Z","timestamp":1431947548000},"page":"141-146","source":"Crossref","is-referenced-by-count":1,"title":["Nonfunctioning Pancreatic Neuroendocrine Neoplasms (Including PP-Producing and Calcitonin-Producing Tumors)"],"prefix":"10.1007","author":[{"given":"Alessandro","family":"Vanoli","sequence":"first","affiliation":[]},{"given":"Enrico","family":"Solcia","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF00471177","volume":"365","author":"L Grimelius","year":"1975","unstructured":"Grimelius L, Hultquist GT, Stenkvist B (1975) Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material. Virchows Arch A Pathol Anat Histol 365:275\u2013288","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/BF01297144","volume":"36","author":"W Kimura","year":"1991","unstructured":"Kimura W, Kuroda A, Morioka Y (1991) Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci 36:933\u2013942","journal-title":"Dig Dis Sci"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00000658-198102000-00010","volume":"193","author":"RB Kent 3rd","year":"1981","unstructured":"Kent RB 3rd, van Heerden JA, Weiland LH (1981) Nonfunctioning islet cell tumors. Ann Surg 193:\u200b185\u2013190","journal-title":"Ann Surg"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0344-0338(88)80043-8","volume":"183","author":"G Kl\u00f6ppel","year":"1988","unstructured":"Kl\u00f6ppel G, Heitz PU (1988) Pancreatic endocrine tumors. Pathol Res Pract 183:155\u2013168","journal-title":"Pathol Res Pract"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A et al (2008) One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063\u20133072","journal-title":"J Clin Oncol"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.surg.2013.08.002","volume":"155","author":"S Crippa","year":"2014","unstructured":"Crippa S, Partelli S, Zamboni G et al (2014) Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors. Surgery 155:145\u2013153","journal-title":"Surgery"},{"key":"16_CR7","volume-title":"Atlas of tumor pathology. Tumors of the pancreas","author":"E Solcia","year":"1997","unstructured":"Solcia E, Capella C, Kl\u00f6ppel G (1997) Atlas of tumor pathology. Tumors of the pancreas. Armed Forces Institute of Pathology, Washington, DC"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/BF00198436","volume":"429","author":"S La Rosa","year":"1996","unstructured":"La Rosa S, Sessa F, Capella C et al (1996) Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch 429:323\u2013333","journal-title":"Virchows Arch"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/01.pas.0000184819.71752.ad","volume":"30","author":"R Singh","year":"2006","unstructured":"Singh R, Basturk O, Klimstra DS et al (2006) Lipid-rich variant of pancreatic endocrine neoplasms. Am J Surg Pathol 30:194\u2013200","journal-title":"Am J Surg Pathol"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12022-012-9221-z","volume":"23","author":"E Fryer","year":"2012","unstructured":"Fryer E, Serra S, Chetty R (2012) Lipid-rich (\u201cclear cell\u201d) neuroendocrine tumors of the pancreas in MEN I patients. Endocr Pathol 23:243\u2013246","journal-title":"Endocr Pathol"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00428-006-0154-0","volume":"448","author":"M Volante","year":"2006","unstructured":"Volante M, La Rosa S, Castellano I et al (2006) Clinico-pathological features of a series of 11 oncocytic endocrine tumours of the pancreas. Virchows Arch 448:545\u2013551","journal-title":"Virchows Arch"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/01.pas.0000164370.81132.25","volume":"29","author":"SY Zee","year":"2005","unstructured":"Zee SY, Hochwald SN, Conlon KC et al (2005) Pleomorphic pancreatic endocrine neoplasms: a variant commonly confused with adenocarcinoma. Am J Surg Pathol 29:1194\u20131200","journal-title":"Am J Surg Pathol"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000318771","volume":"92","author":"L Boninsegna","year":"2010","unstructured":"Boninsegna L, Partelli S, D\u2019Innocenzio MM et al (2010) Pancreatic cystic endocrine tumors: a different morphological entity associated with a less aggressive behavior. Neuroendocrinology 92:246\u2013251","journal-title":"Neuroendocrinology"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1097\/PAS.0b013e31826a0048","volume":"36","author":"AD Singhi","year":"2012","unstructured":"Singhi AD, Chu LC, Tatsas AD et al (2012) Cystic pancreatic neuroendocrine tumors: a clinicopathologic study. Am J Surg Pathol 36:1666\u20131673","journal-title":"Am J Surg Pathol"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.humpath.2008.06.005","volume":"40","author":"S La Rosa","year":"2009","unstructured":"La Rosa S, Klersy C, Uccella S et al (2009) Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol 40:30\u201340","journal-title":"Hum Pathol"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","volume":"449","author":"G Rindi","year":"2006","unstructured":"Rindi G, Kl\u00f6ppel G, Alhman H et al (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395\u2013401","journal-title":"Virchows Arch"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/jnci\/djs208","volume":"104","author":"G Rindi","year":"2012","unstructured":"Rindi G, Falconi M, Klersy C et al (2012) TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst 104:764\u2013777","journal-title":"J Natl Cancer Inst"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0046-8177(82)80183-4","volume":"13","author":"PU Heitz","year":"1982","unstructured":"Heitz PU, Kasper M, Polak JM et al (1982) Pancreatic endocrine tumors. Hum Pathol 13:263\u2013271","journal-title":"Hum Pathol"},{"key":"16_CR19","first-page":"675","volume":"85","author":"LI Larsson","year":"1976","unstructured":"Larsson LI, Schwartz T, Lundqvist G et al (1976) Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors. Possible implication in the watery diarrhea syndrome. Am J Pathol 85:675\u2013684","journal-title":"Am J Pathol"},{"key":"16_CR20","first-page":"134","volume":"113","author":"T Tomita","year":"1983","unstructured":"Tomita T, Friesen SR, Kimmel JR et al (1983) Pancreatic polypeptide-secreting islet-cell tumors. A study of three cases. Am J Pathol 113:134\u2013142","journal-title":"Am J Pathol"},{"key":"16_CR21","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1002\/1097-0142(19840615)53:12<2688::AID-CNCR2820531221>3.0.CO;2-V","volume":"53","author":"A Nobin","year":"1984","unstructured":"Nobin A, Berg M, Ericsson M et al (1984) Pancreatic polypeptide-producing tumors. Report on two cases. Cancer 53:2688\u20132691","journal-title":"Cancer"},{"key":"16_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/archsurg.1984.01390170008003","volume":"119","author":"WE Strodel","year":"1984","unstructured":"Strodel WE, Vinik AI, Lloyd RV et al (1984) Pancreatic polypeptide-producing tumors. Silent lesions of the pancreas? Arch Surg 119:508\u2013514","journal-title":"Arch Surg"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0196-9781(01)00606-4","volume":"23","author":"C Bordi","year":"2002","unstructured":"Bordi C, Azzoni C, D\u2019Adda T et al (2002) Pancreatic polypeptide-related tumors. Peptides 23:339\u2013348","journal-title":"Peptides"},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.0954-6820.1980.tb01159.x","volume":"208","author":"M Gutniak","year":"1980","unstructured":"Gutniak M, Rosenqvist U, Grimelius L et al (1980) Report on a patient with watery diarrhoea syndrome caused by a pancreatic tumour containing neurotensin, enkephalin and calcitonin. Acta Med Scand 208:95\u2013100","journal-title":"Acta Med Scand"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/BF01295980","volume":"26","author":"GE Feurle","year":"1981","unstructured":"Feurle GE, Helmstaedter V, Tischbirek K et al (1981) A multihormonal tumor of the pancreas producing neurotensin. Dig Dis Sci 26:1125\u20131133","journal-title":"Dig Dis Sci"},{"key":"16_CR26","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0016-5085(83)90440-7","volume":"85","author":"E Theodorsson-Norheim","year":"1983","unstructured":"Theodorsson-Norheim E, Oberg K, Rosell S et al (1983) Neurotensinlike immunoreactivity in plasma and tumor tissue from patients with endocrine tumors of the pancreas and gut. Gastroenterology 85:\u200b881\u2013889","journal-title":"Gastroenterology"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/MPA.0b013e3182015f5d","volume":"40","author":"R Schneider","year":"2011","unstructured":"Schneider R, Waldmann J, Swaid Z et al (2011) Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entity. Pancreas 40:213\u2013221","journal-title":"Pancreas"},{"key":"16_CR28","first-page":"1687","volume":"50","author":"M Hyodo","year":"2003","unstructured":"Hyodo M, Nagai H, Sata N et al (2003) Long-term survivor without recurrence after resection of simultaneous solitary pancreatic metastasis from thyroid medullary carcinoma. Hepatogastroenterology 50:\u200b1687\u20131688","journal-title":"Hepatogastroenterology"}],"container-title":["Pancreatic Neuroendocrine Neoplasms"],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-17235-4_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T04:17:50Z","timestamp":1676953070000},"score":26.376581,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-17235-4_16"}},"issued":{"date-parts":[[2015]]},"ISBN":["9783319172347","9783319172354"],"references-count":28,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-17235-4_16","published":{"date-parts":[[2015]]}},{"indexed":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T08:15:48Z","timestamp":1656922548101},"reference-count":0,"publisher":"Juniper Publishers","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CTOIJ"],"DOI":"10.19080\/ctoij.2021.18.556000","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T07:36:55Z","timestamp":1656920215000},"source":"Crossref","is-referenced-by-count":0,"title":["Mast Cell Infiltration and Leukotriene Receptor Expression in Malignant Gynecologic Tumors: Pathological Findings to be Common in Various Carcinogens and Characteristic Mechanisms"],"prefix":"10.19080","volume":"18","author":[{"given":"Masao","family":"Sugamata","sequence":"first","affiliation":[]}],"member":"8164","published-online":{"date-parts":[[2021,6,3]]},"container-title":["Cancer Therapy &amp; Oncology International Journal"],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T07:36:56Z","timestamp":1656920216000},"score":25.917519,"resource":{"primary":{"URL":"https:\/\/juniperpublishers.com\/ctoij\/CTOIJ.MS.ID.556000.php"}},"issued":{"date-parts":[[2021,6,3]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,6,3]]}},"URL":"https:\/\/doi.org\/10.19080\/ctoij.2021.18.556000","ISSN":["2473-554X"],"issn-type":[{"value":"2473-554X","type":"electronic"}],"published":{"date-parts":[[2021,6,3]]}},{"indexed":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T19:21:47Z","timestamp":1714591307908},"reference-count":120,"publisher":"Elsevier","isbn-type":[{"value":"9781416029724","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2008]]},"DOI":"10.1016\/b978-1-4160-2972-4.50022-2","type":"book-chapter","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T00:36:43Z","timestamp":1333499803000},"page":"425-453","source":"Crossref","is-referenced-by-count":1,"title":["Metastatic Tumors of the Ovary (including Pseudomyxoma Peritonei, Hematolymphoid Neoplasms, and Tumors with Functioning Stroma)"],"prefix":"10.1016","author":[{"given":"PHILIP B","family":"CLEMENT","sequence":"first","affiliation":[]},{"given":"ROBERT H","family":"YOUNG","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00004347-198706000-00008","article-title":"Secondary ovarian carcinoma: A clinical and pathological evaluation","volume":"16","author":"Demopoulos","year":"1987","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00000478-200303000-00001","article-title":"The distinction between primary and metastatic mucinous carcinomas in the ovary. Gross and histologic findings in 50 cases","volume":"27","author":"Lee","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib3","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/1097-0142(19840501)53:9<1978::AID-CNCR2820530929>3.0.CO;2-1","article-title":"Metastases to the female genital tract. Analysis of 325 cases","volume":"53","author":"Mazur","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.semdp.2005.11.002","article-title":"Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors","volume":"22","author":"McCluggage","year":"2005","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0090-8258(92)90017-D","article-title":"Nongenital cancers metastatic to the ovary","volume":"44","author":"Petru","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib6","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/1097-0142(19840301)53:5<1164::AID-CNCR2820530523>3.0.CO;2-4","article-title":"Secondary ovarian neoplasia. A clinicopathologic study of 35 cases","volume":"53","author":"Ulbright","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0090-8258(89)90113-3","article-title":"Ovarian involvement in extragenital cancer","volume":"34","author":"Yazigi","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.pap.0000213038.85704.e4","article-title":"From Krukenberg to today: The ever present problems posed by metastatic tumors in the ovary. Part 1. Historical perspective, general principles, mucinous tumors including the Krukenberg tumor","volume":"13","author":"Young","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/PAP.0b013e3180504abf","article-title":"From Krukenberg to today: The ever present problems posed by metastatic tumors in the ovary. Part II","volume":"14","author":"Young","year":"2007","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib10","first-page":"161","article-title":"Differential diagnosis of ovarian tumors based primarily on their patterns and cell types","volume":"18","author":"Young","year":"2001","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib11","first-page":"250","article-title":"Metastatic tumors in the ovary: A problem-oriented approach and review of the recent literature","volume":"8","author":"Young","year":"1991","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ygyno.2005.10.008","article-title":"Primary and metastatic mucinous adenocarcinomas of the ovary: evaluation of the diagnostic approach using tumor size and laterality","volume":"101","author":"Khunamornpong","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0002-9378(94)90105-8","article-title":"Accuracy of frozen section (intraoperative consultation) diagnosis of ovarian tumors","volume":"171","author":"Rose","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/00000478-200307000-00014","article-title":"Primary and metastatic mucinous adenocarcinomas in the ovaries. Incidence in routine practice with a new approach to intraoperative diagnosis","volume":"27","author":"Seidman","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/01.pgp.0000168514.06429.c3","article-title":"Accuracy of frozen section in distinguishing primary ovarian neoplasia from tumors metastatic to the ovary","volume":"24","author":"Stewart","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00000478-198104000-00002","article-title":"Tubular Krukenberg tumor. A problem in histopathologic diagnosis","volume":"5","author":"Bullon","year":"1981","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib17","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1309\/A09ERYMFR64NERDW","article-title":"Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon","volume":"21","author":"Chu","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib18","first-page":"221","article-title":"Krukenberg tumor of the ovaries. A review of 81 records","volume":"32","author":"Hale","year":"1968","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib19","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/1097-0142(19821201)50:11<2438::AID-CNCR2820501132>3.0.CO;2-X","article-title":"Krukenberg tumors of the ovary. A clinicopathologic analysis of 27 cases","volume":"50","author":"Holtz","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.pgp.0000185405.08556.a0","article-title":"Krukenberg tumor of renal pelvic origin: Report of a case with selected comments on ovarian tumors metastatic from the urinary tract","volume":"25","author":"Irving","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.pas.0000190787.85024.cb","article-title":"Krukenberg tumors of the ovary: A clinicopathological analysis of 120 cases with emphasis on their variable pathological manifestations","volume":"30","author":"Kiyokawa","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib22","first-page":"479","article-title":"Krukenberg tumors of the ovary: A clinicopathologic analysis of 112 cases","volume":"39","author":"Yakushiji","year":"1987","journal-title":"Acta Obstet Gynaecol Jpn"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.pap.0000213038.85704.e4","article-title":"From Krukenberg to today: The ever present problems posed by metastatic tumors in the ovary. Part 1. Historical perspective, general principles, mucinous tumors including the Krukenberg tumor","volume":"13","author":"Young","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib24","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/01.pas.0000213256.75316.4a","article-title":"Ovarian metastases of intestinal-type gastric carcinoma. A clinicopathologic study of 4 cases with contrasting features to those of the Krukenberg tumor","volume":"30","author":"Lerwill","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib25","first-page":"39","article-title":"Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update","volume":"24","author":"Baker","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/ajcp\/97.6.751","article-title":"Metastatic ovarian carcinoma of large intestinal origin simulating primary ovarian carcinoma. A clinicopathologic study of 25 cases","volume":"97","author":"Daya","year":"1992","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00004347-199707000-00009","article-title":"Necrosis in 84 ovarian carcinomas: A morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen","volume":"16","author":"DeConstanzo","year":"1997","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1440-1827.2005.01819.x","article-title":"Diagnostic challenge of secondary (metastatic) ovarian tumors simulating primary endometrioid and mucinous neoplasms","volume":"55","author":"Hart","year":"2005","journal-title":"Pathol Int"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00000478-198702000-00005","article-title":"Intestinal adenocarcinomas metastatic to the ovaries. A clinicopathological evaluation of 22 cases","volume":"11","author":"Lash","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2559.2005.02194.x","article-title":"Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features","volume":"47","author":"McCluggage","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.semdp.2005.11.002","article-title":"Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors","volume":"22","author":"McCluggage","year":"2005","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00000478-199807000-00003","article-title":"Metastatic intestinal carcinomas simulating primary ovarian clear cell carcinoma and secretory endometrioid carcinoma. A clinicopathologic and immunohistochemical study of five cases","volume":"22","author":"Young","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004347-198506000-00003","article-title":"Appendiceal carcinoma metastatic to the ovaries and mimicking primary ovarian tumors","volume":"4","author":"Merino","year":"1985","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib34","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/00000478-200308000-00006","article-title":"Appendiceal mucinous neoplasms: A clinicopathological analysis of 107 cases","volume":"27","author":"Misdraji","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib35","first-page":"591","article-title":"Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors","volume":"18","author":"Prayson","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00000478-199301000-00003","article-title":"Association of mucinous tumors of the ovary and appendix. A clinicopathologic study of 25 cases","volume":"17","author":"Seidman","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.semdp.2004.12.002","article-title":"Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms","volume":"21","author":"Young","year":"2004","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00000478-199105000-00001","article-title":"Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei: A clinicopathological analysis of 22 cases supporting an origin in the appendix","volume":"15","author":"Young","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.pas.0000202039.74837.7d","article-title":"Pseudomyxoma peritonei of appendiceal origin: A clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review","volume":"30","author":"Bradley","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib40","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/00000478-200308000-00006","article-title":"Appendiceal mucinous neoplasms: A clinicopathological analysis of 107 cases","volume":"27","author":"Misdraji","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2559.2006.02512.x","article-title":"Kusamura S, Baratti D, et al. CDX-2 expression in pseudomyxoma peritonei: a clinicopathologic analysis of 42 cases","volume":"49","author":"Nonaka","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib42","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/01.MP.0000026617.52466.9F","article-title":"MUC2 is a molecular marker for pseudomyxoma peritonei","volume":"15","author":"O'Connell","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.pap.0000194625.05137.51","article-title":"Appendiceal mucinous tumors and pseudomyxoma peritonei. Histologic features, diagnostic problems, and proposed classification","volume":"12","author":"Pai","year":"2005","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib44","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.pas.0000213281.43036.bb","article-title":"Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: Analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases","volume":"30","author":"Vang","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib45","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/modpathol.3800698","article-title":"Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7","volume":"19","author":"Vang","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.semdp.2004.12.002","article-title":"Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms","volume":"21","author":"Young","year":"2004","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib47","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/PAS.0b013e31804f7aa1","article-title":"Ovarian metastases of appendiceal tumors with goblet cell carcinoid-like and signet-ring cell patterns: A report of 30 cases","volume":"31","author":"Hristov","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.pas.0000190787.85024.cb","article-title":"Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations","volume":"30","author":"Kiyokawa","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib49","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/00000478-199710000-00004","article-title":"The morphological spectrum of ovarian metastases of appendiceal adenocarcinomas. A clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites","volume":"21","author":"Ronnett","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib50","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/1097-0142(197403)33:3<798::AID-CNCR2820330327>3.0.CO;2-L","article-title":"Carcinoid metastatic to the ovary. A clinicopathologic analysis of 35 cases","volume":"33","author":"Robboy","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ygyno.2007.02.034","article-title":"Metastatic carcinoid tumor to the ovary: A clinicopathologic analysis of seventeen cases","volume":"106","author":"Strosberg","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib52","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/ajcp\/92.1.110","article-title":"Hepatoblastoma in an adult with metastasis to the ovary","volume":"92","author":"Green","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib53","unstructured":"Khunamornpong S, Lerwill MF, Siriaunkgul S, et al. Carcinoma of extrahepatic bile ducts and gallbladder metastatic to the ovary: A report of 16 cases (submitted)."},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib54","unstructured":"Khunamornpong S, Siriaunkgul S, Suprasert P, et al. Intrahepatic cholangiocarcinoma metastatic to the ovary: A report of 16 cases of an underemphasized form of secondary tumor in the ovary that may mimic primary neoplasia. Am J Surg Pathol (in press)."},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00000478-200303000-00001","article-title":"The distinction between primary and metastatic mucinous carcinomas in the ovary. Gross and histologic findings in 50 cases","volume":"27","author":"Lee","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib56","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0046-8177(92)90136-Q","article-title":"Hepatocellular carcinoma metastatic to the ovary: A report of three cases discovered during life with discussion of the differential diagnosis of hepatoid tumors of the ovary","volume":"23","author":"Young","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib57","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/00000478-198909000-00004","article-title":"Metastases from carcinomas of the pancreas simulating primary mucinous tumors of the ovary: A report of seven cases","volume":"13","author":"Young","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib58","first-page":"449","article-title":"Ovarian disease in women with breast cancer","volume":"84","author":"Curtin","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib59","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/1097-0142(19890815)64:4<892::AID-CNCR2820640422>3.0.CO;2-C","article-title":"Ovarian metastases of breast carcinoma. A clinicopathologic study of 59 cases","volume":"64","author":"Gagnon","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/bjc.1984.135","article-title":"A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast","volume":"50","author":"Harris","year":"1984","journal-title":"Br J Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib61","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0046-8177(91)90084-3","article-title":"Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary","volume":"22","author":"Monteagudo","year":"1991","journal-title":"Hum Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib62","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.pas.0000176429.88702.36","article-title":"Expression of WT1, CA125 and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary","volume":"29","author":"Tornos","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib63","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0046-8177(89)90137-8","article-title":"Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin","volume":"20","author":"Wick","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib64","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/1097-0142(19810701)48:1<210::AID-CNCR2820480133>3.0.CO;2-H","article-title":"Breast carcinoma masquerading as a primary ovarian neoplasm","volume":"48","author":"Young","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib65","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.PGP.0000071044.12278.43","article-title":"A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma","volume":"22","author":"Cameron","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib66","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.pgp.0000185405.08556.a0","article-title":"Krukenberg tumor of renal pelvic origin: Report of a case with selected comments on ovarian tumors metastatic from the urinary tract","volume":"25","author":"Irving","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib67","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1097\/00000478-200311000-00005","article-title":"Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications","volume":"27","author":"Logani","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/106689699500200310","article-title":"Transitional cell carcinoma of the renal pelvis with symptomatic ovarian metastases","volume":"2","author":"Oliva","year":"1995","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib69","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-2559.2000.00844.x","article-title":"Transitional cell carcinoma of the ovary and bladder are immunophenotypically different","volume":"36","author":"Ordonez","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib70","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00004347-199204000-00003","article-title":"Renal cell carcinoma metastatic to the ovary: a report of three cases emphasizing possible confusion with ovarian clear cell adenocarcinoma","volume":"11","author":"Young","year":"1992","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib71","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00004347-199301000-00002","article-title":"Metastatic ovarian tumors in children: A report of 14 cases and review of the literature","volume":"12","author":"Young","year":"1993","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib72","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004347-198809000-00001","article-title":"Urothelial and ovarian carcinomas of identical cell types: Problems in interpretation. A report of three cases and review of the literature","volume":"7","author":"Young","year":"1988","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib73","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1097-0142(19930101)71:1<177::AID-CNCR2820710128>3.0.CO;2-G","article-title":"Nonpulmonary small cell carcinomas of extragenital origin metastatic to the ovary: A report of seven cases","volume":"71","author":"Eichhorn","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib74","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/01.pas.0000166363.76082.a0","article-title":"Lung carcinoma metastatic to the ovary. A clinicopathological study of 32 cases emphasizing their morphologic spectrum and problems in differential diagnosis","volume":"29","author":"Irving","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib75","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00443902","article-title":"Noninvasive thymoma with widespread blood-borne metastasis","volume":"390","author":"Yoshida","year":"1981","journal-title":"Virchows Arch (Pathol Anat)"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib76","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0090-8258(85)90272-0","article-title":"Ovarian metastases from cancer of the lung: Problems in interpretation. A report of seven cases","volume":"21","author":"Young","year":"1985","journal-title":"Gynecol Oncol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib77","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/00000478-198712000-00006","article-title":"Malignant melanoma metastatic to the ovary","volume":"11","author":"Fitzgibbons","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib78","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.pas.0000126786.69232.55","article-title":"Malignant melanoma involving the ovary. A clinicopathologic and immunohistochemical study of 23 cases","volume":"28","author":"Gupta","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib79","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/00000478-199109000-00005","article-title":"Malignant melanoma metastatic to the ovary: A clinicopathologic analysis of 20 cases","volume":"15","author":"Young","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00004347-199301000-00002","article-title":"Metastatic ovarian tumors in children: A report of 14 cases and review of the literature","volume":"12","author":"Young","year":"1993","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib81","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/01.pap.0000138146.357376.1e","article-title":"Ovarian neoplasms composed of small round cells: a review","volume":"11","author":"McCluggage","year":"2004","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib82","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1097-0142(19830715)52:2<297::AID-CNCR2820520217>3.0.CO;2-Y","article-title":"Ovarian rhabdomyosarcoma presenting as leukemia","volume":"52","author":"Nunez","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib83","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/1097-0142(19890815)64:4<899::AID-CNCR2820640423>3.0.CO;2-P","article-title":"Alveolar rhabdomyosarcoma metastatic to the ovary. A report of two cases and discussion of the differential diagnosis of small cell malignant tumors of the ovary","volume":"64","author":"Young","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib84","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/01.pas.0000155161.55915.c3","article-title":"Gastrointestinal stromal tumors metastatic to the ovary. A report of five cases","volume":"29","author":"Irving","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib85","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1479-828X.1985.tb00751.x","article-title":"Angiosarcoma of breast metastatic to the ovary and placenta","volume":"25","author":"Sedgely","year":"1985","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib86","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00004347-199007000-00004","article-title":"Sarcomas metastatic to the ovary. A report of 21 cases","volume":"9","author":"Young","year":"1990","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib87","first-page":"208","article-title":"Chordoma metastatic to the ovary: Report of a case","volume":"114","author":"Zukerberg","year":"1990","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib88","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1097-0142(19930101)71:1<177::AID-CNCR2820710128>3.0.CO;2-G","article-title":"Nonpulmonary small cell carcinomas of extragenital origin metastatic to the ovary","volume":"71","author":"Eichhorn","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib89","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00004347-199610000-00008","article-title":"Adenoid cystic carcinoma of the submandibular gland with symptomatic ovarian metastases","volume":"15","author":"Longacre","year":"1996","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib90","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00004347-199404000-00012","article-title":"Ovarian metastasis from thyroid carcinoma twelve years after partial thyroidectomy mimicking struma ovarii. Report of a case","volume":"13","author":"Young","year":"1994","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib91","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/1097-0142(19820701)50:1<163::AID-CNCR2820500131>3.0.CO;2-K","article-title":"Hendrickson M, Ross J, et al. Simultaneous presentation of carcinoma involving the ovary and uterine corpus","volume":"50","author":"Eifel","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib92","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.pas.0000152136.81771.12","article-title":"Synchronous and metachronous endocervical and ovarian neoplasms. Evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms","volume":"29","author":"Elishaev","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib93","first-page":"553","article-title":"Coexistence of ovarian neoplasm and endocervical adenocarcinoma","volume":"64","author":"Kaminski","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib94","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00004347-198301040-00009","article-title":"Coexistent endocervical adenocarcinoma and mucinous adenocarcinoma of ovary: A clinicopathological study of four cases","volume":"1","author":"LiVolsi","year":"1983","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib95","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00004347-199707000-00014","article-title":"Cervical squamous cell carcinoma in situ with intraepithelial extension to the upper genital tract and invasion of tubes and ovaries: Report of a case with human papilloma virus analysis","volume":"16","author":"Pins","year":"1997","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib96","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0046-8177(85)80210-0","article-title":"Metastatic and independent cancers of the endometrium and ovary: A clinicopathologic study of 34 cases","volume":"16","author":"Ulbright","year":"1985","journal-title":"Hum Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib97","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.pas.0000213369.71676.25","article-title":"p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary. Utility for identification of metastatic HPV-related endocervical adenocarcinoma","volume":"31","author":"Vang","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib98","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/1097-0142(19930115)71:2<407::AID-CNCR2820710223>3.0.CO;2-G","article-title":"Ovarian metastases from cervical carcinomas other than pure adenocarcinomas: A report of 12 cases","volume":"71","author":"Young","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib99","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00004347-198805000-00001","article-title":"Mucinous tumors of the ovary associated with mucinous adenocarcinomas of the cervix. A clinicopathological analysis of 16 cases","volume":"7","author":"Young","year":"1988","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00004347-199007000-00004","article-title":"Sarcomas metastatic to the ovary. A report of 21 cases","volume":"9","author":"Young","year":"1990","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib101","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000478-199609000-00004","article-title":"Malignant mesotheliomas presenting as ovarian masses: A report of nine cases, including two primary ovarian mesotheliomas","volume":"20","author":"Clement","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib102","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/00000478-199510000-00003","article-title":"Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors","volume":"19","author":"Goldblum","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib103","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0046-8177(92)90094-J","article-title":"Ovarian involvement by the intra-abdominal desmoplastic small round cell tumor with divergent differentiation: A report of three cases","volume":"23","author":"Young","year":"1991","journal-title":"Hum Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib104","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/1097-0142(19870815)60:4<827::AID-CNCR2820600419>3.0.CO;2-A","article-title":"An autopsy study of 1206 acute and chronic leukemias (1958\u20131982)","volume":"60","author":"Barcos","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0968-6053(05)80004-3","article-title":"Malignant lymphoma of the genitourinary tract","volume":"4","author":"Ferry","year":"1997","journal-title":"Curr Diagn Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib106","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1471-0528.1988.tb06611.x","article-title":"Malignant lymphoma presenting as an ovarian tumour: A clinicopathological analysis of 34 cases","volume":"95","author":"Fox","year":"1988","journal-title":"BJOG"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib107","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00000478-199302000-00007","article-title":"Malignant lymphomas involving the ovary. A clinicopathologic analysis of 39 cases","volume":"17","author":"Monterroso","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib108","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/00000478-199710000-00005","article-title":"Granulocytic sarcoma of the female genital tract: A clinicopathologic study of 11 cases","volume":"21","author":"Oliva","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib109","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/1097-0142(19831115)52:10<1933::AID-CNCR2820521026>3.0.CO;2-8","article-title":"Lymphomas or leukemia presenting as ovarian tumors. An analysis of 42 cases","volume":"52","author":"Osborne","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/1097-0142(19800201)45:3<561::AID-CNCR2820450324>3.0.CO;2-A","article-title":"Malignant lymphoma with primary manifestation in the gonad. A clinicopathologic study of 38 patients","volume":"45","author":"Paladugu","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib111","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/modpathol.3880442","article-title":"Ovarian nonHodgkin's lymphoma: a clinicopathologic study of eight primary cases","volume":"14","author":"Vang","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib112","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00125480-200107000-00002","article-title":"NonHodgkin's lymphoma involving the gynecologic tract: a review of 88 cases","volume":"8","author":"Vang","year":"2001","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib113","series-title":"Progress in gynecology, III","first-page":"31","article-title":"Functioning ovarian tumors","author":"Scully","year":"1957"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib114","series-title":"Endocrine pathology of the ovary","author":"Morris","year":"1958"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib115","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/1097-0142(199007\/08)14:4<827::AID-CNCR2820140420>3.0.CO;2-K","article-title":"Luteinization of the stroma of metastatic cancer involving the ovary and its endocrine significance","volume":"14","author":"Scully","year":"1961","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib116","series-title":"The human teratomas","first-page":"215","article-title":"Endocrine aspects of germ cell tumors","author":"Herrington","year":"1983"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib117","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/1097-0142(19900501)65:9<2001::AID-CNCR2820650920>3.0.CO;2-7","article-title":"Ovarian tumors with functioning stroma. An immunohistochemical study of 100 cases with human chorionic gonadotropin monoclonal and polyclonal antibodies","volume":"65","author":"Matias-Guiu","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib118","first-page":"667","article-title":"Oxidative-enzyme activity in normal and pathological human ovaries","volume":"24","author":"Scully","year":"1964","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib119","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004347-198612000-00004","article-title":"Ovarian tumors with peripheral steroid cell proliferation: a report of 24 cases","volume":"5","author":"Rutgers","year":"1986","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/B978-1-4160-2972-4.50022-2_bib120","series-title":"Haines and Taylor Obstetrical and gynecological pathology","article-title":"Ovarian tumors with functioning stroma","author":"Scully","year":"1995"}],"container-title":["Atlas of Gynecologic Surgical Pathology"],"language":"en","deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T02:40:41Z","timestamp":1641955241000},"score":25.798925,"resource":{"primary":{"URL":"https:\/\/www.elsevier.com\/books-and-journals\/deleted-doi"}},"issued":{"date-parts":[[2008]]},"ISBN":["9781416029724"],"references-count":120,"URL":"https:\/\/doi.org\/10.1016\/b978-1-4160-2972-4.50022-2","published":{"date-parts":[[2008]]}},{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:11:50Z","timestamp":1760400710044,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":1289,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1093\/annonc\/mdw199.107","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T01:02:32Z","timestamp":1466730152000},"page":"ii33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["P-113 Multiple neoplasms including hematological malignancies and esophageal cancer"],"prefix":"10.1016","volume":"27","author":[{"given":"K.","family":"Natori","sequence":"first","affiliation":[]},{"given":"D.","family":"Nagase","sequence":"additional","affiliation":[]},{"given":"S.","family":"Ishihara","sequence":"additional","affiliation":[]},{"given":"Y.","family":"Mitsui","sequence":"additional","affiliation":[]},{"given":"A.","family":"Sakai","sequence":"additional","affiliation":[]},{"given":"M.","family":"Kato","sequence":"additional","affiliation":[]},{"given":"K.","family":"Arai","sequence":"additional","affiliation":[]},{"given":"Y.","family":"Kuraishi","sequence":"additional","affiliation":[]},{"given":"H.","family":"Izumi","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419456020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419456020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/27\/suppl_2\/ii33\/7508462\/mdw199.107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:46:43Z","timestamp":1760334403000},"score":25.220854,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419456020"}},"issued":{"date-parts":[[2016,6]]},"references-count":0,"alternative-id":["S0923753419456020"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdw199.107","ISSN":["0923-7534"],"issn-type":[{"type":"print","value":"0923-7534"}],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P-113 Multiple neoplasms including hematological malignancies and esophageal cancer","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/annonc\/mdw199.107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T14:19:46Z","timestamp":1725459586102},"publisher-location":"Basel","reference-count":96,"publisher":"Birkh\u00e4user-Verlag","isbn-type":[{"type":"print","value":"3764371560"}],"content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1007\/3-7643-7378-4_13","type":"book-chapter","created":{"date-parts":[[2006,1,26]],"date-time":"2006-01-26T15:25:14Z","timestamp":1138289114000},"page":"303-320","source":"Crossref","is-referenced-by-count":7,"title":["Genetic instability in human tumors"],"prefix":"10.1007","author":[{"given":"Stavroula","family":"Raptis","sequence":"first","affiliation":[]},{"given":"Bharati","family":"Bapat","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D. Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57\u201370","journal-title":"Cell"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"14800","DOI":"10.1073\/pnas.93.25.14800","volume":"93","author":"I.P. Tomlinson","year":"1996","unstructured":"Tomlinson IP, Novelli MR, Bodmer WF (1996) The mutation rate and cancer. Proc Natl Acad Sci USA 93: 14800\u201314803","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc1170","volume":"3","author":"O.M. Sieber","year":"2003","unstructured":"Sieber OM, Heinimann K, Tomlinson IP (2003) Genomic instability\u2014the engine of tumorigenesis? Nat Rev Cancer 3: 701\u2013708","journal-title":"Nat Rev Cancer"},{"key":"13_CR4","first-page":"3230","volume":"61","author":"L.A. Loeb","year":"2001","unstructured":"Loeb LA (2001) A mutator phenotype in cancer. Cancer Res 61: 3230\u20133239","journal-title":"Cancer Res"},{"key":"13_CR5","first-page":"3075","volume":"51","author":"L.A. Loeb","year":"1991","unstructured":"Loeb LA (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51: 3075\u20133079","journal-title":"Cancer Res"},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.semcancer.2004.06.005","volume":"14","author":"A.P. Feinberg","year":"2004","unstructured":"Feinberg AP (2004) The epigenetics of cancer etiology. Semin Cancer Biol 14: 427\u2013432","journal-title":"Semin Cancer Biol"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.0.CO;2-M","volume":"9","author":"C. Eng","year":"1997","unstructured":"Eng C, Mulligan LM (1997) Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumors, and hirschsprung disease. Hum Mutat 9: 97\u2013109","journal-title":"Hum Mutat"},{"key":"13_CR8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF01882039","volume":"119","author":"D. Hansemann von","year":"1890","unstructured":"von Hansemann D (1890) Virchows Arch Pathol Anat 119: 299\u2013326","journal-title":"Virchows Arch Pathol Anat"},{"key":"13_CR9","volume-title":"Zur Frage der Enstehung Maligner Tumoren","author":"T. Boveri","year":"1914","unstructured":"Boveri T (1914) Zur Frage der Enstehung Maligner Tumoren. Gustav Fischer, Jena. English translation: Boveri M (transl.) (1929) The Origin of Malignant Tumors. Williams and Wilkins, Baltimore"},{"key":"13_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/25292","volume":"396","author":"C. Lengauer","year":"1998","unstructured":"Lengauer C, Kinzler KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396: 643\u2013649","journal-title":"Nature"},{"key":"13_CR11","first-page":"1","volume":"15","author":"M.M. Beau Le","year":"1986","unstructured":"Le Beau MM, Rowley JD (1986) Chromosomal abnormalities in leukemia and lymphoma: clinical and biological significance. Adv Hum Genet 15: 1\u201354","journal-title":"Adv Hum Genet"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1006\/scbi.1999.0126","volume":"9","author":"M. Schwab","year":"1999","unstructured":"Schwab M (1999) Oncogene amplification in solid tumors. Semin Cancer Biol 9: 319\u2013325","journal-title":"Semin Cancer Biol"},{"key":"13_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jcp.10077","volume":"191","author":"T.M. Marti","year":"2002","unstructured":"Marti TM, Kunz C, Fleck O (2002) DNA mismatch repair and mutation avoidance pathways. J Cell Physiol 191: 28\u201341","journal-title":"J Cell Physiol"},{"key":"13_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0300-9084(01)01362-1","volume":"84","author":"S. Jacob","year":"2002","unstructured":"Jacob S, Praz F (2002) DNA mismatch repair defects: role in colorectal carcinogenesis. Biochimie 84: 27\u201347","journal-title":"Biochimie"},{"key":"13_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/hmg\/10.7.735","volume":"10","author":"P. Peltomaki","year":"2001","unstructured":"Peltomaki P (2001) Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 10: 735\u2013740","journal-title":"Hum Mol Genet"},{"key":"13_CR16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nm0296-169","volume":"2","author":"B. Liu","year":"1996","unstructured":"Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, Jass JR, Dunlop M, Wyllie A, Peltomaki P et al. (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2: 169\u2013174","journal-title":"Nat Med"},{"key":"13_CR17","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/jnci\/87.15.1114","volume":"87","author":"G. Marra","year":"1995","unstructured":"Marra G, Boland CR (1995) Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 87: 1114\u20131125","journal-title":"J Natl Cancer Inst"},{"key":"13_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJM199808203390804","volume":"339","author":"J.T. Wijnen","year":"1998","unstructured":"Wijnen JT, Vasen HF, Khan PM, Zwinderman AH, van der Klift H, Mulder A, Tops C, Moller P, Fodde R (1998) Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 339: 511\u2013518","journal-title":"N Engl J Med"},{"key":"13_CR19","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/0092-8674(93)90331-J","volume":"75","author":"R. Parsons","year":"1993","unstructured":"Parsons R, Li GM, Longley MJ, Fang WH, Papadopoulos N, Jen J, de la Chapelle A, Kinzler KW, Vogelstein B, Modrich P (1993) Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75: 1227\u20131236","journal-title":"Cell"},{"key":"13_CR20","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1073\/pnas.91.14.6319","volume":"91","author":"N.P. Bhattacharyya","year":"1994","unstructured":"Bhattacharyya NP, Skandalis A, Ganesh A, Groden J, Meuth M (1994) Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci USA 91: 6319\u20136323","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0003-3995(02)01115-2","volume":"45","author":"A. Duval","year":"2002","unstructured":"Duval A, Hamelin R (2002) Genetic instability in human mismatch repair deficient cancers. Ann Genet 45: 71\u201375","journal-title":"Ann Genet"},{"key":"13_CR22","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1126\/science.286.5446.1897","volume":"286","author":"T. Lindahl","year":"1999","unstructured":"Lindahl T, Wood RD (1999) Quality control by DNA repair. Science 286: 1897\u20131905","journal-title":"Science"},{"issue":"2","key":"13_CR23","doi-asserted-by":"publisher","first-page":"R159","DOI":"10.1093\/hmg\/ddg259","volume":"12","author":"J.P. Cheadle","year":"2003","unstructured":"Cheadle JP, Sampson JR (2003) Exposing the MYtH about base excision repair and human inherited disease. Hum Mol Genet 12 Spec No 2: R159\u2013R165","journal-title":"Hum Mol Genet"},{"key":"13_CR24","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1126\/science.1056154","volume":"291","author":"R.D. Wood","year":"2001","unstructured":"Wood RD, Mitchell M, Sgouros J, Lindahl T (2001) Human DNA repair genes. Science 291: 1284\u20131289","journal-title":"Science"},{"key":"13_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/349431a0","volume":"349","author":"S. Shibutani","year":"1991","unstructured":"Shibutani S, Takeshita M, Grollman AP (1991) Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349: 431\u2013434","journal-title":"Nature"},{"key":"13_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/ng828","volume":"30","author":"N. Al-Tassan","year":"2002","unstructured":"Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, Hodges AK, Davies DR, David SS, Sampson JR et al. (2002) Inherited variants of MYH associated with somatic G:C\u2192T:A mutations in colorectal tumors. Nat Genet 30: 227\u2013232","journal-title":"Nat Genet"},{"key":"13_CR27","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/35077232","volume":"411","author":"J.H. Hoeijmakers","year":"2001","unstructured":"Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411: 366\u201374","journal-title":"Nature"},{"key":"13_CR28","doi-asserted-by":"crossref","first-page":"11135","DOI":"10.1074\/jbc.M108618200","volume":"277","author":"Y. Gu","year":"2002","unstructured":"Gu Y, Parker A, Wilson TM, Bai H, Chang DY, Lu AL (2002) Human MutY homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2\/human MutS homolog 6. J Biol Chem 277: 11135\u201311142","journal-title":"J Biol Chem"},{"key":"13_CR29","first-page":"363","volume":"62","author":"J.P. Cheadle","year":"2002","unstructured":"Cheadle JP, Krawczak M, Thomas MW, Hodges AK, Al-Tassan N, Fleming N, Sampson JR (2002) Different combinations of biallelic APC mutation confer different growth advantages in colorectal tumors. Cancer Res 62: 363\u2013366","journal-title":"Cancer Res"},{"key":"13_CR30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0891-5849(90)90091-V","volume":"8","author":"C.F. Babbs","year":"1990","unstructured":"Babbs CF (1990) Free radicals and the etiology of colon cancer. Free Radic Biol Med 8: 191\u2013200","journal-title":"Free Radic Biol Med"},{"key":"13_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.semcancer.2004.06.007","volume":"14","author":"K. Dixon","year":"2004","unstructured":"Dixon K, Kopras E (2004) Genetic alterations and DNA repair in human carcinogenesis. Semin Cancer Biol 14: 441\u2013448","journal-title":"Semin Cancer Biol"},{"key":"13_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0022-5193(03)00120-6","volume":"223","author":"N.L. Komarova","year":"2003","unstructured":"Komarova NL, Sengupta A, Nowak MA (2003) Mutation-selection networks of cancer initiation: tumor suppressor genes and chromosomal instability. J Theor Biol 223: 433\u2013450","journal-title":"J Theor Biol"},{"key":"13_CR33","doi-asserted-by":"publisher","first-page":"16226","DOI":"10.1073\/pnas.202617399","volume":"99","author":"M.A. Nowak","year":"2002","unstructured":"Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih Ie M, Vogelstein B, Lengauer C (2002) The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci USA 99: 16226\u201316231","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR34","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature03099","volume":"432","author":"H. Rajagopalan","year":"2004","unstructured":"Rajagopalan H, Lengauer C (2004) Aneuploidy and cancer. Nature 432: 338\u2013341","journal-title":"Nature"},{"key":"13_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/2496","volume":"20","author":"H. Zhou","year":"1998","unstructured":"Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S (1998) Tumor amplified kinase STK15\/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20: 189\u2013193","journal-title":"Nat Genet"},{"key":"13_CR36","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/386623a0","volume":"386","author":"C. Lengauer","year":"1997","unstructured":"Lengauer C, Kinzler KW, Vogelstein B (1997) Genetic instability in colorectal cancers. Nature 386: 623\u2013627","journal-title":"Nature"},{"key":"13_CR37","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1200\/JCO.2003.06.018","volume":"21","author":"W.C. Hahn","year":"2003","unstructured":"Hahn WC (2003) Role of telomeres and telomerase in the pathogenesis of human cancer. J Clin Oncol 21: 2034\u20132043","journal-title":"J Clin Oncol"},{"key":"13_CR38","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1126\/science.7544491","volume":"269","author":"J. Feng","year":"1995","unstructured":"Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J et al. (1995) The RNA component of human telomerase. Science 269: 1236\u20131241","journal-title":"Science"},{"key":"13_CR39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.282.5388.493","volume":"282","author":"T.M. Nakamura","year":"1998","unstructured":"Nakamura TM, Cooper JP, Cech TR (1998) Two modes of survival of fission yeast without telomerase. Science 282: 493\u2013496","journal-title":"Science"},{"key":"13_CR40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1126\/science.279.5349.349","volume":"279","author":"A.G. Bodnar","year":"1998","unstructured":"Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349\u2013352","journal-title":"Science"},{"key":"13_CR41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0960-9822(98)70109-5","volume":"8","author":"H. Vaziri","year":"1998","unstructured":"Vaziri H, Benchimol S (1998) Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 8: 279\u2013282","journal-title":"Curr Biol"},{"key":"13_CR42","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1073\/pnas.96.7.3339","volume":"96","author":"A.J. Lustig","year":"1999","unstructured":"Lustig AJ (1999) Crisis intervention: the role of telomerase. Proc Natl Acad Sci USA 96: 3339\u20133341","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR43","doi-asserted-by":"publisher","first-page":"R617","DOI":"10.1016\/S0960-9822(99)80388-1","volume":"9","author":"S.E. Jacobsen","year":"1999","unstructured":"Jacobsen SE (1999) Gene silencing: Maintaining methylation patterns. Curr Biol 9: R617\u2013619","journal-title":"Curr Biol"},{"key":"13_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1101\/gad.947102","volume":"16","author":"A. Bird","year":"2002","unstructured":"Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16: 6\u201321","journal-title":"Genes Dev"},{"key":"13_CR45","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev.genet.30.1.441","volume":"30","author":"P.W. Laird","year":"1996","unstructured":"Laird PW, Jaenisch R (1996) The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet 30: 441\u2013464","journal-title":"Annu Rev Genet"},{"key":"13_CR46","first-page":"4855","volume":"54","author":"M.S. Greenblatt","year":"1994","unstructured":"Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855\u20134878","journal-title":"Cancer Res"},{"key":"13_CR47","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1128\/MCB.14.6.4225","volume":"14","author":"A.N. Magewu","year":"1994","unstructured":"Magewu AN, Jones PA (1994) Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hot spot in human cancer. Mol Cell Biol 14: 4225\u20134232","journal-title":"Mol Cell Biol"},{"key":"13_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrc1279","volume":"4","author":"A.P. Feinberg","year":"2004","unstructured":"Feinberg AP, Tycko B (2004) The history of cancer epigenetics. Nat Rev Cancer 4: 143\u2013153","journal-title":"Nat Rev Cancer"},{"key":"13_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/301089a0","volume":"301","author":"A.P. Feinberg","year":"1983","unstructured":"Feinberg AP, Vogelstein B (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89\u201392","journal-title":"Nature"},{"key":"13_CR50","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1101\/gad.1232504","volume":"18","author":"A.H. Lund","year":"2004","unstructured":"Lund AH, van Lohuizen M (2004) Epigenetics and cancer. Genes Dev 18: 2315\u20132335","journal-title":"Genes Dev"},{"key":"13_CR51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1568-1637(03)00010-2","volume":"2","author":"B. Richardson","year":"2003","unstructured":"Richardson B (2003) Impact of aging on DNA methylation. Ageing Res Rev 2: 245\u2013261","journal-title":"Ageing Res Rev"},{"key":"13_CR52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1126\/science.2579435","volume":"228","author":"S.E. Goelz","year":"1985","unstructured":"Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP (1985) Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228: 187\u2013190","journal-title":"Science"},{"key":"13_CR53","first-page":"1663","volume":"23","author":"Y. Oshimo","year":"2003","unstructured":"Oshimo Y, Nakayama H, Ito R, Kitadai Y, Yoshida K, Chayama K, Yasui W (2003) Promoter methylation of cyclin D2 gene in gastric carcinoma. Int J Oncol 23: 1663\u20131670","journal-title":"Int J Oncol"},{"key":"13_CR54","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/S0002-9440(10)63549-3","volume":"163","author":"Y. Akiyama","year":"2003","unstructured":"Akiyama Y, Maesawa C, Ogasawara S, Terashima M, Masuda T (2003) Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. Am J Pathol 163: 1911\u20131919","journal-title":"Am J Pathol"},{"key":"13_CR55","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood.V82.6.1820.1820","volume":"82","author":"M. Hanada","year":"1993","unstructured":"Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC (1993) bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82: 1820\u20131828","journal-title":"Blood"},{"key":"13_CR56","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/gcc.10092","volume":"35","author":"W.A. Schulz","year":"2002","unstructured":"Schulz WA, Elo JP, Florl AR, Pennanen S, Santourlidis S, Engers R, Buchardt M, Seifert HH, Visakorpi T (2002) Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Genes Chromosomes Cancer 35: 58\u201365","journal-title":"Genes Chromosomes Cancer"},{"key":"13_CR57","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0002-9440(10)64246-0","volume":"161","author":"H. Tsuda","year":"2002","unstructured":"Tsuda H, Takarabe T, Kanai Y, Fukutomi T, Hirohashi S (2002) Correlation of DNA hypomethylation at pericentromeric heterochromatin regions of chromosomes 16 and 1 with histological features and chromosomal abnormalities of human breast carcinomas. Am J Pathol 161: 859\u2013866","journal-title":"Am J Pathol"},{"key":"13_CR58","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.leu.2403218","volume":"18","author":"A. El-Osta","year":"2004","unstructured":"El-Osta A (2004) The rise and fall of genomic methylation in cancer. Leukemia 18: 233\u2013237","journal-title":"Leukemia"},{"key":"13_CR59","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/46214","volume":"402","author":"G.L. Xu","year":"1999","unstructured":"Xu GL, Bestor TH, Bourc\u2019his D, Hsieh CL, Tommerup N, Bugge M, Hulten M, Qu X, Russo JJ, Viegas-Pequignot E (1999) Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402: 187\u2013191","journal-title":"Nature"},{"key":"13_CR60","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0022-3476(88)80698-X","volume":"112","author":"N.J. Carpenter","year":"1988","unstructured":"Carpenter NJ, Filipovich A, Blaese RM, Carey TL, Berkel AI (1988) Variable immunodeficiency with abnormal condensation of the heterochromatin of chromosomes 1, 9, and 16. J Pediatr 112: 757\u2013760","journal-title":"J Pediatr"},{"key":"13_CR61","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/gcc.10110","volume":"35","author":"A. Yeh","year":"2002","unstructured":"Yeh A, Wei M, Golub SB, Yamashiro DJ, Murty VV, Tycko B (2002) Chromosome arm 16q in Wilms tumors: unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene. Genes Chromosomes Cancer 35: 156\u2013163","journal-title":"Genes Chromosomes Cancer"},{"key":"13_CR62","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0165-4608(98)00143-5","volume":"109","author":"G.Z. Qu","year":"1999","unstructured":"Qu GZ, Grundy PE, Narayan A, Ehrlich M (1999) Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. Cancer Genet Cytogenet 109: 34\u201339","journal-title":"Cancer Genet Cytogenet"},{"key":"13_CR63","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1126\/science.1083558","volume":"300","author":"F. Gaudet","year":"2003","unstructured":"Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R (2003) Induction of tumors in mice by genomic hypomethylation. Science 300: 489\u2013492","journal-title":"Science"},{"key":"13_CR64","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF00286709","volume":"83","author":"V. Greger","year":"1989","unstructured":"Greger V, Passarge E, Hopping W, Messmer E, Horsthemke B (1989) Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 83: 155\u2013158","journal-title":"Hum Genet"},{"key":"13_CR65","doi-asserted-by":"crossref","first-page":"9700","DOI":"10.1073\/pnas.91.21.9700","volume":"91","author":"J.G. Herman","year":"1994","unstructured":"Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM et al. (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700\u20139704","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR66","first-page":"4531","volume":"55","author":"M. Gonzalez-Zulueta","year":"1995","unstructured":"Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA (1995) Methylation of the 5\u2019 CpG island of the p16\/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55: 4531\u20134535","journal-title":"Cancer Res"},{"key":"13_CR67","first-page":"5195","volume":"55","author":"J.R. Graff","year":"1995","unstructured":"Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE, Baylin SB (1995) E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55: 5195\u20135199","journal-title":"Cancer Res"},{"key":"13_CR68","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/(SICI)1097-0215(19970317)70:6<644::AID-IJC3>3.0.CO;2-V","volume":"70","author":"M.O. Hiltunen","year":"1997","unstructured":"Hiltunen MO, Alhonen L, Koistinaho J, Myohanen S, Paakkonen M, Marin S, Kosma VM, Janne J (1997) Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer 70: 644\u2013648","journal-title":"Int J Cancer"},{"key":"13_CR69","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-230X(08)60702-2","volume":"72","author":"S.B. Baylin","year":"1998","unstructured":"Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72: 141\u2013196","journal-title":"Adv Cancer Res"},{"key":"13_CR70","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.1073\/pnas.95.9.5246","volume":"95","author":"Y.E. Whang","year":"1998","unstructured":"Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL (1998) Inactivation of the tumor suppressor PTEN\/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 95: 5246\u20135250","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR71","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0304-3835(02)00511-6","volume":"190","author":"K.P. Nephew","year":"2003","unstructured":"Nephew KP, Huang TH (2003) Epigenetic gene silencing in cancer initiation and progression. Cancer Lett 190: 125\u2013133","journal-title":"Cancer Lett"},{"key":"13_CR72","doi-asserted-by":"publisher","first-page":"6479","DOI":"10.1038\/sj.onc.1206774","volume":"22","author":"R.L. Momparler","year":"2003","unstructured":"Momparler RL (2003) Cancer epigenetics. Oncogene 22: 6479\u20136483","journal-title":"Oncogene"},{"key":"13_CR73","first-page":"3455","volume":"58","author":"J.M. Cunningham","year":"1998","unstructured":"Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, Thibodeau SN (1998) Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58: 3455\u20133460","journal-title":"Cancer Res"},{"key":"13_CR74","doi-asserted-by":"publisher","first-page":"8698","DOI":"10.1073\/pnas.95.15.8698","volume":"95","author":"M.L. Veigl","year":"1998","unstructured":"Veigl ML, Kasturi L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S, Li GM, Drummond J, Modrich PL, Sedwick WD et al. (1998) Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci USA 95: 8698\u20138702","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR75","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1023\/A:1025861527711","volume":"23","author":"W.M. Grady","year":"2004","unstructured":"Grady WM (2004) Genomic instability and colon cancer. Cancer Metastasis Rev 23: 11\u201327","journal-title":"Cancer Metastasis Rev"},{"key":"13_CR76","first-page":"2368","volume":"60","author":"M. Esteller","year":"2000","unstructured":"Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, Issa JP, Sidransky D, Baylin SB, Herman JG (2000) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 60: 2368\u20132371","journal-title":"Cancer Res"},{"key":"13_CR77","first-page":"6335","volume":"61","author":"M. Nakamura","year":"2001","unstructured":"Nakamura M, Sakaki T, Hashimoto H, Nakase H, Ishida E, Shimada K, Konishi N (2001) Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas. Cancer Res 61: 6335\u20136339","journal-title":"Cancer Res"},{"key":"13_CR78","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/72785","volume":"24","author":"J.F. Costello","year":"2000","unstructured":"Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC et al. (2000) Aberrant CpG-island methylation has non-random and specific-type-specific patterns. Nat Genet 24: 132\u2013138","journal-title":"Nat Genet"},{"key":"13_CR79","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0021-9258(17)35981-1","volume":"261","author":"T.L. Kautiainen","year":"1986","unstructured":"Kautiainen TL, Jones PA (1986) DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. J Biol Chem 261: 1594\u20131598","journal-title":"J Biol Chem"},{"key":"13_CR80","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/jnci\/85.15.1235","volume":"85","author":"J.P. Issa","year":"1993","unstructured":"Issa JP, Vertino PM, Wu J, Sazawal S, Celano P, Nelkin BD, Hamilton SR, Baylin SB (1993) Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 85: 1235\u20131240","journal-title":"J Natl Cancer Inst"},{"key":"13_CR81","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1101\/sqb.2000.65.81","volume":"65","author":"K. Bebenek","year":"2000","unstructured":"Bebenek K, Kunkel TA (2000) Streisinger revisited: DNA synthesis errors mediated by substrate misalignments. Cold Spring Harb Symp Quant Biol 65: 81\u201391","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"13_CR82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1040-8428(99)00019-0","volume":"32","author":"J.P. Issa","year":"1999","unstructured":"Issa JP (1999) Aging, DNA methylation and cancer. Crit Rev Oncol Hematol 32: 31\u201343","journal-title":"Crit Rev Oncol Hematol"},{"key":"13_CR83","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1074\/jbc.275.4.2727","volume":"275","author":"J.R. Graff","year":"2000","unstructured":"Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG (2000) Methylation patterns of the E-cadherin 5\u2019 CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 275: 2727\u20132732","journal-title":"J Biol Chem"},{"key":"13_CR84","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1073\/pnas.96.11.6107","volume":"96","author":"S. Ramchandani","year":"1999","unstructured":"Ramchandani S, Bhattacharya SK, Cervoni N, Szyf M (1999) DNA methylation is a reversible biological signal. Proc Natl Acad Sci USA 96: 6107\u20136112","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR85","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0092-8674(00)81532-9","volume":"99","author":"A.P. Bird","year":"1999","unstructured":"Bird AP, Wolffe AP (1999) Methylation-induced repression\u2014belts, braces, and chromatin. Cell 99: 451\u2013454","journal-title":"Cell"},{"key":"13_CR86","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/5047","volume":"21","author":"E.E. Cameron","year":"1999","unstructured":"Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21: 103\u2013107","journal-title":"Nat Genet"},{"key":"13_CR87","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1073\/pnas.98.2.392","volume":"98","author":"A.P. Feinberg","year":"2001","unstructured":"Feinberg AP (2001) Cancer epigenetics takes center stage. Proc Natl Acad Sci USA 98: 392\u2013394","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR88","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/362749a0","volume":"362","author":"O. Ogawa","year":"1993","unstructured":"Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms\u2019 tumor. Nature 362: 749\u2013751","journal-title":"Nature"},{"key":"13_CR89","first-page":"5723","volume":"56","author":"J.S. Thompson","year":"1996","unstructured":"Thompson JS, Reese KJ, DeBaun MR, Perlman EJ, Feinberg AP (1996) Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms\u2019 tumor. Cancer Res 56: 5723\u20135727","journal-title":"Cancer Res"},{"key":"13_CR90","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1073\/pnas.96.1.214","volume":"96","author":"Y. Yu","year":"1999","unstructured":"Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y, Cuevas B, Kuo WL, Gray JW, Siciliano M et al. (1999) NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci USA 96: 214\u2013219","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR91","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/3260","volume":"4","author":"H. Cui","year":"1998","unstructured":"Cui H, Horon IL, Ohlsson R, Hamilton SR, Feinberg AP (1998) Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 4: 1276\u20131280","journal-title":"Nat Med"},{"key":"13_CR92","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1006\/scbi.1999.0123","volume":"9","author":"J. Breivik","year":"1999","unstructured":"Breivik J, Gaudernack G (1999) Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis. Semin Cancer Biol 9: 245\u2013254","journal-title":"Semin Cancer Biol"},{"key":"13_CR93","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00001622-200101000-00013","volume":"13","author":"A. Lindblom","year":"2001","unstructured":"Lindblom A (2001) Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol 13: 63\u201369","journal-title":"Curr Opin Oncol"},{"key":"13_CR94","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.1073\/pnas.081082898","volume":"98","author":"A. Bardelli","year":"2001","unstructured":"Bardelli A, Cahill DP, Lederer G, Speicher MR, Kinzler KW, Vogelstein B, Lengauer C (2001) Carcinogen-specific induction of genetic instability. Proc Natl Acad Sci USA 98: 5770\u20135775","journal-title":"Proc Natl Acad Sci USA"},{"key":"13_CR95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrfmmm.2004.05.001","volume":"551","author":"A.R. Collins","year":"2004","unstructured":"Collins AR, Ferguson LR (2004) Nutrition and carcinogenesis. Mutat Res 551: 1\u20138","journal-title":"Mutat Res"},{"key":"13_CR96","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1053\/gast.1996.v110.pm8964404","volume":"110","author":"K. Kervinen","year":"1996","unstructured":"Kervinen K, Sodervik H, Makela J, Lehtola J, Niemi M, Kairaluoma MI, Kesaniemi YA (1996) Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology 110: 1785\u20131790","journal-title":"Gastroenterology"}],"container-title":["Experientia Supplementum","Cancer: Cell Structures, Carcinogens and Genomic Instability"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/3-7643-7378-4_13.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T06:42:51Z","timestamp":1627022571000},"score":25.16473,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/3-7643-7378-4_13"}},"issued":{"date-parts":[[null]]},"ISBN":["3764371560"],"references-count":96,"URL":"https:\/\/doi.org\/10.1007\/3-7643-7378-4_13"},{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T14:19:44Z","timestamp":1725459584087},"publisher-location":"Basel","reference-count":142,"publisher":"Birkh\u00e4user-Verlag","isbn-type":[{"type":"print","value":"3764371560"}],"content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1007\/3-7643-7378-4_9","type":"book-chapter","created":{"date-parts":[[2006,1,26]],"date-time":"2006-01-26T15:25:14Z","timestamp":1138289114000},"page":"201-221","source":"Crossref","is-referenced-by-count":0,"title":["Abnormalities of cell structures in tumors: apoptosis in tumors"],"prefix":"10.1007","author":[{"given":"Herman H.","family":"Cheung","sequence":"first","affiliation":[]},{"given":"Vinay","family":"Arora","sequence":"additional","affiliation":[]},{"given":"Robert G.","family":"Korneluk","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0022-1910(64)90034-4","volume":"10","author":"R.A. Lockshin","year":"1964","unstructured":"Lockshin RA, Williams CM (1964) Programmed cell death. II. Endocrine potentiation of the breakdown of the intersegmental muscles of silkmoths. J Insect Physiol 10: 643\u2013649","journal-title":"J Insect Physiol"},{"key":"9_CR2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"J.F. Kerr","year":"1972","unstructured":"Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239\u2013257","journal-title":"Br J Cancer"},{"key":"9_CR3","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1126\/science.7878464","volume":"267","author":"C.B. Thompson","year":"1995","unstructured":"Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456\u20131462","journal-title":"Science"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D. Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57\u201370","journal-title":"Cell"},{"key":"9_CR5","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0002-9440(10)65649-0","volume":"153","author":"Y. Soini","year":"1998","unstructured":"Soini Y, Paakko P, Lehto VP (1998) Histopathological evaluation of apoptosis in cancer. Am J Pathol 153: 1041\u20131053","journal-title":"Am J Pathol"},{"key":"9_CR6","doi-asserted-by":"crossref","first-page":"REVIEWS0003","DOI":"10.1186\/gb-2000-1-3-reviews0003","volume":"1","author":"JN Tittel","year":"2000","unstructured":"Tittel JN, Steller H (2000) A comparison of programmed cell death between species. Genome Biol 1: REVIEWS0003","journal-title":"Genome Biol"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1084\/jem.186.1.25","volume":"186","author":"S.A. Susin","year":"1997","unstructured":"Susin SA, Zamzami N, Castedo M, Daugas E, Wang HG, Geley S, Fassy F, Reed JC, Kroemer G (1997) The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas\/APO-1\/CD95-and ceramide-induced apoptosis. J Exp Med 186: 25\u201337","journal-title":"J Exp Med"},{"key":"9_CR8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0074-7696(08)62312-8","volume":"68","author":"A.H. Wyllie","year":"1980","unstructured":"Wyllie AH, Kerr JF, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68: 251\u2013306","journal-title":"Int Rev Cytol"},{"key":"9_CR9","first-page":"18","volume":"13","author":"N.I. Walker","year":"1988","unstructured":"Walker NI, Harmon BV, Gobe GC, Kerr JF (1988) Patterns of cell death. Methods Achiev Exp Pathol 13: 18\u201354","journal-title":"Methods Achiev Exp Pathol"},{"key":"9_CR10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0065-2776(08)60822-6","volume":"50","author":"J.J. Cohen","year":"1991","unstructured":"Cohen JJ (1991) Programmed cell death in the immune system. Adv Immunol 50: 55\u201385","journal-title":"Adv Immunol"},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00000478-199701000-00010","volume":"21","author":"M.C. Cummings","year":"1997","unstructured":"Cummings MC, Winterford CM, Walker NI (1997) Apoptosis. Am J Surg Pathol 21: 88\u2013101","journal-title":"Am J Surg Pathol"},{"key":"9_CR12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00174615","volume":"181","author":"P.G. Clarke","year":"1990","unstructured":"Clarke PG (1990) Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl) 181: 195\u2013213","journal-title":"Anat Embryol (Berl)"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/284555a0","volume":"284","author":"A.H. Wyllie","year":"1980","unstructured":"Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555\u2013556","journal-title":"Nature"},{"key":"9_CR14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1383-5742(02)00110-2","volume":"543","author":"S. Huettenbrenner","year":"2003","unstructured":"Huettenbrenner S, Maier S, Leisser C, Polgar D, Strasser S, Grusch M, Krupitza G (2003) The evolution of cell death programs as prerequisites of multicellularity. Mutat Res 543: 235\u2013249","journal-title":"Mutat Res"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1126\/science.281.5381.1312","volume":"281","author":"N.A. Thornberry","year":"1998","unstructured":"Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312\u20131316","journal-title":"Science"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1046\/j.1365-2141.2003.04663.x","volume":"123","author":"H.J. Brady","year":"2003","unstructured":"Brady HJ (2003) Apoptosis and leukaemia. Br J Haematol 123: 577\u2013585","journal-title":"Br J Haematol"},{"key":"9_CR17","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1074\/jbc.272.15.9677","volume":"272","author":"R.V. Talanian","year":"1997","unstructured":"Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D, Ghayur T, Brady KD, Wong WW (1997) Substrate specificities of caspase family proteases. J Biol Chem 272: 9677\u20139682","journal-title":"J Biol Chem"},{"key":"9_CR18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/oxfordjournals.bmb.a011625","volume":"53","author":"N.A. Thornberry","year":"1997","unstructured":"Thornberry NA (1997) The caspase family of cysteine proteases. Br Med Bull 53: 478\u2013490","journal-title":"Br Med Bull"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev.biochem.69.1.217","volume":"69","author":"A. Strasser","year":"2000","unstructured":"Strasser A, O\u2019Connor L, Dixit VM (2000) Apoptosis signaling. Annu Rev Biochem 69: 217\u2013245","journal-title":"Annu Rev Biochem"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.semcancer.2004.04.002","volume":"14","author":"B. Nachmias","year":"2004","unstructured":"Nachmias B, Ashhab Y, Ben-Yehuda D (2004) The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol 14: 231\u2013243","journal-title":"Semin Cancer Biol"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1126\/science.1099320","volume":"305","author":"D.R. Green","year":"2004","unstructured":"Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305: 626\u2013629","journal-title":"Science"},{"key":"9_CR22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/35004029","volume":"2","author":"J.C. Goldstein","year":"2000","unstructured":"Goldstein JC, Waterhouse NJ, Juin P, Evan GI, Green DR (2000) The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol 2: 156\u2013162","journal-title":"Nat Cell Biol"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1074\/jbc.275.9.6067","volume":"275","author":"K. Cain","year":"2000","unstructured":"Cain K, Bratton SB, Langlais C, Walker G, Brown DG, Sun XM, Cohen GM (2000) Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes. J Biol Chem 275: 6067\u20136070","journal-title":"J Biol Chem"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1038\/sj.onc.1207523","volume":"23","author":"X. Saelens","year":"2004","unstructured":"Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, Vandenabeele P (2004) Toxic proteins released from mitochondria in cell death. Oncogene 23: 2861\u20132874","journal-title":"Oncogene"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1126\/science.1081208","volume":"300","author":"L. Scorrano","year":"2003","unstructured":"Scorrano L, Oakes SA, Opferman JT, Cheng EH, Sorcinelli MD, Pozzan T, Korsmeyer SJ (2003) BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 300: 135\u2013139","journal-title":"Science"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1083\/jcb.150.4.887","volume":"150","author":"T. Nakagawa","year":"2000","unstructured":"Nakagawa T, Yuan J (2000) Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 150: 887\u2013894","journal-title":"J Cell Biol"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"34287","DOI":"10.1074\/jbc.M204973200","volume":"277","author":"N. Morishima","year":"2002","unstructured":"Morishima N, Nakanishi K, Takenouchi H, Shibata T, Yasuhiko Y (2002) An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem 277: 34287\u201334294","journal-title":"J Biol Chem"},{"key":"9_CR28","doi-asserted-by":"crossref","first-page":"33869","DOI":"10.1074\/jbc.M102225200","volume":"276","author":"R.V. Rao","year":"2001","unstructured":"Rao RV, Hermel E, Castro-Obregon S, del Rio G, Ellerby LM, Ellerby HM, Bredesen DE (2001) Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J Biol Chem 276: 33869\u201333874","journal-title":"J Biol Chem"},{"key":"9_CR29","doi-asserted-by":"crossref","first-page":"21836","DOI":"10.1074\/jbc.M202726200","volume":"277","author":"R.V. Rao","year":"2002","unstructured":"Rao RV, Castro-Obregon S, Frankowski H, Schuler M, Stoka V, del Rio G, Bredesen DE, Ellerby HM (2002) Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J Biol Chem 277: 21836\u201321842","journal-title":"J Biol Chem"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1083\/jcb.200302084","volume":"162","author":"W.X. Zong","year":"2003","unstructured":"Zong WX, Li C, Hatzivassiliou G, Lindsten T, Yu QC, Yuan J, Thompson CB (2003) Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J Cell Biol 162: 59\u201369","journal-title":"J Cell Biol"},{"key":"9_CR31","doi-asserted-by":"crossref","first-page":"10932","DOI":"10.1016\/S0021-9258(18)82075-0","volume":"268","author":"N. Itoh","year":"1993","unstructured":"Itoh N, Nagata S (1993) A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 268: 10932\u201310937","journal-title":"J Biol Chem"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/0092-8674(93)90464-2","volume":"74","author":"L.A. Tartaglia","year":"1993","unstructured":"Tartaglia LA, Ayres TM, Wong GH, Goeddel DV (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845\u2013853","journal-title":"Cell"},{"key":"9_CR33","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1074\/jbc.270.14.7795","volume":"270","author":"M.P. Boldin","year":"1995","unstructured":"Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D (1995) A novel protein that interacts with the death domain of Fas\/APO1 contains a sequence motif related to the death domain. J Biol Chem 270: 7795\u20137798","journal-title":"J Biol Chem"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0092-8674(95)90071-3","volume":"81","author":"A.M. Chinnaiyan","year":"1995","unstructured":"Chinnaiyan AM, ORourke K, Tewari M, Dixit VM (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505\u2013512","journal-title":"Cell"},{"key":"9_CR35","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1002\/j.1460-2075.1995.tb00245.x","volume":"14","author":"F.C. Kischkel","year":"1995","unstructured":"Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas\/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14: 5579\u20135588","journal-title":"EMBO J"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0092-8674(00)81265-9","volume":"85","author":"M.P. Boldin","year":"1996","unstructured":"Boldin MP, Goncharov TM, Goltsev YV, Wallach D (1996) Involvement of MACH, a novel MORT1\/FADD-interacting protease, in Fas\/APO-1-and TNF receptor-induced cell death. Cell 85: 803\u2013815","journal-title":"Cell"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0092-8674(00)81266-0","volume":"85","author":"M. Muzio","year":"1996","unstructured":"Muzio M, Chinnaiyan AM, Kischkel FC, O\u2019Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R et al. (1996) FLICE, a novel FADD-homologous ICE\/CED-3-like protease, is recruited to the CD95 (Fas\/APO-1) death-inducing signaling complex. Cell 85: 817\u2013827","journal-title":"Cell"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1074\/jbc.273.5.2926","volume":"273","author":"M. Muzio","year":"1998","unstructured":"Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM (1998) An induced proximity model for caspase-8 activation. J Biol Chem 273: 2926\u20132930","journal-title":"J Biol Chem"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"27084","DOI":"10.1074\/jbc.273.42.27084","volume":"273","author":"H.R. Stennicke","year":"1998","unstructured":"Stennicke HR, Jurgensmeier JM, Shin H, Deveraux Q, Wolf BB, Yang X, Zhou Q, Ellerby HM, Ellerby LM, Bredesen D et al. (1998) Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 273: 27084\u201327090","journal-title":"J Biol Chem"},{"key":"9_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev.immunol.21.120601.141029","volume":"21","author":"V.S. Marsden","year":"2003","unstructured":"Marsden VS, Strasser A (2003) Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol 21: 71\u2013105","journal-title":"Annu Rev Immunol"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1023\/A:1011379307472","volume":"6","author":"M. Holcik","year":"2001","unstructured":"Holcik M, Gibson H, Korneluk RG (2001) XIAP: apoptotic brake and promising therapeutic target. Apoptosis 6: 253\u2013261","journal-title":"Apoptosis"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"8568","DOI":"10.1038\/sj.onc.1207101","volume":"22","author":"P. Liston","year":"2003","unstructured":"Liston P, Fong WG, Korneluk RG (2003) The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22: 8568\u20138580","journal-title":"Oncogene"},{"key":"9_CR43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/40901","volume":"388","author":"Q.L. Deveraux","year":"1997","unstructured":"Deveraux QL, Takahashi R, Salvesen GS, Reed JC (1997) X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388: 300\u2013304","journal-title":"Nature"},{"key":"9_CR44","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.1074\/jbc.273.14.7787","volume":"273","author":"R. Takahashi","year":"1998","unstructured":"Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, Salvesen GS, Reed JC (1998) A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 273: 7787\u20137790","journal-title":"J Biol Chem"},{"key":"9_CR45","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S1097-2765(01)00347-1","volume":"8","author":"C.M. Pickart","year":"2001","unstructured":"Pickart CM (2001) Ubiquitin enters the new millennium. Mol Cell 8: 499\u2013504","journal-title":"Mol Cell"},{"key":"9_CR46","doi-asserted-by":"crossref","first-page":"26661","DOI":"10.1016\/S0021-9258(19)61427-4","volume":"275","author":"H. Huang","year":"2000","unstructured":"Huang H, Joazeiro CA, Bonfoco E, Kamada S, Leverson JD, Hunter T (2000) The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J Biol Chem 275: 26661\u201326664","journal-title":"J Biol Chem"},{"key":"9_CR47","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.1073\/pnas.161506698","volume":"98","author":"Y. Suzuki","year":"2001","unstructured":"Suzuki Y, Nakabayashi Y, Takahashi R (2001) Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc Natl Acad Sci USA 98: 8662\u20138667","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR48","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrm830","volume":"3","author":"G.S. Salvesen","year":"2002","unstructured":"Salvesen GS, Duckett CS (2002) IAP proteins: blocking the road to death\u2019s door. Nat Rev Mol Cell Biol 3: 401\u2013410","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9_CR49","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/35055027","volume":"3","author":"P. Liston","year":"2001","unstructured":"Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW, Korneluk RG (2001) Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat Cell Biol 3: 128\u2013133","journal-title":"Nat Cell Biol"},{"key":"9_CR50","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1038\/sj.onc.1207519","volume":"23","author":"C.W. Distelhorst","year":"2004","unstructured":"Distelhorst CW, Shore GC (2004) Bcl-2 and calcium: controversy beneath the surface. Oncogene 23: 2875\u20132880","journal-title":"Oncogene"},{"key":"9_CR51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbamcr.2003.10.011","volume":"1644","author":"N.M. Droin","year":"2004","unstructured":"Droin NM, Green DR (2004) Role of Bcl-2 family members in immunity and disease. Biochim Biophys Acta 1644: 179\u2013188","journal-title":"Biochim Biophys Acta"},{"key":"9_CR52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbamcr.2003.08.009","volume":"1644","author":"V. Kirkin","year":"2004","unstructured":"Kirkin V, Joos S, Zornig M (2004) The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 1644: 229\u2013249","journal-title":"Biochim Biophys Acta"},{"key":"9_CR53","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1126\/science.290.5497.1761","volume":"290","author":"J. Zha","year":"2000","unstructured":"Zha J, Weiler S, Oh KJ, Wei MC, Korsmeyer SJ (2000) Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 290: 1761\u20131765","journal-title":"Science"},{"key":"9_CR54","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1101\/gad.14.16.2060","volume":"14","author":"M.C. Wei","year":"2000","unstructured":"Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB, Korsmeyer SJ (2000) tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev 14: 2060\u20132071","journal-title":"Genes Dev"},{"key":"9_CR55","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1128\/MCB.20.3.929-935.2000","volume":"20","author":"R. Eskes","year":"2000","unstructured":"Eskes R, Desagher S, Antonsson B, Martinou JC (2000) Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 20: 929\u2013935","journal-title":"Mol Cell Biol"},{"key":"9_CR56","doi-asserted-by":"publisher","first-page":"16589","DOI":"10.1074\/jbc.273.26.16589","volume":"273","author":"T. Kuwana","year":"1998","unstructured":"Kuwana T, Smith JJ, Muzio M, Dixit V, Newmeyer DD, Kornbluth S (1998) Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J Biol Chem 273: 16589\u201316594","journal-title":"J Biol Chem"},{"key":"9_CR57","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","volume":"94","author":"H. Li","year":"1998","unstructured":"Li H., Zhu H, Xu CJ, Yuan J (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491\u2013501","journal-title":"Cell"},{"key":"9_CR58","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0092-8674(00)81589-5","volume":"94","author":"X. Luo","year":"1998","unstructured":"Luo X, Budihardjo I, Zou H, Slaughter C, Wang X (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481\u2013490","journal-title":"Cell"},{"key":"9_CR59","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0161-5890(02)00252-3","volume":"39","author":"C. Borner","year":"2003","unstructured":"Borner C (2003) The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 39: 615\u2013647","journal-title":"Mol Immunol"},{"key":"9_CR60","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1093\/emboj\/20.11.2690","volume":"20","author":"P. Pinton","year":"2001","unstructured":"Pinton P, Ferrari D, Rapizzi E, Di Virgilio F, Pozzan T, Rizzuto R (2001) The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. EMBO J 20: 2690\u20132701","journal-title":"EMBO J"},{"key":"9_CR61","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1471-4159.2003.01590.x","volume":"84","author":"F. Darios","year":"2003","unstructured":"Darios F, Lambeng N, Troadec JD, Michel PP, Ruberg M (2003) Ceramide increases mitochondrial free calcium levels via caspase 8 and Bid: role in initiation of cell death. J Neurochem 84: 643\u2013654","journal-title":"J Neurochem"},{"key":"9_CR62","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/ncb1063","volume":"5","author":"D. Boehning","year":"2003","unstructured":"Boehning D, Patterson RL, Sedaghat L, Glebova NO, Kurosaki T, Snyder SH (2003) Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol 5: 1051\u20131061","journal-title":"Nat Cell Biol"},{"key":"9_CR63","doi-asserted-by":"publisher","first-page":"10872","DOI":"10.1073\/pnas.190210897","volume":"97","author":"Y. Ionov","year":"2000","unstructured":"Ionov Y, Yamamoto H, Krajewski S, Reed JC, Perucho M (2000) Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. Proc Natl Acad Sci USA 97: 10872\u201310877","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1535-6108(02)00241-6","volume":"3","author":"J.C. Reed","year":"2003","unstructured":"Reed JC (2003) Apoptosis-targeted therapies for cancer. Cancer Cell 3: 17\u201322","journal-title":"Cancer Cell"},{"key":"9_CR65","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1136\/bmj.322.7301.1538","volume":"322","author":"J. Sjostrom","year":"2001","unstructured":"Sjostrom J, Bergh J (2001) How apoptosis is regulated, and what goes wrong in cancer. BMJ 322: 1538\u20131539","journal-title":"BMJ"},{"key":"9_CR66","first-page":"6788","volume":"60","author":"A. Sigal","year":"2000","unstructured":"Sigal A, Rotter V (2000) Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res 60: 6788\u20136793","journal-title":"Cancer Res"},{"key":"9_CR67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/79152","volume":"26","author":"G.S. Jimenez","year":"2000","unstructured":"Jimenez GS, Nister M, Stommel JM, Beeche M, Barcarse EA, Zhang XQ, O\u2019Gorman S, Wahl GM (2000) A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nat Genet 26: 37\u201343","journal-title":"Nat Genet"},{"key":"9_CR68","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/0092-8674(92)90421-8","volume":"70","author":"B. Vogelstein","year":"1992","unstructured":"Vogelstein B, Kinzler KW (1992) p53 function and dysfunction. Cell 70: 523\u2013526","journal-title":"Cell"},{"key":"9_CR69","first-page":"912","volume":"3","author":"S. Haupt","year":"2004","unstructured":"Haupt S, Haupt Y (2004) Improving Cancer Therapy Through p53 Management. Cell Cycle 3: 912\u2013916","journal-title":"Cell Cycle"},{"key":"9_CR70","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1038\/sj.onc.1207516","volume":"23","author":"E.A. Slee","year":"2004","unstructured":"Slee EA, O\u2019Connor DJ, Lu X (2004) To die or not to die: how does p53 decide? Oncogene 23: 2809\u20132818","journal-title":"Oncogene"},{"key":"9_CR71","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/387296a0","volume":"387","author":"Y. Haupt","year":"1997","unstructured":"Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296\u2013299","journal-title":"Nature"},{"key":"9_CR72","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/sj.onc.1201459","volume":"15","author":"C.A. Midgley","year":"1997","unstructured":"Midgley CA, Lane DP (1997) p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene 15: 1179\u20131189","journal-title":"Oncogene"},{"key":"9_CR73","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1006\/jmbi.1999.3387","volume":"295","author":"T. Buschmann","year":"2000","unstructured":"Buschmann T, Minamoto T, Wagle N, Fuchs SY, Adler V, Mai M, Ronai Z (2000) Analysis of JNK, Mdm2 and p14(ARF) contribution to the regulation of mutant p53 stability. J Mol Biol 295: 1009\u201310021","journal-title":"J Mol Biol"},{"key":"9_CR74","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.1038\/sj.onc.1203130","volume":"18","author":"R.V. Sionov","year":"1999","unstructured":"Sionov RV, Haupt Y (1999) The cellular response to p53: the decision between life and death. Oncogene 18: 6145\u20136157","journal-title":"Oncogene"},{"key":"9_CR75","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/377646a0","volume":"377","author":"L. Buckbinder","year":"1995","unstructured":"Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646\u2013649","journal-title":"Nature"},{"key":"9_CR76","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/nm0596-574","volume":"2","author":"C. Friesen","year":"1996","unstructured":"Friesen C, Herr I, Krammer PH, Debatin KM (1996) Involvement of the CD95 (APO-1\/FAS) receptor\/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2: 574\u2013577","journal-title":"Nat Med"},{"key":"9_CR77","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.284.5411.156","volume":"284","author":"M.S. Soengas","year":"1999","unstructured":"Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW, Lowe SW (1999) Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284: 156\u2013159","journal-title":"Science"},{"key":"9_CR78","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/385637a0","volume":"385","author":"C. Yin","year":"1997","unstructured":"Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T (1997) Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385: 637\u2013640","journal-title":"Nature"},{"key":"9_CR79","doi-asserted-by":"publisher","first-page":"6728","DOI":"10.1128\/MCB.24.15.6728-6741.2004","volume":"24","author":"S. Erster","year":"2004","unstructured":"Erster S, Mihara M, Kim RH, Petrenko O, Moll UM (2004) In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol 24: 6728\u20136741","journal-title":"Mol Cell Biol"},{"key":"9_CR80","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/ncb1123","volume":"6","author":"J.I. Leu","year":"2004","unstructured":"Leu JI, Dumont P, Hafey M, Murphy ME, George DL (2004) Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 6: 443\u2013450","journal-title":"Nat Cell Biol"},{"key":"9_CR81","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.275.5302.967","volume":"275","author":"N. Rampino","year":"1997","unstructured":"Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M (1997) Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275: 967\u2013969","journal-title":"Science"},{"key":"9_CR82","first-page":"4328","volume":"60","author":"S. Kondo","year":"2000","unstructured":"Kondo S, Shinomura Y, Miyazaki Y, Kiyohara T, Tsutsui S, Kitamura S, Nagasawa Y, Nakahara M, Kanayama S, Matsuzawa Y (2000) Mutations of the bak gene in human gastric and colorectal cancers. Cancer Res 60: 4328\u20134330","journal-title":"Cancer Res"},{"key":"9_CR83","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.cdd.4401193","volume":"10","author":"A. Mrozek","year":"2003","unstructured":"Mrozek A, Petrowsky H, Sturm I, Kraus J, Hermann S, Hauptmann S, Lorenz M, Dorken B, Daniel PT (2003) Combined p53\/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability. Cell Death Differ 10: 461\u2013467","journal-title":"Cell Death Differ"},{"key":"9_CR84","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","volume":"108","author":"R.W. Johnstone","year":"2002","unstructured":"Johnstone RW, Ruefli AA, Lowe SW (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell 108: 153\u2013164","journal-title":"Cell"},{"key":"9_CR85","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1200\/JCO.1999.17.9.2941","volume":"17","author":"J.C. Reed","year":"1999","unstructured":"Reed JC (1999) Dysregulation of apoptosis in cancer. J Clin Oncol 17: 2941\u20132953","journal-title":"J Clin Oncol"},{"key":"9_CR86","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","volume":"13","author":"S.R. Datta","year":"1999","unstructured":"Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev 13: 2905\u20132927","journal-title":"Genes Dev"},{"key":"9_CR87","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","volume":"91","author":"S.R. Datta","year":"1997","unstructured":"Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231\u2013241","journal-title":"Cell"},{"key":"9_CR88","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1126\/science.278.5338.687","volume":"278","author":"L. Peso del","year":"1997","unstructured":"del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278: 687\u2013689","journal-title":"Science"},{"key":"9_CR89","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ijc.2910640412","volume":"64","author":"A. Bellacosa","year":"1995","unstructured":"Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V et al. (1995) Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 64: 280\u2013285","journal-title":"Int J Cancer"},{"key":"9_CR90","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1073\/pnas.93.8.3636","volume":"93","author":"J.Q. Cheng","year":"1996","unstructured":"Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK, Testa JR (1996) Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sci USA 93: 3636\u20133641","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR91","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1074\/jbc.M108302200","volume":"277","author":"L.D. Mayo","year":"2002","unstructured":"Mayo LD, Dixon JE, Durden DL, Tonks NK, Donner DB (2002) PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J Biol Chem 277: 5484\u20135489","journal-title":"J Biol Chem"},{"key":"9_CR92","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature02369","volume":"428","author":"H.G. Wendel","year":"2004","unstructured":"Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J, Lowe SW (2004) Survival signaling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428: 332\u2013337","journal-title":"Nature"},{"key":"9_CR93","doi-asserted-by":"publisher","first-page":"8983","DOI":"10.1038\/sj.onc.1207115","volume":"22","author":"T.F. Franke","year":"2003","unstructured":"Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C (2003) PI3K\/Akt and apoptosis: size matters. Oncogene 22: 8983\u20138998","journal-title":"Oncogene"},{"key":"9_CR94","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00001622-199701000-00013","volume":"9","author":"W.S. el-Deiry","year":"1997","unstructured":"el-Deiry WS (1997) Role of oncogenes in resistance and killing by cancer therapeutic agents. Curr Opin Oncol 9: 79\u201387","journal-title":"Curr Opin Oncol"},{"key":"9_CR95","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1046\/j.1432-1327.2001.01936.x","volume":"268","author":"D. Roymans","year":"2001","unstructured":"Roymans D, Slegers H (2001) Phosphatidylinositol 3-kinases in tumor progression. Eur J Biochem 268: 487\u2013498","journal-title":"Eur J Biochem"},{"key":"9_CR96","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0092-8674(00)80674-1","volume":"100","author":"A. Cristofano Di","year":"2000","unstructured":"Di Cristofano A, Pandolfi PP (2000) The multiple roles of PTEN in tumor suppression. Cell 100: 387\u2013390","journal-title":"Cell"},{"key":"9_CR97","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","volume":"30","author":"J.A. Fresno Vara","year":"2004","unstructured":"Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonzalez-Baron M (2004) PI3K\/Akt signaling pathway and cancer. Cancer Treat Rev 30: 193\u2013204","journal-title":"Cancer Treat Rev"},{"key":"9_CR98","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/excr.2000.5130","volume":"264","author":"L. Simpson","year":"2001","unstructured":"Simpson L, Parsons R (2001) PTEN: life as a tumor suppressor. Exp Cell Res 264: 29\u201341","journal-title":"Exp Cell Res"},{"key":"9_CR99","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.4049\/jimmunol.164.6.3229","volume":"164","author":"D. Rosen","year":"2000","unstructured":"Rosen D, Li JH, Keidar S, Markon I, Orda R, Berke G (2000) Tumor immunity in perforin-deficient mice: a role for CD95 (Fas\/APO-1). J Immunol 164: 3229\u20133235","journal-title":"J Immunol"},{"key":"9_CR100","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/83416","volume":"7","author":"K. Takeda","year":"2001","unstructured":"Takeda K, Hayakawa Y, Smyth MJ, Kayagaki N, Yamaguchi N, Kakuta S, Iwakura Y, Yagita H, Okumura K (2001) Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 7: 94\u2013100","journal-title":"Nat Med"},{"key":"9_CR101","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s001090000112","volume":"78","author":"M. Muschen","year":"2000","unstructured":"Muschen M, Warskulat U, Beckmann MW (2000) Defining CD95 as a tumor suppressor gene. J Mol Med 78: 312\u2013325","journal-title":"J Mol Med"},{"key":"9_CR102","first-page":"4942","volume":"61","author":"M.S. Shin","year":"2001","unstructured":"Shin MS, Kim HS, Lee SH, Park WS, Kim SY, Park JY, Lee JH, Lee SK, Lee SN, Jung SS et al. (2001) Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers. Cancer Res 61: 4942\u20134946","journal-title":"Cancer Res"},{"key":"9_CR103","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/75007","volume":"6","author":"T. Teitz","year":"2000","unstructured":"Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM, Kidd VJ (2000) Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6: 529\u2013535","journal-title":"Nat Med"},{"key":"9_CR104","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood.V94.5.1727","volume":"94","author":"C.G. Tepper","year":"1999","unstructured":"Tepper CG, Seldin MF (1999) Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt\u2019s lymphoma. Blood 94: 1727\u20131737","journal-title":"Blood"},{"key":"9_CR105","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/35051606","volume":"409","author":"M.S. Soengas","year":"2001","unstructured":"Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA et al. (2001) Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409: 207\u2013211","journal-title":"Nature"},{"key":"9_CR106","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.bjc.6602092","volume":"91","author":"D.L. Dai","year":"2004","unstructured":"Dai DL, Martinka M, Bush JA, Li G (2004) Reduced Apaf-1 expression in human cutaneous melanomas. Br J Cancer 91: 1089\u20131095","journal-title":"Br J Cancer"},{"key":"9_CR107","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jcp.10256","volume":"196","author":"P. Hersey","year":"2003","unstructured":"Hersey P, Zhang XD (2003) Overcoming resistance of cancer cells to apoptosis. J Cell Physiol 196: 9\u201318","journal-title":"J Cell Physiol"},{"key":"9_CR108","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ijc.10776","volume":"103","author":"V. Bilim","year":"2003","unstructured":"Bilim V, Kasahara T, Hara N, Takahashi K, Tomita Y (2003) Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro. Int J Cancer 103: 29\u201337","journal-title":"Int J Cancer"},{"key":"9_CR109","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1006\/geno.2000.6364","volume":"70","author":"W.G. Fong","year":"2000","unstructured":"Fong WG, Liston P, Rajcan-Separovic E, St Jean M, Craig C, Korneluk RG (2000) Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 70: 113\u2013122","journal-title":"Genomics"},{"key":"9_CR110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/73432","volume":"24","author":"D.T. Ross","year":"2000","unstructured":"Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M et al. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24: 227\u2013235","journal-title":"Nat Genet"},{"key":"9_CR111","first-page":"1796","volume":"6","author":"I. Tamm","year":"2000","unstructured":"Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A et al. (2000) Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6: 1796\u20131803","journal-title":"Clin Cancer Res"},{"key":"9_CR112","first-page":"831","volume":"63","author":"L. Yang","year":"2003","unstructured":"Yang L, Mashima T, Sato S, Mochizuki M, Sakamoto H, Yamori T, Oh-Hara T, Tsuruo T (2003) Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Cancer Res 63: 831\u2013837","journal-title":"Cancer Res"},{"key":"9_CR113","first-page":"2100","volume":"8","author":"M. Parton","year":"2002","unstructured":"Parton M, Krajewski S, Smith I, Krajewska M, Archer C, Naito M, Ahern R, Reed J, Dowsett M (2002) Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy. Clin Cancer Res 8: 2100\u20132108","journal-title":"Clin Cancer Res"},{"key":"9_CR114","first-page":"6815","volume":"63","author":"L. Yang","year":"2003","unstructured":"Yang L, Cao Z, Yan H, Wood WC (2003) Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 63: 6815\u20136824","journal-title":"Cancer Res"},{"key":"9_CR115","first-page":"5659","volume":"60","author":"H. Sasaki","year":"2000","unstructured":"Sasaki H, Sheng Y, Kotsuji F, Tsang BK (2000) Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res 60: 5659\u20135666","journal-title":"Cancer Res"},{"key":"9_CR116","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1535-6108(03)00332-5","volume":"5","author":"A.D. Schimmer","year":"2004","unstructured":"Schimmer AD, Welsh K, Pinilla C, Wang Z, Krajewska M, Bonneau MJ, Pedersen IM, Kitada S, Scott FL, Bailly-Maitre B et al. (2004) Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. Cancer Cell 5: 25\u201335","journal-title":"Cancer Cell"},{"key":"9_CR117","first-page":"25","volume":"12","author":"H. Okano","year":"2003","unstructured":"Okano H, Shiraki K, Inoue H, Kawakita T, Saitou Y, Enokimura N, Yamamoto N, Sugimoto K, Fujikawa K, Murata K et al. (2003) Over-expression of Smac promotes TRAIL-induced cell death in human hepatocellular carcinoma. Int J Mol Med 12: 25\u201328","journal-title":"Int J Mol Med"},{"key":"9_CR118","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1034\/j.1600-0463.2003.t01-1-1110202.x","volume":"111","author":"N.J. Yoo","year":"2003","unstructured":"Yoo NJ, Kim HS, Kim SY, Park WS, Park CH, Jeon HM, Jung ES, Lee JY, Lee SH (2003) Immunohistochemical analysis of Smac\/DIABLO expression in human carcinomas and sarcomas. APMIS 111: 382\u2013388","journal-title":"APMIS"},{"key":"9_CR119","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0014-4827(03)00073-9","volume":"286","author":"I.A. McNeish","year":"2003","unstructured":"McNeish IA, Bell S, McKay T, Tenev T, Marani M, Lemoine NR (2003) Expression of Smac\/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway. Exp Cell Res 286: 186\u2013198","journal-title":"Exp Cell Res"},{"key":"9_CR120","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm735","volume":"8","author":"S. Fulda","year":"2002","unstructured":"Fulda S, Wick W, Weller M, Debatin KM (2002) Smac agonists sensitize for Apo2L\/TRAIL-or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8: 808\u2013815","journal-title":"Nat Med"},{"key":"9_CR121","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1101\/gad.1097903","volume":"17","author":"Q.H. Yang","year":"2003","unstructured":"Yang QH, Church-Hajduk R, Ren J, Newton ML, Du C (2003) Omi\/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev 17: 1487\u20131496","journal-title":"Genes Dev"},{"key":"9_CR122","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.drup.2004.01.003","volume":"7","author":"R. Ravi","year":"2004","unstructured":"Ravi R, Bedi A (2004) NF-kappaB in cancer \u2014 a friend turned foe. Drug Resist Update 7: 53\u201367","journal-title":"Drug Resist Update"},{"key":"9_CR123","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.bcp.2004.04.026","volume":"68","author":"S. Shishodia","year":"2004","unstructured":"Shishodia S, Aggarwal BB (2004) Nuclear factor-kappaB: a friend or a foe in cancer? Biochem Pharmacol 68: 1071\u20131080","journal-title":"Biochem Pharmacol"},{"key":"9_CR124","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI11991","volume":"107","author":"A.S. Baldwin","year":"2001","unstructured":"Baldwin AS (2001) Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107: 241\u2013246","journal-title":"J Clin Invest"},{"key":"9_CR125","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.RES.88.3.262","volume":"88","author":"R. Lee","year":"2001","unstructured":"Lee R, Collins T (2001) Nuclear factor-kappaB and cell survival: IAPs call for support. Circ Res 88: 262\u2013264","journal-title":"Circ Res"},{"key":"9_CR126","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1535-6108(03)00170-3","volume":"4","author":"J.C. Bell","year":"2003","unstructured":"Bell JC, Lichty B, Stojdl D (2003) Getting oncolytic virus therapies off the ground. Cancer Cell 4: 7\u201311","journal-title":"Cancer Cell"},{"key":"9_CR127","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1126\/science.1102974","volume":"305","author":"C. Denicourt","year":"2004","unstructured":"Denicourt C, Dowdy SF (2004) MEDICINE: Targeting Apoptotic Pathways in Cancer Cells. Science 305: 1411\u20131413","journal-title":"Science"},{"key":"9_CR128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.drup.2004.03.002","volume":"7","author":"S. Shankar","year":"2004","unstructured":"Shankar S, Srivastava RK (2004) Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications. Drug Resist Update 7: 139\u2013156","journal-title":"Drug Resist Update"},{"key":"9_CR129","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.2174\/1381612043384402","volume":"10","author":"R. Wetzker","year":"2004","unstructured":"Wetzker R, Rommel C (2004) Phosphoinositide 3-kinases as targets for therapeutic intervention. Curr Pharm Des 10: 1915\u20131922","journal-title":"Curr Pharm Des"},{"key":"9_CR130","first-page":"S69","volume":"54","author":"H.Q. Xiong","year":"2004","unstructured":"Xiong HQ (2004) Molecular targeting therapy for pancreatic cancer. Cancer Chemother Pharmacol 54: S69\u2013S77","journal-title":"Cancer Chemother Pharmacol"},{"key":"9_CR131","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nm0298-232","volume":"4","author":"B. Jansen","year":"1998","unstructured":"Jansen B, Schlagbauer-Wadl H, Brown BD, Bryan RN, van Elsas A, Muller M, Wolff K, Eichler HG, Pehamberger H (1998) bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nat Med 4: 232\u2013234","journal-title":"Nat Med"},{"key":"9_CR132","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s001090100251","volume":"79","author":"V. Wacheck","year":"2001","unstructured":"Wacheck V, Heere-Ress E, Halaschek-Wiener J, Lucas T, Meyer H, Eichler HG, Jansen B (2001) Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xeno-transplantation model. J Mol Med 79: 587\u2013593","journal-title":"J Mol Med"},{"key":"9_CR133","first-page":"3920","volume":"7","author":"K.N. Chi","year":"2001","unstructured":"Chi KN, Gleave ME, Klasa R, Murray N, Bryce C, Lopes de Menezes DE, D\u2019Aloisio S, Tolcher AW (2001) A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer. Clin Cancer Res 7: 3920\u20133927","journal-title":"Clin Cancer Res"},{"key":"9_CR134","first-page":"1621","volume":"56","author":"Z. Han","year":"1996","unstructured":"Han Z, Chatterjee D, Early J, Pantazis P, Hendrickson EA, Wyche JH (1996) Isolation and characterization of an apoptosis-resistant variant of human leukemia HL-60 cells that has switched expression from Bcl-2 to Bcl-xL. Cancer Res 56: 1621\u20131628","journal-title":"Cancer Res"},{"key":"9_CR135","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/jnci\/93.6.463","volume":"93","author":"O. Gautschi","year":"2001","unstructured":"Gautschi O, Tschopp S, Olie RA, Leech SH, Simoes-Wust AP, Ziegler A, Baumann B, Odermatt B, Hall J, Stahel RA et al. (2001) Activity of a novel bcl-2\/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins. J Natl Cancer Inst 93: 463\u2013471","journal-title":"J Natl Cancer Inst"},{"key":"9_CR136","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1053\/j.seminoncol.2003.08.015","volume":"30","author":"S. Wang","year":"2003","unstructured":"Wang S, Yang D, Lippman ME (2003) Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonists. Semin Oncol 30: 133\u2013142","journal-title":"Semin Oncol"},{"key":"9_CR137","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/1566523034578410","volume":"3","author":"N. Shinoura","year":"2003","unstructured":"Shinoura N, Hamada H (2003) Gene therapy using an adenovirus vector for apoptosis-related genes is a highly effective therapeutic modality for killing glioma cells. Curr Gene Ther 3: 147\u2013153","journal-title":"Curr Gene Ther"},{"key":"9_CR138","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1535-6108(02)00127-7","volume":"2","author":"A. Letai","year":"2002","unstructured":"Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ (2002) Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2: 183\u2013192","journal-title":"Cancer Cell"},{"key":"9_CR139","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/35080103","volume":"2","author":"M. Holcik","year":"2001","unstructured":"Holcik M, Korneluk RG (2001) XIAP, the guardian angel. Nat Rev Mol Cell Biol 2: 550\u2013556","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9_CR140","first-page":"2826","volume":"9","author":"Y. Hu","year":"2003","unstructured":"Hu Y, Cherton-Horvat G, Dragowska V, Baird S, Korneluk RG, Durkin JP, Mayer LD, LaCasse EC (2003) Antisense Oligonucleotides Targeting XIAP Induce Apoptosis and Enhance Chemotherapeutic Activity against Human Lung Cancer Cells in Vitro and in Vivo. Clin Cancer Res 9: 2826\u20132836","journal-title":"Clin Cancer Res"},{"volume-title":"Apoptosis in Health and Disease: Clinical and Therapeutic Aspects","year":"2005","key":"9_CR141","unstructured":"Holcik M, LaCasse EC, MacKenzie AE, Korneluk RG (eds): (2005) Apoptosis in Health and Disease: Clinical and Therapeutic Aspects. Cambridge University Press, Cambridge; in press"},{"key":"9_CR142","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1126\/science.1098231","volume":"305","author":"L. Li","year":"2004","unstructured":"Li L, Thomas RM, Suzuki H, De Brabander JK, Wang X, Harran PG (2004) A Small Molecule Smac Mimic Potentiates TRAIL-and TNF{alpha}-Mediated Cell Death. Science 305: 1471\u20131474","journal-title":"Science"}],"container-title":["Experientia Supplementum","Cancer: Cell Structures, Carcinogens and Genomic Instability"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/3-7643-7378-4_9.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T09:40:00Z","timestamp":1683366000000},"score":25.132593,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/3-7643-7378-4_9"}},"issued":{"date-parts":[[null]]},"ISBN":["3764371560"],"references-count":142,"URL":"https:\/\/doi.org\/10.1007\/3-7643-7378-4_9"},{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:57:04Z","timestamp":1774400224888,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":457,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1097\/jto.0000000000000301","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T14:36:04Z","timestamp":1408026964000},"page":"1240-1242","source":"Crossref","is-referenced-by-count":13,"title":["RET Mutations in Neuroendocrine Tumors: Including Small-Cell Lung Cancer"],"prefix":"10.1016","volume":"9","author":[{"given":"Charles M.","family":"Rudin","sequence":"first","affiliation":[]},{"given":"Alexander","family":"Drilon","sequence":"additional","affiliation":[]},{"given":"J.T.","family":"Poirier","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1097\/JTO.0000000000000301_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/328170a0","article-title":"A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases","volume":"328","author":"Fusco","year":"1987","journal-title":"Nature"},{"key":"10.1097\/JTO.0000000000000301_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.critrevonc.2013.12.007","article-title":"An update on molecular biology of thyroid cancers","volume":"90","author":"Omur","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1097\/JTO.0000000000000301_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1097\/JTO.0000000000000301_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm.2658","article-title":"RET, ROS1 and ALK fusions in lung cancer","volume":"18","author":"Takeuchi","year":"2012","journal-title":"Nat Med"},{"key":"10.1097\/JTO.0000000000000301_bib5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1101\/gr.133645.111","article-title":"A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing","volume":"22","author":"Ju","year":"2012","journal-title":"Genome Res"},{"key":"10.1097\/JTO.0000000000000301_bib6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/cr.2012.27","article-title":"Identification of RET gene fusion by exon array analyses in \u201cpan-negative\u201d lung cancer from never smokers","volume":"22","author":"Li","year":"2012","journal-title":"Cell Res"},{"key":"10.1097\/JTO.0000000000000301_bib7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nm.2673","article-title":"Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies","volume":"18","author":"Lipson","year":"2012","journal-title":"Nat Med"},{"key":"10.1097\/JTO.0000000000000301_bib8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1158\/2159-8290.CD-13-0035","article-title":"Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas","volume":"3","author":"Drilon","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1097\/JTO.0000000000000301_bib9","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1242\/dev.128.20.3963","article-title":"RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons","volume":"128","author":"Enomoto","year":"2001","journal-title":"Development"},{"key":"10.1097\/JTO.0000000000000301_bib10","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"key":"10.1097\/JTO.0000000000000301_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/thy.2010.0328","article-title":"Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation","volume":"21","author":"Jasim","year":"2011","journal-title":"Thyroid"},{"key":"10.1097\/JTO.0000000000000301_bib12","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1349-7006.1995.tb03304.x","article-title":"A novel somatic point mutation of the RET Proto-oncogene in tumor tissues of small cell lung cancer patients","volume":"86","author":"Futami","year":"1995","journal-title":"Jpn J Cancer Res"},{"key":"10.1097\/JTO.0000000000000301_bib13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/(SICI)1098-2264(199804)21:4<326::AID-GCC6>3.0.CO;2-0","article-title":"Investigation of the genes for RET and its ligand complex, GDNF\/GFR alpha-I, in small cell lung carcinoma","volume":"21","author":"Mulligan","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1097\/JTO.0000000000000301_bib14","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.2396","article-title":"Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer","volume":"44","author":"Peifer","year":"2012","journal-title":"Nat Genet"},{"key":"10.1097\/JTO.0000000000000301_bib15","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ng.2405","article-title":"Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer","volume":"44","author":"Rudin","year":"2012","journal-title":"Nat Genet"}],"container-title":["Journal of Thoracic Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415306663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415306663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T13:24:23Z","timestamp":1649942663000},"score":24.990387,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415306663"}},"issued":{"date-parts":[[2014,9]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1556086415306663"],"URL":"https:\/\/doi.org\/10.1097\/jto.0000000000000301","ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"published":{"date-parts":[[2014,9]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T22:07:48Z","timestamp":1649023668129},"reference-count":0,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Rep"],"published-print":{"date-parts":[[1994]]},"DOI":"10.3892\/or_00000197","type":"journal-article","created":{"date-parts":[[2008,12,10]],"date-time":"2008-12-10T13:11:02Z","timestamp":1228914662000},"source":"Crossref","is-referenced-by-count":0,"title":["Claudin expression in rectal well-differentiated endocrine neoplasms (carcinoid tumors)"],"prefix":"10.3892","author":[{"family":"Okabe","sequence":"first","affiliation":[]}],"member":"2249","container-title":["Oncology Reports"],"link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or_00000197\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T08:55:02Z","timestamp":1493283302000},"score":24.886723,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/or\/article.jsp?article_id=or_21_1_113"}},"issued":{"date-parts":[[1994]]},"references-count":0,"URL":"https:\/\/doi.org\/10.3892\/or_00000197","ISSN":["1021-335X"],"issn-type":[{"value":"1021-335X","type":"print"}],"published":{"date-parts":[[1994]]}},{"indexed":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T05:31:18Z","timestamp":1732339878468,"version":"3.28.0"},"publisher-location":"Stuttgart","reference-count":0,"publisher":"Georg Thieme Verlag","isbn-type":[{"type":"print","value":"9783131464910"},{"type":"electronic","value":"9783131640819"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2011]]},"DOI":"10.1055\/b-0034-85948","type":"book-chapter","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T23:19:59Z","timestamp":1400627999000},"source":"Crossref","is-referenced-by-count":0,"title":["17 Cystic Salivary Gland Tumors Including Cystic Neoplasms"],"prefix":"10.1055","member":"194","container-title":["Salivary Gland Disorders and Diseases: Diagnosis and Management"],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ebooks\/pdf\/10.1055\/b-0034-85948.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T13:29:50Z","timestamp":1732282190000},"score":24.806591,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/b-0034-85948"}},"editor":[{"given":"Patrick J.","family":"Bradley","sequence":"additional","affiliation":[]},{"given":"Orlando","family":"Guntinas-Lichius","sequence":"additional","affiliation":[]}],"issued":{"date-parts":[[2011]]},"ISBN":["9783131464910","9783131640819"],"references-count":0,"URL":"https:\/\/doi.org\/10.1055\/b-0034-85948","published":{"date-parts":[[2011]]}},{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T16:15:45Z","timestamp":1720628145186},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1991,1,1]],"date-time":"1991-01-01T00:00:00Z","timestamp":662688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer and Clinical Oncology"],"published-print":{"date-parts":[[1991,1]]},"DOI":"10.1016\/0277-5379(91)91323-b","type":"journal-article","created":{"date-parts":[[2004,4,18]],"date-time":"2004-04-18T02:00:54Z","timestamp":1082253654000},"page":"S44","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S3","title":["Induction of multidrug resistance genes by carcinogens"],"prefix":"10.1016","volume":"27","member":"78","container-title":["European Journal of Cancer and Clinical Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:027753799191323B?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:027753799191323B?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T04:54:55Z","timestamp":1550033695000},"score":24.757277,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/027753799191323B"}},"issued":{"date-parts":[[1991,1]]},"references-count":0,"alternative-id":["027753799191323B"],"URL":"https:\/\/doi.org\/10.1016\/0277-5379(91)91323-b","ISSN":["0277-5379"],"issn-type":[{"value":"0277-5379","type":"print"}],"published":{"date-parts":[[1991,1]]}},{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T04:47:18Z","timestamp":1745470038949,"version":"3.40.4"},"reference-count":0,"publisher":"S. Karger AG","issue":"2","license":[{"start":{"date-parts":[[1976,1,1]],"date-time":"1976-01-01T00:00:00Z","timestamp":189302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[1976,1,1]],"date-time":"1976-01-01T00:00:00Z","timestamp":189302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncology"],"published-print":{"date-parts":[[1976]]},"DOI":"10.1159\/000225104","type":"journal-article","created":{"date-parts":[[2009,6,10]],"date-time":"2009-06-10T17:42:04Z","timestamp":1244655724000},"page":"58-60","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Environmental Carcinogens for Cancer in Man"],"prefix":"10.1159","volume":"33","author":[{"given":"A.L.","family":"Brown","sequence":"first","affiliation":[]}],"member":"127","published-online":{"date-parts":[[2009,6,9]]},"container-title":["Oncology"],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/225104","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/225104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T22:50:47Z","timestamp":1745448647000},"score":24.72159,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000225104"}},"issued":{"date-parts":[[1976]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2004,7,1]]}},"URL":"https:\/\/doi.org\/10.1159\/000225104","archive":["Portico"],"ISSN":["0030-2414","1423-0232"],"issn-type":[{"type":"print","value":"0030-2414"},{"type":"electronic","value":"1423-0232"}],"published":{"date-parts":[[1976]]}},{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T04:47:15Z","timestamp":1745470035953,"version":"3.40.4"},"reference-count":0,"publisher":"S. Karger AG","issue":"2","license":[{"start":{"date-parts":[[1975,1,1]],"date-time":"1975-01-01T00:00:00Z","timestamp":157766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[1975,1,1]],"date-time":"1975-01-01T00:00:00Z","timestamp":157766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncology"],"published-print":{"date-parts":[[1975]]},"DOI":"10.1159\/000225012","type":"journal-article","created":{"date-parts":[[2009,6,10]],"date-time":"2009-06-10T17:42:04Z","timestamp":1244655724000},"page":"103-114","source":"Crossref","is-referenced-by-count":1,"title":["Behavioral Parameters in Rats and Mice Bearing Tumors, Carcinogens and Inflammatory Agents in the Brain"],"prefix":"10.1159","volume":"31","author":[{"given":"L.L.","family":"Gershbein","sequence":"first","affiliation":[]},{"given":"I.","family":"Benuck","sequence":"additional","affiliation":[]},{"given":"P.S.","family":"Shurrager","sequence":"additional","affiliation":[]}],"member":"127","published-online":{"date-parts":[[2009,6,9]]},"container-title":["Oncology"],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/225012","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/225012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T22:49:31Z","timestamp":1745448571000},"score":24.694101,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000225012"}},"issued":{"date-parts":[[1975]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2004,7,1]]}},"URL":"https:\/\/doi.org\/10.1159\/000225012","archive":["Portico"],"ISSN":["0030-2414","1423-0232"],"issn-type":[{"type":"print","value":"0030-2414"},{"type":"electronic","value":"1423-0232"}],"published":{"date-parts":[[1975]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T20:54:08Z","timestamp":1649019248515},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1985,2,1]],"date-time":"1985-02-01T00:00:00Z","timestamp":476064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer and Clinical Oncology"],"published-print":{"date-parts":[[1985,2]]},"DOI":"10.1016\/0277-5379(85)90186-5","type":"journal-article","created":{"date-parts":[[2004,4,17]],"date-time":"2004-04-17T23:24:35Z","timestamp":1082244275000},"page":"270","source":"Crossref","is-referenced-by-count":0,"title":["1st Biennial Gordon Research Conference on Hormonal Carcinogens"],"prefix":"10.1016","volume":"21","member":"78","container-title":["European Journal of Cancer and Clinical Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0277537985901865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0277537985901865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T22:20:57Z","timestamp":1550010057000},"score":24.379969,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0277537985901865"}},"issued":{"date-parts":[[1985,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,2]]}},"alternative-id":["0277537985901865"],"URL":"https:\/\/doi.org\/10.1016\/0277-5379(85)90186-5","ISSN":["0277-5379"],"issn-type":[{"value":"0277-5379","type":"print"}],"published":{"date-parts":[[1985,2]]}},{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:10:28Z","timestamp":1758741028641,"version":"3.44.0"},"reference-count":140,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780120066322"}],"license":[{"start":{"date-parts":[[1980,1,1]],"date-time":"1980-01-01T00:00:00Z","timestamp":315532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1980,1,1]],"date-time":"1980-01-01T00:00:00Z","timestamp":315532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[1980]]},"DOI":"10.1016\/s0065-230x(08)60362-0","type":"book-chapter","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T09:37:56Z","timestamp":1205401076000},"page":"201-235","source":"Crossref","is-referenced-by-count":26,"title":["Tumor Antigens on Neoplasms Induced by Chemical Carcinogens and by DNA- and RNA-Containing Viruses: Properties of the Solubilized Antigens"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/S0065-230X(08)60362-0_bib1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1073\/pnas.73.4.1097","volume":"73","author":"Ahmad-Zadeh","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0065-230X(08)60362-0_bib2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ijc.2910240514","volume":"24","author":"Alaba","year":"1979","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0042-6822(77)90314-2","volume":"76","author":"Anderson","year":"1977","journal-title":"Virology"},{"key":"10.1016\/S0065-230X(08)60362-0_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0042-6822(77)90301-4","volume":"76","author":"Anderson","year":"1977","journal-title":"Virology"},{"key":"10.1016\/S0065-230X(08)60362-0_bib5","first-page":"3539","volume":"36","author":"Appella","year":"1976","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-230X(08)60362-0_bib6","series-title":"\u201cBiological Markers of Neoplasia: Basic and Applied Aspects\u201d","first-page":"213","author":"Appella","year":"1978"},{"key":"10.1016\/S0065-230X(08)60362-0_bib7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0042-6822(77)90145-3","volume":"81","author":"Arcement","year":"1977","journal-title":"Virology"},{"key":"10.1016\/S0065-230X(08)60362-0_bib8","first-page":"144","volume":"7","author":"Baldwin","year":"1971","journal-title":"Isr. J. Med. Sci."},{"key":"10.1016\/S0065-230X(08)60362-0_bib9","first-page":"433","volume":"13","author":"Baldwin","year":"1974","journal-title":"Isr. J. Med.Sci."},{"key":"10.1016\/S0065-230X(08)60362-0_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1749-6632.1976.tb41632.x","volume":"276","author":"Baldwin","year":"1976","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/S0065-230X(08)60362-0_bib11","first-page":"177","volume":"VI","author":"Baldwin","year":"1977"},{"key":"10.1016\/S0065-230X(08)60362-0_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/bjc.1973.164","volume":"28","author":"Baldwin","year":"1973","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ijc.2910110216","volume":"11","author":"Baldwin","year":"1973","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib14","series-title":"\u201cBiological Markers of Neoplasia: Basic and Applied Aspects\u201d","first-page":"11","author":"Baldwin","year":"1978"},{"key":"10.1016\/S0065-230X(08)60362-0_bib15","first-page":"1189","volume":"3","author":"Baldwin","year":"1979","journal-title":"Transplant. Proc."},{"key":"10.1016\/S0065-230X(08)60362-0_bib16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/262554a0","volume":"262","author":"Barbacid","year":"1976","journal-title":"Nature (London)"},{"key":"10.1016\/S0065-230X(08)60362-0_bib17","first-page":"337","volume":"69","author":"Barra","year":"1977","journal-title":"Colloq. Inst. Sant\u00e9 Recherche Med."},{"key":"10.1016\/S0065-230X(08)60362-0_bib18","first-page":"275","volume":"20","author":"Bauer","year":"1975","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/S0065-230X(08)60362-0_bib19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ijc.2910200412","volume":"20","author":"Beth","year":"1977","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib20","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1073\/pnas.71.8.3234","volume":"71","author":"Bilello","year":"1974","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0065-230X(08)60362-0_bib21","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1073\/pnas.50.6.1148","volume":"50","author":"Black","year":"1963","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0065-230X(08)60362-0_bib22","first-page":"1471","volume":"5","author":"Bodmer","year":"1973","journal-title":"Transplant. Proc."},{"key":"10.1016\/S0065-230X(08)60362-0_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ijc.2910210316","volume":"21","author":"Bubenik","year":"1978","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bjc.1978.24","volume":"37","author":"Burton","year":"1978","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ijc.2910210115","volume":"21","author":"Carbone","year":"1978","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib26","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1073\/pnas.73.7.2254","volume":"73","author":"Carroll","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0065-230X(08)60362-0_bib27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/269438a0","volume":"269","author":"Chang","year":"1977","journal-title":"Nature (London)"},{"key":"10.1016\/S0065-230X(08)60362-0_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1128\/jvi.29.1.69-75.1979","volume":"29","author":"Chang","year":"1979","journal-title":"J. Virol."},{"key":"10.1016\/S0065-230X(08)60362-0_bib29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ijc.2910150314","volume":"15","author":"Chang","year":"1975","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3181\/00379727-132-34208","volume":"132","author":"Coggin","year":"1969","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/S0065-230X(08)60362-0_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ijc.2910160314","volume":"16","author":"Dean","year":"1975","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib32","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ijc.2910200620","volume":"20","author":"Dean","year":"1977","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3181\/00379727-113-28261","volume":"113","author":"Defendi","year":"1963","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/S0065-230X(08)60362-0_bib34","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ijc.2910200420","volume":"20","author":"Deichman","year":"1977","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib35","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1084\/jem.146.3.720","volume":"146","author":"DeLeo","year":"1977","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-230X(08)60362-0_bib36","series-title":"\u201cBiological Markers of Neoplasia: Basic and Applied Aspects\u201d","first-page":"25","author":"DeLeo","year":"1978"},{"key":"10.1016\/S0065-230X(08)60362-0_bib37","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1073\/pnas.76.5.2420","volume":"76","author":"DeLeo Jay","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0065-230X(08)60362-0_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0042-6822(73)90363-2","volume":"51","author":"Del Villano","year":"1973","journal-title":"Virology"},{"key":"10.1016\/S0065-230X(08)60362-0_bib39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/267054a0","volume":"267","author":"DeNoronha","year":"1977","journal-title":"Nature (London)"},{"key":"10.1016\/S0065-230X(08)60362-0_bib40","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1073\/pnas.73.7.2505","volume":"73","author":"Deppert","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0065-230X(08)60362-0_bib41","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/jnci\/52.1.259","volume":"52","author":"Drapkin","year":"1974","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0065-230X(08)60362-0_bib42","first-page":"37","volume":"37","author":"Economou","year":"1977","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-230X(08)60362-0_bib43","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ijc.2910180511","volume":"18","author":"Embleton","year":"1976","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/233195a0","volume":"233","author":"Essex","year":"1971","journal-title":"Nature (London)"},{"key":"10.1016\/S0065-230X(08)60362-0_bib45","series-title":"\u201cBiological Markers of Neoplasia: Basic and Applied Aspects\u201d","first-page":"47","author":"Fenyo","year":"1978"},{"key":"10.1016\/S0065-230X(08)60362-0_bib46","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/260355a0","volume":"260","author":"Fenyo","year":"1976","journal-title":"Nature (London)"},{"key":"10.1016\/S0065-230X(08)60362-0_bib47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/273052a0","volume":"273","author":"Flaherty","year":"1978","journal-title":"Nature (London)"},{"key":"10.1016\/S0065-230X(08)60362-0_bib48","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1073\/pnas.54.2.445","volume":"54","author":"Girardi","year":"1965","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0065-230X(08)60362-0_bib49","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/0042-6822(70)90314-4","volume":"42","author":"Girardi","year":"1970","journal-title":"Virology"},{"key":"10.1016\/S0065-230X(08)60362-0_bib50","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4049\/jimmunol.118.3.920","volume":"118","author":"Gooding","year":"1977","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-230X(08)60362-0_bib51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.115.1.181","volume":"115","author":"Habel","year":"1962","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-230X(08)60362-0_bib52","series-title":"\u201cPrinciples of Immunology\u201d","first-page":"417","author":"Hauschka","year":"1973"},{"key":"10.1016\/S0065-230X(08)60362-0_bib53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ijc.2910030408","volume":"3","author":"Hellstr\u00f6m","year":"1968","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib54","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ijc.2910210311","volume":"21","author":"Hellstr\u00f6m","year":"1978","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0092-8674(74)90041-5","volume":"3","author":"Henderson","year":"1974","journal-title":"Cell"},{"key":"10.1016\/S0065-230X(08)60362-0_bib56","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/jnci\/58.6.1785","volume":"58","author":"Henriksen","year":"1977","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0065-230X(08)60362-0_bib57","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1073\/pnas.75.7.3322","volume":"75","author":"Henriksen","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0065-230X(08)60362-0_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/1097-0142(197002)25:2<373::AID-CNCR2820250215>3.0.CO;2-L","volume":"25","author":"Holmes","year":"1970","journal-title":"Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib59","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ijc.2910150118","volume":"15","author":"Howell","year":"1975","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0042-6822(75)90203-2","volume":"66","author":"Hunsman","year":"1975","journal-title":"Virology"},{"key":"10.1016\/S0065-230X(08)60362-0_bib61","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jvi.14.5.1274-1280.1974","volume":"14","author":"Ikeda","year":"1974","journal-title":"J. Virol."},{"key":"10.1016\/S0065-230X(08)60362-0_bib62","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1073\/pnas.74.3.1259","volume":"74","author":"Ito","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0065-230X(08)60362-0_bib63","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1073\/pnas.74.10.4666","volume":"74","author":"Ito","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0065-230X(08)60362-0_bib64","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1073\/pnas.75.7.3055","volume":"75","author":"Jay","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"year":"1980","author":"Jay","series-title":"\u201cSymposia on Quantitative Biology.\u201d","key":"10.1016\/S0065-230X(08)60362-0_bib65"},{"key":"10.1016\/S0065-230X(08)60362-0_bib66","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1128\/jvi.23.3.787-798.1977","volume":"23","author":"Karshin","year":"1977","journal-title":"J. Virol."},{"key":"10.1016\/S0065-230X(08)60362-0_bib67","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.4049\/jimmunol.115.5.1254","volume":"115","author":"Klein","year":"1975","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-230X(08)60362-0_bib68","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ijc.2910150308","volume":"15","author":"Knight","year":"1975","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib69","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0042-6822(72)90278-4","volume":"47","author":"Kurth","year":"1972","journal-title":"Virology"},{"key":"10.1016\/S0065-230X(08)60362-0_bib70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/279197a0","volume":"279","author":"Kurth","year":"1979","journal-title":"Nature (London)"},{"key":"10.1016\/S0065-230X(08)60362-0_bib71","first-page":"135","volume":"4","author":"Law","year":"1975"},{"key":"10.1016\/S0065-230X(08)60362-0_bib72","series-title":"\u201cBiological Markers of Neoplasia: Basic and Applied Aspects\u201d","first-page":"35","author":"Law Appella","year":"1978"},{"key":"10.1016\/S0065-230X(08)60362-0_bib73","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ijc.2910220315","volume":"22","author":"Law","year":"1978","journal-title":"Int. J. Cancer"},{"unstructured":"L.W. Law G.C. DuBois M.J. Rogers E. Appella M.A. Pierotti G. Parmiani (1980) Transplant. Proc. (in press).","key":"10.1016\/S0065-230X(08)60362-0_bib74"},{"key":"10.1016\/S0065-230X(08)60362-0_bib75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/jvi.22.1.65-73.1977","volume":"22","author":"Ledbetter","year":"1977","journal-title":"J. Virol."},{"key":"10.1016\/S0065-230X(08)60362-0_bib76","first-page":"4112","volume":"37","author":"Leffell","year":"1977","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-230X(08)60362-0_bib77","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0042-6822(76)90028-3","volume":"75","author":"Lejneva","year":"1976","journal-title":"Virology"},{"key":"10.1016\/S0065-230X(08)60362-0_bib78","first-page":"2","volume":"24","author":"Levy","year":"1977","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/S0065-230X(08)60362-0_bib79","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1128\/jvi.12.4.836-840.1973","volume":"12","author":"Lewis","year":"1973","journal-title":"J. Virol."},{"key":"10.1016\/S0065-230X(08)60362-0_bib80","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/jnci\/58.6.1661","volume":"58","author":"Liu","year":"1977","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0065-230X(08)60362-0_bib81","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/0006-291X(76)90752-X","volume":"71","author":"Luborsky","year":"1976","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0065-230X(08)60362-0_bib82","first-page":"1743","volume":"27","author":"McCoy","year":"1967","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-230X(08)60362-0_bib83","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4049\/jimmunol.119.1.306","volume":"119","author":"McCoy","year":"1977","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-230X(08)60362-0_bib84","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1126\/science.973137","volume":"194","author":"Martin","year":"1976","journal-title":"Science"},{"key":"10.1016\/S0065-230X(08)60362-0_bib85","first-page":"703","volume":"47","author":"Meltzer","year":"1971","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0065-230X(08)60362-0_bib86","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ijc.2910200216","volume":"20","author":"Meschini","year":"1977","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib87","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0065-230X(08)60519-9","volume":"14","author":"Meyer","year":"1971","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/S0065-230X(08)60362-0_bib88","first-page":"327","volume":"69","author":"Mora","year":"1977","journal-title":"Colloq. Inst. Sant\u00e9 Recherche Med."},{"key":"10.1016\/S0065-230X(08)60362-0_bib89","first-page":"3406","volume":"37","author":"Natori","year":"1977","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-230X(08)60362-0_bib90","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/jnci\/59.4.1331","volume":"59","author":"Natori","year":"1977","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0065-230X(08)60362-0_bib91","first-page":"273","volume":"67","author":"Old","year":"1973","journal-title":"Harvey Lect."},{"key":"10.1016\/S0065-230X(08)60362-0_bib92","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.ge.11.120177.001015","volume":"17","author":"Old","year":"1977","journal-title":"Ann. Rev. Genet."},{"key":"10.1016\/S0065-230X(08)60362-0_bib93","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.1962.tb26446.x","volume":"101","author":"Old","year":"1962","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/S0065-230X(08)60362-0_bib94","series-title":"\u201cAdvances in Leukemia Research\u201d","first-page":"90","author":"Oroszlan","year":"1977"},{"key":"10.1016\/S0065-230X(08)60362-0_bib95","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1128\/jvi.14.6.1559-1574.1974","volume":"14","author":"Oroszlan","year":"1974","journal-title":"J. Virol."},{"key":"10.1016\/S0065-230X(08)60362-0_bib96","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.4049\/jimmunol.120.6.1981","volume":"120","author":"Padarathsingh","year":"1978","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-230X(08)60362-0_bib97","first-page":"1205","volume":"35","author":"Paranjpe","year":"1975","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-230X(08)60362-0_bib98","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF01844015","volume":"7","author":"Parmiani","year":"1979","journal-title":"Immunogenetics"},{"key":"10.1016\/S0065-230X(08)60362-0_bib99","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ijc.2910160508","volume":"16","author":"Parmiani","year":"1975","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib100","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/jnci\/61.5.1229","volume":"61","author":"Parmiani","year":"1978","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0065-230X(08)60362-0_bib101","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00200081","volume":"3","author":"Pasternak","year":"1978","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/S0065-230X(08)60362-0_bib102","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.4049\/jimmunol.115.6.1717","volume":"115","author":"Pellis","year":"1975","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-230X(08)60362-0_bib103","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4049\/jimmunol.113.2.708","volume":"113","author":"Pellis","year":"1974","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-230X(08)60362-0_bib104","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0019-2791(75)90044-0","volume":"12","author":"Prat","year":"1975","journal-title":"Immunochemistry"},{"key":"10.1016\/S0065-230X(08)60362-0_bib105","first-page":"527","volume":"61","author":"Prat","year":"1978","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0065-230X(08)60362-0_bib106","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0065-230X(08)60547-3","volume":"23","author":"Prehn","year":"1976","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/S0065-230X(08)60362-0_bib107","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/bjc.1974.213","volume":"30","author":"Price","year":"1974","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib108","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/bjc.1974.212","volume":"30","author":"Price","year":"1974","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib109","series-title":"\u201cImmunologic Aspects of Cancer\u201d","first-page":"155","author":"Price","year":"1978"},{"key":"10.1016\/S0065-230X(08)60362-0_bib110","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/bjc.1979.113","volume":"39","author":"Price","year":"1979","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib111","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/bjc.1979.234","volume":"40","author":"Price","year":"1979","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib112","first-page":"3385","volume":"37","author":"Rao","year":"1977","journal-title":"Cancer Res."},{"unstructured":"M.J. Rogers (1979) Transplantation (in press).","key":"10.1016\/S0065-230X(08)60362-0_bib113"},{"key":"10.1016\/S0065-230X(08)60362-0_bib114","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ijc.2910230116","volume":"23","author":"Rogers","year":"1979","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ijc.2910200220","volume":"20","author":"Rogers","year":"1977","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib116","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ijc.2910210218","volume":"21","author":"Rogers","year":"1977","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib117","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/jnci\/59.4.1291","volume":"4","author":"Rogers","year":"1977","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0065-230X(08)60362-0_bib118","first-page":"349","volume":"69","author":"Rogers","year":"1977","journal-title":"Colloq. Inst. Sant\u00e9 Recherche Med."},{"key":"10.1016\/S0065-230X(08)60362-0_bib119","series-title":"\u201cBiological Markers of Neoplasia: Basic and Applied Aspects\u201d","first-page":"53","author":"Rogers","year":"1978"},{"key":"10.1016\/S0065-230X(08)60362-0_bib120","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1073\/pnas.76.3.1415","volume":"76","author":"Rogers","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0065-230X(08)60362-0_bib121","doi-asserted-by":"crossref","first-page":"11126","DOI":"10.1016\/S0021-9258(19)86639-5","volume":"254","author":"Rogers","year":"1979","journal-title":"J. Biol. Chem."},{"unstructured":"M.J. Rogers M.A. Pierotti G. Parmiani E. Appella (1980) Transplant. Proc. (in press).","key":"10.1016\/S0065-230X(08)60362-0_bib122"},{"key":"10.1016\/S0065-230X(08)60362-0_bib123","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ijc.2910200113","volume":"20","author":"Siegert","year":"1977","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib124","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0092-8674(78)90018-1","volume":"15","author":"Silver","year":"1978","journal-title":"Cell"},{"key":"10.1016\/S0065-230X(08)60362-0_bib125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/227141a0","volume":"227","author":"Smith","year":"1970","journal-title":"Nature (London)"},{"key":"10.1016\/S0065-230X(08)60362-0_bib126","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/247457a0","volume":"247","author":"Snary","year":"1974","journal-title":"Nature (London)"},{"key":"10.1016\/S0065-230X(08)60362-0_bib127","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1128\/jvi.30.2.523-532.1979","volume":"30","author":"Soule","year":"1979","journal-title":"J. Virol."},{"key":"10.1016\/S0065-230X(08)60362-0_bib128","series-title":"\u201cMembrane Molecular Biology\u201d","first-page":"27","author":"Steck","year":"1972"},{"key":"10.1016\/S0065-230X(08)60362-0_bib129","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1073\/pnas.74.3.1219","volume":"74","author":"Stephenson","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0065-230X(08)60362-0_bib130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00007890-197003000-00005","volume":"9","author":"Takasugi","year":"1970","journal-title":"Transplantation"},{"key":"10.1016\/S0065-230X(08)60362-0_bib131","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0022-1759(73)90027-6","volume":"3","author":"Tanigaki","year":"1973","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/S0065-230X(08)60362-0_bib132","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1073\/pnas.74.9.3745","volume":"74","author":"Tenen","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0065-230X(08)60362-0_bib133","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3181\/00379727-123-31558","volume":"123","author":"Tevethia","year":"1966","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/S0065-230X(08)60362-0_bib134","first-page":"185","volume":"IV","author":"Tevethia","year":"1975"},{"key":"10.1016\/S0065-230X(08)60362-0_bib135","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ijc.2910050203","volume":"5","author":"Tevethia","year":"1970","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-230X(08)60362-0_bib136","first-page":"1684","volume":"34","author":"Ting","year":"1974","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-230X(08)60362-0_bib137","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/261312a0","volume":"261","author":"Trinchieri","year":"1976","journal-title":"Nature (London)"},{"key":"10.1016\/S0065-230X(08)60362-0_bib138","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(76)90039-8","volume":"9","author":"Tung","year":"1976","journal-title":"Cell"},{"key":"10.1016\/S0065-230X(08)60362-0_bib139","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/jnci\/58.6.1671","volume":"58","author":"Walia","year":"1977","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0065-230X(08)60362-0_bib140","doi-asserted-by":"crossref","first-page":"981","DOI":"10.4049\/jimmunol.117.3.981","volume":"117","author":"Warnatz","year":"1976","journal-title":"J. Immunol."}],"container-title":["Advances in Cancer Research"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X08603620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X08603620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:45:27Z","timestamp":1758739527000},"score":24.332859,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065230X08603620"}},"issued":{"date-parts":[[1980]]},"ISBN":["9780120066322"],"references-count":140,"URL":"https:\/\/doi.org\/10.1016\/s0065-230x(08)60362-0","ISSN":["0065-230X"],"issn-type":[{"type":"print","value":"0065-230X"}],"published":{"date-parts":[[1980]]}},{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T20:47:56Z","timestamp":1725914876270},"publisher-location":"Cham","reference-count":106,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319554280"},{"type":"electronic","value":"9783319554303"}],"license":[{"start":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T00:00:00Z","timestamp":1509408000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-55430-3_35","type":"book-chapter","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T10:13:19Z","timestamp":1509358399000},"page":"595-624","source":"Crossref","is-referenced-by-count":0,"title":["Second Neoplasms After Successful Treatment for Pediatric Central Nervous System Tumors"],"prefix":"10.1007","author":[{"given":"Mark J.","family":"Amsbaugh","sequence":"first","affiliation":[]},{"given":"Shiao Y.","family":"Woo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,10,31]]},"reference":[{"issue":"3","key":"35_CR1","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3171\/jns.1994.81.3.0466","volume":"81","author":"S Albrecht","year":"1994","unstructured":"Albrecht S, Goodman JC, Rajagopolan S, Levy M, Cech DA, Cooley LD (1994) Malignant meningioma in Gorlin\u2019s syndrome: cytogenetic and p53 gene analysis. Case report. J Neurosurg 81(3):466\u2013471. doi: 10.3171\/jns.1994.81.3.0466","journal-title":"J Neurosurg"},{"issue":"7","key":"35_CR2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s003819900125","volume":"16","author":"A Amirjamshidi","year":"2000","unstructured":"Amirjamshidi A, Abbassioun K (2000) Radiation-induced tumors of the central nervous system occurring in childhood and adolescence. Four unusual lesions in three patients and a review of the literature. Childs Nerv Syst 16(7):390\u2013397","journal-title":"Childs Nerv Syst"},{"issue":"5","key":"35_CR3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.ijrobp.2011.10.034","volume":"83","author":"MJ Amsbaugh","year":"2012","unstructured":"Amsbaugh MJ, Grosshans DR, McAleer MF, Zhu R, Wages C, Crawford CN, Palmer M, De Gracia B, Woo S, Mahajan A (2012) Proton therapy for spinal ependymomas: planning, acute toxicities, and preliminary outcomes. Int J Radiat Oncol Biol Phys 83(5):1419\u20131424. doi: 10.1016\/j.ijrobp.2011.10.034","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"35_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ejpn.2009.12.006","volume":"14","author":"GT Armstrong","year":"2010","unstructured":"Armstrong GT (2010) Long-term survivors of childhood central nervous system malignancies: the experience of the Childhood Cancer Survivor Study. Eur J Paediatr Neurol 14(4):298\u2013303. doi: 10.1016\/j.ejpn.2009.12.006","journal-title":"Eur J Paediatr Neurol"},{"issue":"13","key":"35_CR5","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/jnci\/djp148","volume":"101","author":"GT Armstrong","year":"2009","unstructured":"Armstrong GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W, Hudson MM, Donaldson SS, King AA, Stovall M, Krull KR, Robison LL, Packer RJ (2009) Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. J Natl Cancer Inst 101(13):946\u2013958. doi: 10.1093\/jnci\/djp148","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"35_CR6","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1182\/blood.V99.12.4257","volume":"99","author":"S Bhatia","year":"2002","unstructured":"Bhatia S, Sather HN, Pabustan OB, Trigg ME, Gaynon PS, Robison LL (2002) Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 99(12):4257\u20134264","journal-title":"Blood"},{"issue":"8","key":"35_CR7","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1016\/s1470-2045(13)70107-4","volume":"14","author":"DC Bowers","year":"2013","unstructured":"Bowers DC, Nathan PC, Constine L, Woodman C, Bhatia S, Keller K, Bashore L (2013) Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review. Lancet Oncol 14(8):e321\u2013e328. doi: 10.1016\/s1470-2045(13)70107-4","journal-title":"Lancet Oncol"},{"issue":"10","key":"35_CR8","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/cncr.20253","volume":"100","author":"A Broniscer","year":"2004","unstructured":"Broniscer A, Ke W, Fuller CE, Wu J, Gajjar A, Kun LE (2004) Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude Children\u2019s Research Hospital experience. Cancer 100(10):2246\u20132252. doi: 10.1002\/cncr.20253","journal-title":"Cancer"},{"issue":"5 Suppl","key":"35_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3171\/ped.2007.106.5.379","volume":"106","author":"S Burn","year":"2007","unstructured":"Burn S, Gunny R, Phipps K, Gaze M, Hayward R (2007) Incidence of cavernoma development in children after radiotherapy for brain tumors. J Neurosurg 106(5 Suppl):379\u2013383. doi: 10.3171\/ped.2007.106.5.379","journal-title":"J Neurosurg"},{"issue":"2","key":"35_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ejca.2006.10.004","volume":"43","author":"MC Cardous-Ubbink","year":"2007","unstructured":"Cardous-Ubbink MC, Heinen RC, Bakker PJ, van den Berg H, Oldenburger F, Caron HN, Voute PA, van Leeuwen FE (2007) Risk of second malignancies in long-term survivors of childhood cancer. Eur J Cancer (Oxford, England: 1990) 43(2):351\u2013362. doi: 10.1016\/j.ejca.2006.10.004","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"issue":"1","key":"35_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.radonc.2006.08.005","volume":"81","author":"AS Carret","year":"2006","unstructured":"Carret AS, Tabori U, Crooks B, Hukin J, Odame I, Johnston DL, Keene DL, Freeman C, Bouffet E (2006) Outcome of secondary high-grade glioma in children previously treated for a malignant condition: a study of the Canadian Pediatric Brain Tumour Consortium. Radiother Oncol 81(1):33\u201338. doi: 10.1016\/j.radonc.2006.08.005","journal-title":"Radiother Oncol"},{"key":"35_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25285","author":"DL Casey","year":"2014","unstructured":"Casey DL, Friedman DN, Moskowitz CS, Hilden PD, Sklar CA, Wexler LH, Wolden SL (2014) Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT). Pediatr Blood Cancer. doi: 10.1002\/pbc.25285","journal-title":"Pediatr Blood Cancer"},{"issue":"1041","key":"35_CR13","doi-asserted-by":"publisher","first-page":"20140211","DOI":"10.1259\/bjr.20140211","volume":"87","author":"M Chojnacka","year":"2014","unstructured":"Chojnacka M, Pedziwiatr K, Skowronska-Gardas A, Perek-Polnik M, Perek D, Olasek P (2014) Second brain tumors following central nervous system radiotherapy in childhood. Br J Radiol 87(1041):20140211. doi: 10.1259\/bjr.20140211","journal-title":"Br J Radiol"},{"issue":"1","key":"35_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijrobp.2013.04.030","volume":"87","author":"CS Chung","year":"2013","unstructured":"Chung CS, Yock TI, Nelson K, Xu Y, Keating NL, Tarbell NJ (2013) Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys 87(1):46\u201352. doi: 10.1016\/j.ijrobp.2013.04.030","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"35_CR15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/bjc.1987.35","volume":"55","author":"SC Darby","year":"1987","unstructured":"Darby SC, Doll R, Gill SK, Smith PG (1987) Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer 55(2):179\u2013190","journal-title":"Br J Cancer"},{"issue":"11\u201312","key":"35_CR16","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1038\/sj.bjc.6690300","volume":"79","author":"F Vathaire de","year":"1999","unstructured":"de Vathaire F, Hawkins M, Campbell S, Oberlin O, Raquin MA, Schlienger JY, Shamsaldin A, Diallo I, Bell J, Grimaud E, Hardiman C, Lagrange JL, Daly-Schveitzer N, Panis X, Zucker JM, Sancho-Garnier H, Eschwege F, Chavaudra J, Lemerle J (1999) Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer 79(11\u201312):1884\u20131893. doi: 10.1038\/sj.bjc.6690300","journal-title":"Br J Cancer"},{"issue":"8","key":"35_CR17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/08880010390243031","volume":"20","author":"SR Devarahally","year":"2003","unstructured":"Devarahally SR, Severson RK, Chuba P, Thomas R, Bhambhani K, Hamre MR (2003) Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence. Pediatr Hematol Oncol 20(8):617\u2013625","journal-title":"Pediatr Hematol Oncol"},{"issue":"3","key":"35_CR18","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.ijrobp.2009.01.040","volume":"74","author":"I Diallo","year":"2009","unstructured":"Diallo I, Haddy N, Adjadj E, Samand A, Quiniou E, Chavaudra J, Alziar I, Perret N, Guerin S, Lefkopoulos D, de Vathaire F (2009) Frequency distribution of second solid cancer locations in relation to the irradiated volume among 115 patients treated for childhood cancer. Int J Radiat Oncol Biol Phys 74(3):876\u2013883. doi: 10.1016\/j.ijrobp.2009.01.040","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"35_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/ana.410440305","volume":"44","author":"PK Duffner","year":"1998","unstructured":"Duffner PK, Krischer JP, Horowitz ME, Cohen ME, Burger PC, Friedman HS, Kun LE (1998) Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study. Ann Neurol 44(3):313\u2013316. doi: 10.1002\/ana.410440305","journal-title":"Ann Neurol"},{"issue":"10","key":"35_CR20","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s00381-004-1120-2","volume":"21","author":"R Duhem","year":"2005","unstructured":"Duhem R, Vinchon M, Leblond P, Soto-Ares G, Dhellemmes P (2005) Cavernous malformations after cerebral irradiation during childhood: report of nine cases. Childs Nerv Syst 21(10):922\u2013925. doi: 10.1007\/s00381-004-1120-2","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"35_CR21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.wneu.2014.12.009","volume":"83","author":"AA Elsamadicy","year":"2015","unstructured":"Elsamadicy AA, Babu R, Kirkpatrick JP, Adamson DC (2015) Radiation-induced malignant gliomas: a current review. World Neurosurg 83(4):530\u2013542. doi: 10.1016\/j.wneu.2014.12.009","journal-title":"World Neurosurg"},{"issue":"5","key":"35_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/s1470-2045(07)70107-9","volume":"8","author":"P Flint-Richter","year":"2007","unstructured":"Flint-Richter P, Sadetzki S (2007) Genetic predisposition for the development of radiation-associated meningioma: an epidemiological study. Lancet Oncol 8(5):403\u2013410. doi: 10.1016\/s1470-2045(07)70107-9","journal-title":"Lancet Oncol"},{"issue":"2","key":"35_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1055\/s-2007-973687","volume":"28","author":"JM Friedman","year":"1997","unstructured":"Friedman JM, Birch P (1997) An association between optic glioma and other tumours of the central nervous system in neurofibromatosis type 1. Neuropediatrics 28(2):131\u2013132. doi: 10.1055\/s-2007-973687","journal-title":"Neuropediatrics"},{"issue":"8","key":"35_CR24","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1158\/1055-9965.EPI-05-0066","volume":"14","author":"DL Friedman","year":"2005","unstructured":"Friedman DL, Kadan-Lottick NS, Whitton J, Mertens AC, Yasui Y, Liu Y, Meadows AT, Robison LL, Strong LC (2005) Increased risk of cancer among siblings of long-term childhood cancer survivors: a report from the childhood cancer survivor study. Cancer Epidemiol Biomark Prev 14(8):1922\u20131927. doi: 10.1158\/1055-9965.EPI-05-0066","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"14","key":"35_CR25","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/jnci\/djq238","volume":"102","author":"DL Friedman","year":"2010","unstructured":"Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP (2010) Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 102(14):1083\u20131095. doi: 10.1093\/jnci\/djq238","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"35_CR26","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/1097-0215(20001115)88:4<672::AID-IJC24>3.0.CO;2-N","volume":"88","author":"S Garwicz","year":"2000","unstructured":"Garwicz S, Anderson H, Olsen JH, Dollner H, Hertz H, Jonmundsson G, Langmark F, Lanning M, Moller T, Sankila R, Tulinius H (2000) Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer 88(4):672\u2013678","journal-title":"Int J Cancer"},{"issue":"12","key":"35_CR27","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1002\/1097-0142(19930615)71:12<4091::AID-CNCR2820711247>3.0.CO;2-G","volume":"71","author":"TT Ghim","year":"1993","unstructured":"Ghim TT, Seo JJ, O\u2019Brien M, Meacham L, Crocker I, Krawiecki N (1993) Childhood intracranial meningiomas after high-dose irradiation. Cancer 71(12):4091\u20134095","journal-title":"Cancer"},{"issue":"10","key":"35_CR28","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1002\/cncr.11356","volume":"97","author":"DG Gold","year":"2003","unstructured":"Gold DG, Neglia JP, Dusenbery KE (2003) Second neoplasms after megavoltage radiation for pediatric tumors. Cancer 97(10):2588\u20132596. doi: 10.1002\/cncr.11356","journal-title":"Cancer"},{"issue":"3","key":"35_CR29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/pbc.21153","volume":"49","author":"Y Goshen","year":"2007","unstructured":"Goshen Y, Stark B, Kornreich L, Michowiz S, Feinmesser M, Yaniv I (2007) High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 49(3):294\u2013297. doi: 10.1002\/pbc.21153","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"35_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ijc.22197","volume":"120","author":"S Guerin","year":"2007","unstructured":"Guerin S, Guibout C, Shamsaldin A, Dondon MG, Diallo I, Hawkins M, Oberlin O, Hartmann O, Michon J, Le Deley MC, de Vathaire F (2007) Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study. Int J Cancer 120(1):96\u2013102. doi: 10.1002\/ijc.22197","journal-title":"Int J Cancer"},{"issue":"1","key":"35_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijrobp.2006.01.027","volume":"65","author":"EJ Hall","year":"2006","unstructured":"Hall EJ (2006) Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65(1):1\u20137. doi: 10.1016\/j.ijrobp.2006.01.027","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"35_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/pbc.20448","volume":"45","author":"DM Hammal","year":"2005","unstructured":"Hammal DM, Bell CL, Craft AW, Parker L (2005) Second primary tumors in children and young adults in the North of England (1968\u201399). Pediatr Blood Cancer 45(2):155\u2013161. doi: 10.1002\/pbc.20448","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"35_CR33","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1002\/cncr.10596","volume":"94","author":"S Heckl","year":"2002","unstructured":"Heckl S, Aschoff A, Kunze S (2002) Radiation-induced cavernous hemangiomas of the brain: a late effect predominantly in children. Cancer 94(12):3285\u20133291. doi: 10.1002\/cncr.10596","journal-title":"Cancer"},{"issue":"11","key":"35_CR34","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1001\/jama.297.11.1207","volume":"297","author":"N Hijiya","year":"2007","unstructured":"Hijiya N, Hudson MM, Lensing S, Zacher M, Onciu M, Behm FG, Razzouk BI, Ribeiro RC, Rubnitz JE, Sandlund JT, Rivera GK, Evans WE, Relling MV, Pui CH (2007) Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. JAMA 297(11):1207\u20131215. doi: 10.1001\/jama.297.11.1207","journal-title":"JAMA"},{"issue":"10","key":"35_CR35","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1002\/ijc.22827","volume":"121","author":"PD Inskip","year":"2007","unstructured":"Inskip PD, Curtis RE (2007) New malignancies following childhood cancer in the United States, 1973\u20132002. Int J Cancer 121(10):2233\u20132240. doi: 10.1002\/ijc.22827","journal-title":"Int J Cancer"},{"issue":"7","key":"35_CR36","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/pbc.20025","volume":"42","author":"J Jazbec","year":"2004","unstructured":"Jazbec J, Ecimovic P, Jereb B (2004) Second neoplasms after treatment of childhood cancer in Slovenia. Pediatr Blood Cancer 42(7):574\u2013581. doi: 10.1002\/pbc.20025","journal-title":"Pediatr Blood Cancer"},{"issue":"9184","key":"35_CR37","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/s0140-6736(05)76922-1","volume":"354","author":"H Jenkinson","year":"1999","unstructured":"Jenkinson H, Hawkins M (1999) Secondary brain tumours in children with ALL. Lancet 354(9184):1126. doi: 10.1016\/s0140-6736(05)76922-1","journal-title":"Lancet"},{"issue":"11","key":"35_CR38","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/sj.bjc.6602226","volume":"91","author":"HC Jenkinson","year":"2004","unstructured":"Jenkinson HC, Hawkins MM, Stiller CA, Winter DL, Marsden HB, Stevens MC (2004) Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer 91(11):1905\u20131910. doi: 10.1038\/sj.bjc.6602226","journal-title":"Br J Cancer"},{"issue":"1","key":"35_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00381-003-0798-x","volume":"20","author":"M Kantar","year":"2004","unstructured":"Kantar M, Cetingul N, Kansoy S, Anacak Y, Demirtas E, Ersahin Y, Mutluer S (2004) Radiotherapy-induced secondary cranial neoplasms in children. Childs Nerv Syst 20(1):46\u201349. doi: 10.1007\/s00381-003-0798-x","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"35_CR40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/bjc.1987.199","volume":"56","author":"JE Kingston","year":"1987","unstructured":"Kingston JE, Hawkins MM, Draper GJ, Marsden HB, Kinnier Wilson LM (1987) Patterns of multiple primary tumours in patients treated for cancer during childhood. Br J Cancer 56(3):331\u2013338","journal-title":"Br J Cancer"},{"issue":"6","key":"35_CR41","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0959-8049(02)00875-4","volume":"39","author":"G Klein","year":"2003","unstructured":"Klein G, Michaelis J, Spix C, Wibbing R, Eggers G, Ritter J, Kaatsch P (2003) Second malignant neoplasms after treatment of childhood cancer. Eur J Cancer (Oxford, England: 1990) 39(6):808\u2013817","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"issue":"7","key":"35_CR42","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1118\/1.2207252","volume":"33","author":"EE Klein","year":"2006","unstructured":"Klein EE, Maserang B, Wood R, Mansur D (2006) Peripheral doses from pediatric IMRT. Med Phys 33(7):2525\u20132531","journal-title":"Med Phys"},{"issue":"9071","key":"35_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/s0140-6736(97)01116-1","volume":"350","author":"SJ Kony","year":"1997","unstructured":"Kony SJ, de Vathaire F, Chompret A, Shamsaldim A, Grimaud E, Raquin MA, Oberlin O, Brugieres L, Feunteun J, Eschwege F, Chavaudra J, Lemerle J, Bonaiti-Pellie C (1997) Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet 350(9071):91\u201395. doi: 10.1016\/s0140-6736(97)01116-1","journal-title":"Lancet"},{"issue":"2","key":"35_CR44","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1215\/s1522-8517-02-00030-3","volume":"5","author":"DN Korones","year":"2003","unstructured":"Korones DN, Padowski J, Factor BA, Constine LS (2003) Do children with optic pathway tumors have an increased frequency of other central nervous system tumors? Neuro-Oncology 5(2):116\u2013120. doi: 10.1215\/s1522-8517-02-00030-3","journal-title":"Neuro-Oncology"},{"issue":"4","key":"35_CR45","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.ijrobp.2005.03.053","volume":"62","author":"SF Kry","year":"2005","unstructured":"Kry SF, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA, Rosen II (2005) The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62(4):1195\u20131203. doi: 10.1016\/j.ijrobp.2005.03.053","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"35_CR46","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1055\/s-2008-1073043","volume":"25","author":"C Kuenzle","year":"1994","unstructured":"Kuenzle C, Weissert M, Roulet E, Bode H, Schefer S, Huisman T, Landau K, Boltshauser E (1994) Follow-up of optic pathway gliomas in children with neurofibromatosis type 1. Neuropediatrics 25(6):295\u2013300. doi: 10.1055\/s-2008-1073043","journal-title":"Neuropediatrics"},{"issue":"2 Suppl","key":"35_CR47","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3171\/ped.2006.104.2.103","volume":"104","author":"SM Lew","year":"2006","unstructured":"Lew SM, Morgan JN, Psaty E, Lefton DR, Allen JC, Abbott R (2006) Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma. J Neurosurg 104(2 Suppl):103\u2013107. doi: 10.3171\/ped.2006.104.2.103","journal-title":"J Neurosurg"},{"issue":"3","key":"35_CR48","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/(sici)1097-0215(19981029)78:3<269::aid-ijc1>3.0.co;2-t","volume":"78","author":"MP Little","year":"1998","unstructured":"Little MP, de Vathaire F, Shamsaldin A, Oberlin O, Campbell S, Grimaud E, Chavaudra J, Haylock RG, Muirhead CR (1998) Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer 78(3):269\u2013275. doi: 10.1002\/(sici)1097-0215(19981029)78:3<269::aid-ijc1>3.0.co;2-t","journal-title":"Int J Cancer"},{"issue":"9","key":"35_CR49","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1182\/blood.V95.9.2770.009k16_2770_2775","volume":"95","author":"L Loning","year":"2000","unstructured":"Loning L, Zimmermann M, Reiter A, Kaatsch P, Henze G, Riehm H, Schrappe M (2000) Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood 95(9):2770\u20132775","journal-title":"Blood"},{"issue":"6","key":"35_CR50","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.3171\/jns.2002.97.6.1378","volume":"97","author":"RR Lonser","year":"2002","unstructured":"Lonser RR, Walbridge S, Vortmeyer AO, Pack SD, Nguyen TT, Gogate N, Olson JJ, Akbasak A, Bobo RH, Goffman T, Zhuang Z, Oldfield EH (2002) Induction of glioblastoma multiforme in nonhuman primates after therapeutic doses of fractionated whole-brain radiation therapy. J Neurosurg 97(6):1378\u20131389. doi: 10.3171\/jns.2002.97.6.1378","journal-title":"J Neurosurg"},{"issue":"4","key":"35_CR51","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/pbc.20921","volume":"48","author":"AC MacArthur","year":"2007","unstructured":"MacArthur AC, Spinelli JJ, Rogers PC, Goddard KJ, Phillips N, McBride ML (2007) Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada. Pediatr Blood Cancer 48(4):453\u2013459. doi: 10.1002\/pbc.20921","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"35_CR52","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00381-009-0829-3","volume":"25","author":"A Makidono","year":"2009","unstructured":"Makidono A, Kobayashi N, Saida Y, Manabe A, Kawamori J, Suzuki K (2009) Metachronous gliomas following cranial irradiation for mixed germ cell tumors. Childs Nerv Syst 25(6):713\u2013718. doi: 10.1007\/s00381-009-0829-3","journal-title":"Childs Nerv Syst"},{"issue":"12","key":"35_CR53","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/bjo.37.12.758","volume":"37","author":"I Mann","year":"1953","unstructured":"Mann I, Yates PC, Ainslie JP (1953) Unusual case of double primary orbital tumour. Br J Ophthalmol 37(12):758\u2013762","journal-title":"Br J Ophthalmol"},{"key":"35_CR54","doi-asserted-by":"publisher","first-page":"f2360","DOI":"10.1136\/bmj.f2360","volume":"346","author":"JD Mathews","year":"2013","unstructured":"Mathews JD, Forsythe AV, Brady Z, Butler MW, Goergen SK, Byrnes GB, Giles GG, Wallace AB, Anderson PR, Guiver TA, McGale P, Cain TM, Dowty JG, Bickerstaffe AC, Darby SC (2013) Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ 346:f2360. doi: 10.1136\/bmj.f2360","journal-title":"BMJ"},{"issue":"6","key":"35_CR55","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ejca.2008.02.012","volume":"44","author":"M Maule","year":"2008","unstructured":"Maule M, Scelo G, Pastore G, Brennan P, Hemminki K, Pukkala E, Weiderpass E, Olsen JH, Tracey E, McBride ML, Brewster DH, Pompe-Kirn V, Tonita JM, Kliewer EV, Chia KS, Jonasson JG, Martos C, Magnani C, Boffetta P (2008) Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study. Eur J Cancer (Oxford, England: 1990) 44(6):830\u2013839. doi: 10.1016\/j.ejca.2008.02.012","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"issue":"4","key":"35_CR56","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1200\/JCO.1985.3.4.532","volume":"3","author":"AT Meadows","year":"1985","unstructured":"Meadows AT, Baum E, Fossati-Bellani F, Green D, Jenkin RD, Marsden B, Nesbit M, Newton W, Oberlin O, Sallan SG et al (1985) Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol 3(4):532\u2013538","journal-title":"J Clin Oncol"},{"issue":"14","key":"35_CR57","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1200\/jco.2008.21.1920","volume":"27","author":"AT Meadows","year":"2009","unstructured":"Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, Hammond S, Yasui Y, Inskip PD (2009) Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 27(14):2356\u20132362. doi: 10.1200\/jco.2008.21.1920","journal-title":"J Clin Oncol"},{"issue":"3","key":"35_CR58","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0360-3016(02)02982-6","volume":"54","author":"R Miralbell","year":"2002","unstructured":"Miralbell R, Lomax A, Cella L, Schneider U (2002) Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 54(3):824\u2013829","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"35_CR59","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1088\/0031-9155\/59\/12\/2883","volume":"59","author":"M Moteabbed","year":"2014","unstructured":"Moteabbed M, Yock TI, Paganetti H (2014) The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumors. Phys Med Biol 59(12):2883\u20132899. doi: 10.1088\/0031-9155\/59\/12\/2883","journal-title":"Phys Med Biol"},{"issue":"6","key":"35_CR60","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1080\/02841860500218819","volume":"44","author":"X Mu","year":"2005","unstructured":"Mu X, Bjork-Eriksson T, Nill S, Oelfke U, Johansson KA, Gagliardi G, Johansson L, Karlsson M, Zackrisson DB (2005) Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study. Acta Oncol (Stockholm, Sweden) 44(6):554\u2013562. doi: 10.1080\/02841860500218819","journal-title":"Acta Oncol (Stockholm, Sweden)"},{"issue":"19","key":"35_CR61","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/nejm199111073251902","volume":"325","author":"JP Neglia","year":"1991","unstructured":"Neglia JP, Meadows AT, Robison LL, Kim TH, Newton WA, Ruymann FB, Sather HN, Hammond GD (1991) Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 325(19):1330\u20131336. doi: 10.1056\/nejm199111073251902","journal-title":"N Engl J Med"},{"issue":"21","key":"35_CR62","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/jnci\/djj411","volume":"98","author":"JP Neglia","year":"2006","unstructured":"Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, Yasui Y, Kasper CE, Mertens AC, Donaldson SS, Meadows AT, Inskip PD (2006) New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98(21):1528\u20131537. doi: 10.1093\/jnci\/djj411","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"35_CR63","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1088\/0031-9155\/54\/8\/002","volume":"54","author":"WD Newhauser","year":"2009","unstructured":"Newhauser WD, Fontenot JD, Mahajan A, Kornguth D, Stovall M, Zheng Y, Taddei PJ, Mirkovic D, Mohan R, Cox JD, Woo S (2009) The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol 54(8):2277\u20132291. doi: 10.1088\/0031-9155\/54\/8\/002","journal-title":"Phys Med Biol"},{"issue":"3","key":"35_CR64","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.ijrobp.2007.10.034","volume":"70","author":"F Nguyen","year":"2008","unstructured":"Nguyen F, Rubino C, Guerin S, Diallo I, Samand A, Hawkins M, Oberlin O, Lefkopoulos D, De Vathaire F (2008) Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields. Int J Radiat Oncol Biol Phys 70(3):908\u2013915. doi: 10.1016\/j.ijrobp.2007.10.034","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"35_CR65","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1651-2227.1991.tb11812.x","volume":"80","author":"R Nygaard","year":"1991","unstructured":"Nygaard R, Garwicz S, Haldorsen T, Hertz H, Jonmundsson GK, Lanning M, Moe PJ (1991) Second malignant neoplasms in patients treated for childhood leukemia. A population-based cohort study from the Nordic countries. The Nordic Society of Pediatric Oncology and Hematology (NOPHO). Acta Paediatr Scand 80(12):1220\u20131228","journal-title":"Acta Paediatr Scand"},{"issue":"15","key":"35_CR66","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355(15):1572\u20131582. doi: 10.1056\/NEJMsa060185","journal-title":"N Engl J Med"},{"issue":"24","key":"35_CR67","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/nejm199512143332403","volume":"333","author":"JH Olsen","year":"1995","unstructured":"Olsen JH, Boice JD Jr, Seersholm N, Bautz A, Fraumeni JF Jr (1995) Cancer in the parents of children with cancer. N Engl J Med 333(24):1594\u20131599. doi: 10.1056\/nejm199512143332403","journal-title":"N Engl J Med"},{"issue":"11","key":"35_CR68","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/jnci\/djp104","volume":"101","author":"JH Olsen","year":"2009","unstructured":"Olsen JH, Moller T, Anderson H, Langmark F, Sankila R, Tryggvadottir L, Winther JF, Rechnitzer C, Jonmundsson G, Christensen J, Garwicz S (2009) Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst 101(11):806\u2013813. doi: 10.1093\/jnci\/djp104","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"35_CR69","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/neuonc\/nos267","volume":"15","author":"RJ Packer","year":"2013","unstructured":"Packer RJ, Zhou T, Holmes E, Vezina G, Gajjar A (2013) Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children\u2019s Oncology Group trial A9961. Neuro-Oncology 15(1):97\u2013103. doi: 10.1093\/neuonc\/nos267","journal-title":"Neuro-Oncology"},{"key":"35_CR70","volume-title":"Holland-Frei cancer medicine","author":"E Pan","year":"2003","unstructured":"Pan E, Prados MD (2003) Familial tumors syndromes of the central nervous system. In: Pollock RE, Weichselbaum RR (eds) Holland-Frei cancer medicine. BC Decker, Hamilton (ON)"},{"issue":"5","key":"35_CR71","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.ijrobp.2007.12.018","volume":"71","author":"AC Paulino","year":"2008","unstructured":"Paulino AC, Mai WY, Chintagumpala M, Taher A, Teh BS (2008) Radiation-induced malignant gliomas: is there a role for reirradiation? Int J Radiat Oncol Biol Phys 71(5):1381\u20131387. doi: 10.1016\/j.ijrobp.2007.12.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"35_CR72","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.ijrobp.2009.01.052","volume":"75","author":"AC Paulino","year":"2009","unstructured":"Paulino AC, Ahmed IM, Mai WY, Teh BS (2009) The influence of pretreatment characteristics and radiotherapy parameters on time interval to development of radiation-associated meningioma. Int J Radiat Oncol Biol Phys 75(5):1408\u20131414. doi: 10.1016\/j.ijrobp.2009.01.052","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9840","key":"35_CR73","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/s0140-6736(12)60815-0","volume":"380","author":"MS Pearce","year":"2012","unstructured":"Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, Howe NL, Ronckers CM, Rajaraman P, Craft AW, Parker L, Berrington de Gonz\u00e1lez A (2012) Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 380(9840):499\u2013505. doi: 10.1016\/s0140-6736(12)60815-0","journal-title":"Lancet"},{"issue":"4","key":"35_CR74","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s11764-013-0292-8","volume":"7","author":"SM Perkins","year":"2013","unstructured":"Perkins SM, Dewees T, Shinohara ET, Reddy MM, Frangoul H (2013) Risk of subsequent malignancies in survivors of childhood leukemia. J Cancer Surviv 7(4):544\u2013550. doi: 10.1007\/s11764-013-0292-8","journal-title":"J Cancer Surviv"},{"issue":"1","key":"35_CR75","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/pbc.20690","volume":"47","author":"KM Peterson","year":"2006","unstructured":"Peterson KM, Shao C, McCarter R, MacDonald TJ, Byrne J (2006) An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors. Pediatr Blood Cancer 47(1):83\u201388. doi: 10.1002\/pbc.20690","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"35_CR76","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00381-009-0814-x","volume":"25","author":"BL Pettorini","year":"2009","unstructured":"Pettorini BL, Narducci A, de Carlo A, Abet F, Caldarelli M, Massimi L, Tamburrini G, Di Rocco C (2009) Thyroid neoplasm after central nervous system irradiation for medulloblastoma in childhood: report of two cases. Childs Nerv Syst 25(5):631\u2013634. doi: 10.1007\/s00381-009-0814-x","journal-title":"Childs Nerv Syst"},{"issue":"9172","key":"35_CR77","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/s0140-6736(98)11079-6","volume":"354","author":"MV Relling","year":"1999","unstructured":"Relling MV, Rubnitz JE, Rivera GK, Boyett JM, Hancock ML, Felix CA, Kun LE, Walter AW, Evans WE, Pui CH (1999) High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 354(9172):34\u201339. doi: 10.1016\/s0140-6736(98)11079-6","journal-title":"Lancet"},{"issue":"22","key":"35_CR78","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1001\/jama.2011.747","volume":"305","author":"RC Reulen","year":"2011","unstructured":"Reulen RC, Frobisher C, Winter DL, Kelly J, Lancashire ER, Stiller CA, Pritchard-Jones K, Jenkinson HC, Hawkins MM (2011) Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 305(22):2311\u20132319. doi: 10.1001\/jama.2011.747","journal-title":"JAMA"},{"issue":"2","key":"35_CR79","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00381-006-0199-z","volume":"23","author":"BF Romeike","year":"2007","unstructured":"Romeike BF, Kim YJ, Steudel WI, Graf N (2007) Diffuse high-grade gliomas as second malignant neoplasms after radio-chemotherapy for pediatric malignancies. Childs Nerv Syst 23(2):185\u2013193. doi: 10.1007\/s00381-006-0199-z","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"35_CR80","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ijc.2910590402","volume":"59","author":"P Rosso","year":"1994","unstructured":"Rosso P, Terracini B, Fears TR, Jankovic M, Fossati Bellani F, Arrighini A, Carli M, Cordero di Montezemolo L, Garre ML, Guazzelli C et al (1994) Second malignant tumors after elective end of therapy for a first cancer in childhood: a multicenter study in Italy. Int J Cancer 59(4):451\u2013456","journal-title":"Int J Cancer"},{"issue":"4","key":"35_CR81","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1667\/RR3329","volume":"163","author":"S Sadetzki","year":"2005","unstructured":"Sadetzki S, Chetrit A, Freedman L, Stovall M, Modan B, Novikov I (2005) Long-term follow-up for brain tumor development after childhood exposure to ionizing radiation for tinea capitis. Radiat Res 163(4):424\u2013432","journal-title":"Radiat Res"},{"issue":"1","key":"35_CR82","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0959-8049(98)00341-4","volume":"35","author":"E Salminen","year":"1999","unstructured":"Salminen E, Pukkala E, Teppo L (1999) Second cancers in patients with brain tumours\u2014impact of treatment. Eur J Cancer (Oxford, England: 1990) 35(1):102\u2013105","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"issue":"2","key":"35_CR83","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11060-008-9565-x","volume":"89","author":"M Salvati","year":"2008","unstructured":"Salvati M, D\u2019Elia A, Melone GA, Brogna C, Frati A, Raco A, Delfini R (2008) Radio-induced gliomas: 20-year experience and critical review of the pathology. J Neuro-Oncol 89(2):169\u2013177. doi: 10.1007\/s11060-008-9565-x","journal-title":"J Neuro-Oncol"},{"issue":"19","key":"35_CR84","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1056\/nejm199805073381902","volume":"338","author":"R Sankila","year":"1998","unstructured":"Sankila R, Olsen JH, Anderson H, Garwicz S, Glattre E, Hertz H, Langmark F, Lanning M, Moller T, Tulinius H (1998) Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology. N Engl J Med 338(19):1339\u20131344. doi: 10.1056\/nejm199805073381902","journal-title":"N Engl J Med"},{"issue":"16","key":"35_CR85","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1200\/jco.2005.03.8349","volume":"24","author":"S Sharif","year":"2006","unstructured":"Sharif S, Ferner R, Birch JM, Gillespie JE, Gattamaneni HR, Baser ME, Evans DG (2006) Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol 24(16):2570\u20132575. doi: 10.1200\/jco.2005.03.8349","journal-title":"J Clin Oncol"},{"issue":"4","key":"35_CR86","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00004032-200310000-00003","volume":"85","author":"RE Shore","year":"2003","unstructured":"Shore RE, Moseson M, Harley N, Pasternack BS (2003) Tumors and other diseases following childhood x-ray treatment for ringworm of the scalp (Tinea capitis). Health Phys 85(4):404\u2013408","journal-title":"Health Phys"},{"issue":"12","key":"35_CR87","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/1097-0142(19830615)51:12<2159::AID-CNCR2820511202>3.0.CO;2-L","volume":"51","author":"E Shore-Freedman","year":"1983","unstructured":"Shore-Freedman E, Abrahams C, Recant W, Schneider AB (1983) Neurilemomas and salivary gland tumors of the head and neck following childhood irradiation. Cancer 51(12):2159\u20132163","journal-title":"Cancer"},{"issue":"15","key":"35_CR88","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1200\/jco.2009.27.0421","volume":"28","author":"MA Smith","year":"2010","unstructured":"Smith MA, Seibel NL, Altekruse SF, Ries LA, Melbert DL, O\u2019Leary M, Smith FO, Reaman GH (2010) Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28(15):2625\u20132634. doi: 10.1200\/jco.2009.27.0421","journal-title":"J Clin Oncol"},{"issue":"8","key":"35_CR89","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/1097-0142(19890415)63:8<1514::AID-CNCR2820630810>3.0.CO;2-Y","volume":"63","author":"D Soffer","year":"1989","unstructured":"Soffer D, Gomori JM, Siegal T, Shalit MN (1989) Intracranial meningiomas after high-dose irradiation. Cancer 63(8):1514\u20131519","journal-title":"Cancer"},{"issue":"7","key":"35_CR90","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00043426-200110000-00008","volume":"23","author":"T Stavrou","year":"2001","unstructured":"Stavrou T, Bromley CM, Nicholson HS, Byrne J, Packer RJ, Goldstein AM, Reaman GH (2001) Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol Oncol 23(7):431\u2013436","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"35_CR91","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00066-008-1817-3","volume":"184","author":"V Strenger","year":"2008","unstructured":"Strenger V, Sovinz P, Lackner H, Dornbusch HJ, Lingitz H, Eder HG, Moser A, Urban C (2008) Intracerebral cavernous hemangioma after cranial irradiation in childhood. Incidence and risk factors. Strahlenther Onkol 184(5):276\u2013280. doi: 10.1007\/s00066-008-1817-3","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"35_CR92","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0360-3016(00)00609-X","volume":"48","author":"P Strojan","year":"2000","unstructured":"Strojan P, Popovic M, Jereb B (2000) Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature. Int J Radiat Oncol Biol Phys 48(1):65\u201373","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"35_CR93","doi-asserted-by":"publisher","first-page":"205427041452456","DOI":"10.1177\/2054270414524567","volume":"5","author":"E Sugden","year":"2014","unstructured":"Sugden E, Taylor A, Pretorius P, Kennedy C, Bhangoo R (2014) Meningiomas occurring during long-term survival after treatment for childhood cancer. JRSM Open 5(4):2054270414524567. doi: 10.1177\/2054270414524567","journal-title":"JRSM Open"},{"issue":"4","key":"35_CR94","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1080\/02841860600658633","volume":"45","author":"G Svahn-Tapper","year":"2006","unstructured":"Svahn-Tapper G, Garwicz S, Anderson H, Shamsaldin A, De Vathaire F, Olsen JH, Dollner H, Hertz H, Jonmundsson G, Langmark F, Lanning M, Sankila R, Tulinius H, Moller T (2006) Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: a population-based case-control study in the five Nordic countries. Acta Oncol (Stockholm, Sweden) 45(4):438\u2013448. doi: 10.1080\/02841860600658633","journal-title":"Acta Oncol (Stockholm, Sweden)"},{"issue":"34","key":"35_CR95","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.1200\/jco.2009.22.4386","volume":"27","author":"AJ Taylor","year":"2009","unstructured":"Taylor AJ, Frobisher C, Ellison DW, Reulen RC, Winter DL, Taylor RE, Stiller CA, Lancashire ER, Tudor EC, Baggott C, May S, Hawkins MM (2009) Survival after second primary neoplasms of the brain or spinal cord in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study. J Clin Oncol 27(34):5781\u20135787. doi: 10.1200\/jco.2009.22.4386","journal-title":"J Clin Oncol"},{"issue":"36","key":"35_CR96","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1200\/jco.2009.27.0090","volume":"28","author":"AJ Taylor","year":"2010","unstructured":"Taylor AJ, Little MP, Winter DL, Sugden E, Ellison DW, Stiller CA, Stovall M, Frobisher C, Lancashire ER, Reulen RC, Hawkins MM (2010) Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study. J Clin Oncol 28(36):5287\u20135293. doi: 10.1200\/jco.2009.27.0090","journal-title":"J Clin Oncol"},{"issue":"2 Suppl","key":"35_CR97","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2307\/3578892","volume":"137","author":"DE Thompson","year":"1994","unstructured":"Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S et al (1994) Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958\u20131987. Radiat Res 137(2 Suppl):S17\u2013S67","journal-title":"Radiat Res"},{"issue":"1","key":"35_CR98","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1096-911X(199701)28:1<59::AID-MPO11>3.0.CO;2-5","volume":"28","author":"CF Torres","year":"1997","unstructured":"Torres CF, Korones DN, Pilcher W (1997) Multiple ependymomas in a patient with Turcot\u2019s syndrome. Med Pediatr Oncol 28(1):59\u201361","journal-title":"Med Pediatr Oncol"},{"issue":"5","key":"35_CR99","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/jnci\/djr533","volume":"104","author":"LB Travis","year":"2012","unstructured":"Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD Jr (2012) Second malignant neoplasms and cardiovascular disease following radiotherapy. J Natl Cancer Inst 104(5):357\u2013370. doi: 10.1093\/jnci\/djr533","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"35_CR100","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/neuonc\/nou279","volume":"17","author":"K Tsui","year":"2015","unstructured":"Tsui K, Gajjar A, Li C, Srivastava D, Broniscer A, Wetmore C, Kun LE, Merchant TE, Ellison DW, Orr BA, Boop FA, Klimo P, Ross J, Robison LL, Armstrong GT (2015) Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy. Neuro-Oncology 17(3):448\u2013456. doi: 10.1093\/neuonc\/nou279","journal-title":"Neuro-Oncology"},{"issue":"1","key":"35_CR101","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2008.12.016","volume":"91","author":"M Tubiana","year":"2009","unstructured":"Tubiana M (2009) Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 91(1):4\u201315. ; discussion 11\u201313. doi: 10.1016\/j.radonc.2008.12.016","journal-title":"Radiother Oncol"},{"issue":"3","key":"35_CR102","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00381-011-1390-4","volume":"27","author":"M Vinchon","year":"2011","unstructured":"Vinchon M, Leblond P, Caron S, Delestret I, Baroncini M, Coche B (2011) Radiation-induced tumors in children irradiated for brain tumor: a longitudinal study. Childs Nerv Syst 27(3):445\u2013453. doi: 10.1007\/s00381-011-1390-4","journal-title":"Childs Nerv Syst"},{"issue":"7","key":"35_CR103","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.ejca.2009.01.015","volume":"45","author":"K Hoff von","year":"2009","unstructured":"von Hoff K, Hinkes B, Gerber NU, Deinlein F, Mittler U, Urban C, Benesch M, Warmuth-Metz M, Soerensen N, Zwiener I, Goette H, Schlegel PG, Pietsch T, Kortmann RD, Kuehl J, Rutkowski S (2009) Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT\u201991. Eur J Cancer (Oxford, England: 1990) 45(7):1209\u20131217. doi: 10.1016\/j.ejca.2009.01.015","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"issue":"12","key":"35_CR104","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1200\/JCO.1998.16.12.3761","volume":"16","author":"AW Walter","year":"1998","unstructured":"Walter AW, Hancock ML, Pui CH, Hudson MM, Ochs JS, Rivera GK, Pratt CB, Boyett JM, Kun LE (1998) Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children\u2019s Research Hospital. J Clin Oncol 16(12):3761\u20133767","journal-title":"J Clin Oncol"},{"issue":"9283","key":"35_CR105","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/s0140-6736(01)05838-x","volume":"358","author":"JF Winther","year":"2001","unstructured":"Winther JF, Sankila R, Boice JD, Tulinius H, Bautz A, Barlow L, Glattre E, Langmark F, Moller TR, Mulvihill JJ, Olafsdottir GH, Ritvanen A, Olsen JH (2001) Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study. Lancet 358(9283):711\u2013717. doi: 10.1016\/s0140-6736(01)05838-x","journal-title":"Lancet"},{"issue":"10","key":"35_CR106","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s00381-013-2098-4","volume":"29","author":"SH You","year":"2013","unstructured":"You SH, Lyu CJ, Kim DS, Suh CO (2013) Second primary brain tumors following cranial irradiation for pediatric solid brain tumors. Childs Nerv Syst 29(10):1865\u20131870. doi: 10.1007\/s00381-013-2098-4","journal-title":"Childs Nerv Syst"}],"container-title":["Radiation Oncology for Pediatric CNS Tumors"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-55430-3_35","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T19:56:42Z","timestamp":1603223802000},"score":24.246248,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-55430-3_35"}},"issued":{"date-parts":[[2017,10,31]]},"ISBN":["9783319554280","9783319554303"],"references-count":106,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-55430-3_35","published":{"date-parts":[[2017,10,31]]}},{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T03:12:09Z","timestamp":1725505929998},"publisher-location":"Boston, MA","reference-count":0,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9780387755861"},{"type":"electronic","value":"9780387755878"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2008]]},"DOI":"10.1007\/978-0-387-75587-8_16","type":"book-chapter","created":{"date-parts":[[2008,3,22]],"date-time":"2008-03-22T04:07:10Z","timestamp":1206158830000},"page":"423-452","source":"Crossref","is-referenced-by-count":4,"title":["Radiology of Soft Tissue Tumors Including Melanoma"],"prefix":"10.1007","author":[{"given":"M. J.","family":"Shelly","sequence":"first","affiliation":[]},{"given":"P. J.","family":"MacMahon","sequence":"additional","affiliation":[]},{"given":"S.","family":"Eustace","sequence":"additional","affiliation":[]}],"member":"297","container-title":["Cancer Treatment and Research","Imaging in Oncology"],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-0-387-75587-8_16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T23:54:29Z","timestamp":1619654069000},"score":24.228882,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-0-387-75587-8_16"}},"issued":{"date-parts":[[2008]]},"ISBN":["9780387755861","9780387755878"],"references-count":0,"URL":"https:\/\/doi.org\/10.1007\/978-0-387-75587-8_16","ISSN":["0927-3042"],"issn-type":[{"type":"print","value":"0927-3042"}],"published":{"date-parts":[[2008]]}},{"indexed":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T04:03:38Z","timestamp":1714881818780},"reference-count":34,"publisher":"Elsevier","isbn-type":[{"value":"9780125862707","type":"print"}],"license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[1985]]},"DOI":"10.1016\/b978-0-12-586270-7.50010-0","type":"book-chapter","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T19:18:37Z","timestamp":1408043917000},"page":"41-53","source":"Crossref","is-referenced-by-count":0,"title":["CHARACTERISTICS OF TUMOR ANTIGENS ON TUMORS INDUCED BY CHEMICAL CARCINOGENS. SOME RECENT FINDINGS"],"prefix":"10.1016","author":[{"given":"Lloyd W.","family":"Law","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ijc.2910250213","volume":"25","author":"Law","year":"1980","journal-title":"Int. J. Cancer"},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib2","first-page":"2477","volume":"28","author":"Vaage","year":"1968","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib3","first-page":"1281","volume":"44","author":"Carswell","year":"1970","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib4","first-page":"289","volume":"42","author":"Morton","year":"1969","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib5","first-page":"106","volume":"34","author":"Krlpke","year":"1980","journal-title":"Adv. Cancer"},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib6","first-page":"361","volume":"41","author":"Old","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1084\/jem.159.2.537","volume":"159","author":"Olsson","year":"1984","journal-title":"J. Exp. Med."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1084\/jem.158.1.53","volume":"158","author":"Houghton","year":"1983","journal-title":"J. Exp. Med."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib9","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.4049\/jimmunol.132.6.3211","volume":"132","author":"Rogers","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib10","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1084\/jem.154.6.1764","volume":"154","author":"Albino","year":"1981","journal-title":"J. Exp. Med."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib11","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.1073\/pnas.79.24.7669","volume":"79","author":"DuBois","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib12","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1084\/jem.146.3.720","volume":"146","author":"DeLeo","year":"1977","journal-title":"J. Exp. Med."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib13","first-page":"359","volume":"38","author":"Natori","year":"1978","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib14","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ijc.2910150603","volume":"15","author":"Klein","year":"1975","journal-title":"Int. J. Cancer"},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib15","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1084\/jem.154.3.964","volume":"154","author":"Pravtcheva","year":"1981","journal-title":"J. Exp. Med."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib16","first-page":"46","volume":"XII","author":"Law","year":"1980","journal-title":"Transpl. Proc."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib17","series-title":"\u201cProc. IV Int. Congress of Immunol.\u201d","first-page":"659","author":"Lennox","year":"1980"},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib18","first-page":"1765","volume":"13","author":"DuBois","year":"1981","journal-title":"Transplant. Proc."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/bjc.1984.145","volume":"50","author":"Law","year":"1984","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1128\/JVI.29.1.69-75.1979","volume":"29","author":"Chang","year":"1979","journal-title":"J. Virol."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ijc.2910230116","volume":"23","author":"Rogers","year":"1979","journal-title":"Int. J. Cancer"},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib22","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1073\/pnas.75.7.3055","volume":"75","author":"Jay","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib23","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4049\/jimmunol.132.2.953","volume":"132","author":"O'Connell","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib24","series-title":"\u201cViral Oncology\u201d","first-page":"581","author":"Tevethia","year":"1980"},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib25","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.130.1.490","volume":"130","author":"Campbell","year":"1983","journal-title":"J. Immunol."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib26","author":"DuBois","year":"1984","journal-title":"Int. J. Cancer"},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/ajcp\/80.4.429","volume":"80","author":"Hsu","year":"1983","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00199240","volume":"16","author":"Saunders","year":"1983","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/304165a0","volume":"304","author":"Wortzel","year":"1983","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0065-230X(08)61034-9","volume":"39","author":"Boon","year":"1983","journal-title":"Advances in Cancer Res."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib31","unstructured":"Woodruff, M. F. A., Ansell, J. B., Hodson, B. A., and"},{"key":"10.1016\/B978-0-12-586270-7.50010-0_sbref31","first-page":"1046","volume":"42","author":"Wang","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/B978-0-12-586270-7.50010-0_sbref32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/bjc.1984.2","volume":"49","author":"Micklem","year":"1984","journal-title":"British J. Cancer"},{"key":"10.1016\/B978-0-12-586270-7.50010-0_bib33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ijc.2910330420","volume":"33","author":"Law","year":"1984","journal-title":"Int. J. Cancer"}],"container-title":["Immunity to Cancer"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780125862707500100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780125862707500100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T23:32:51Z","timestamp":1689463971000},"score":24.153904,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780125862707500100"}},"issued":{"date-parts":[[1985]]},"ISBN":["9780125862707"],"references-count":34,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-586270-7.50010-0","published":{"date-parts":[[1985]]}},{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T09:59:17Z","timestamp":1743069557261,"version":"3.40.3"},"publisher-location":"Cham","reference-count":41,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030041519"},{"type":"electronic","value":"9783030041526"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-04152-6_7","type":"book-chapter","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T04:02:55Z","timestamp":1559275375000},"page":"175-183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumors of the\u00a0Skull Including Chordoma"],"prefix":"10.1007","author":[{"given":"Roland","family":"Goldbrunner","sequence":"first","affiliation":[]},{"given":"J\u00f6rg-Christian","family":"Tonn","sequence":"additional","affiliation":[]},{"given":"Volker","family":"Neuschmelting","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,6,1]]},"reference":[{"key":"7_CR1","first-page":"449","volume":"40","author":"WS Tucker","year":"1997","unstructured":"Tucker WS, Nasser-Sharif FJ (1997) Benign skull lesions. Can J Surg 40:449\u2013455","journal-title":"Can J Surg"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/00001665-200405000-00032","volume":"15","author":"U Bilkay","year":"2004","unstructured":"Bilkay U, Erdem O, Ozek C, Helvaci E, Kilic K, Ertan Y, Gurler T (2004) Benign osteoma with Gardner syndrome: review of the literature and report of a case. J Craniofac Surg 15:506\u2013509","journal-title":"J Craniofac Surg"},{"key":"7_CR3","volume-title":"Bone tumors: diagnosis, treatment and prognosis","author":"AG Huvos","year":"1991","unstructured":"Huvos AG (1991) Bone tumors: diagnosis, treatment and prognosis. W.B. Saunders, Philadelphia"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S1010-5182(05)80614-6","volume":"19","author":"DS Vege","year":"1991","unstructured":"Vege DS, Borges AM, Aggrawal K, Balasubramaniam G, Parikh DM, Bhaser B (1991) Osteosarcoma of the craniofacial bones. A clinico-pathological study. J Craniomaxillofac Surg 19:90\u201393","journal-title":"J Craniomaxillofac Surg"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/019459988609400104","volume":"94","author":"JF Kveton","year":"1986","unstructured":"Kveton JF, Brackmann DE, Glasscock ME III, House WF, Hitselberger WE (1986) Chondrosarcoma of the skull base. Otolaryngol Head Neck Surg 94:23\u201332","journal-title":"Otolaryngol Head Neck Surg"},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/01.rlu.0000113856.77103.7e","volume":"29","author":"Y Zhibin","year":"2004","unstructured":"Zhibin Y, Quanyong L, Libo C, Jun Z, Hankui L, Jifang Z, Ruisen Z (2004) The role of radionuclide bone scintigraphy in fibrous dysplasia of bone. Clin Nucl Med 29:177\u2013180","journal-title":"Clin Nucl Med"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1053\/jpsu.2000.7843","volume":"35","author":"Y Low","year":"2000","unstructured":"Low Y, Foo CL, Seow WT (2000) Childhood temporal bone osteoblastoma: a case report. J Pediatr Surg 35:1127\u20131129","journal-title":"J Pediatr Surg"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0165-4608(90)90084-N","volume":"45","author":"WP Shen","year":"1990","unstructured":"Shen WP, Young RF, Walter BN, Choi BH, Smith M, Katz J (1990) Molecular analysis of a myxoid chondrosarcoma with rearrangements of chromosomes 10 and 22. Cancer Genet Cytogenet 45:207\u2013215","journal-title":"Cancer Genet Cytogenet"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1179\/crn.2004.021","volume":"22","author":"EL Gaudet Jr","year":"2004","unstructured":"Gaudet EL Jr, Nuss DW, Johnson DH Jr, Miranne LS Jr (2004) Chondroblastoma of the temporal bone involving the temporomandibular joint, mandibular condyle, and middle cranial fossa: case report and review of the literature. Cranio 22:160\u2013168","journal-title":"Cranio"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1002\/hed.24880","volume":"39","author":"SW Park","year":"2017","unstructured":"Park SW, Kim JH, Park JH, Moon KC, Paeng JC, Choi BS, Lee Y, Kim JH, Yoo RE, Kang KM, Kim SC, Choi SH, Yun TJ, Sohn CH (2017) Temporal bone chondroblastoma: imaging characteristics with pathologic correlation. Head Neck 39:2171\u20132179","journal-title":"Head Neck"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/PAT.0000000000000050","volume":"46","author":"VY Jo","year":"2014","unstructured":"Jo VY, Fletcher CD (2014) WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology 46:95\u2013104","journal-title":"Pathology"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF01808691","volume":"78","author":"M Hassounah","year":"1985","unstructured":"Hassounah M, Al Mefty O, Akhtar M, Jinkins JR, Fox JL (1985) Primary cranial and intracranial chondrosarcoma. A survey. Acta Neurochir 78:123\u2013132","journal-title":"Acta Neurochir"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/00005537-200201000-00023","volume":"112","author":"B Neff","year":"2002","unstructured":"Neff B, Sataloff RT, Storey L, Hawkshaw M, Spiegel JR (2002) Chondrosarcoma of the skull base. Laryngoscope 112:134\u2013139","journal-title":"Laryngoscope"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1002\/cncr.23073","volume":"110","author":"K Almefty","year":"2007","unstructured":"Almefty K, Pravdenkova S, Colli BO, Al-Mefty O, Gokden M (2007) Chordoma and chondrosarcoma: similar, but quite different, skull base tumors. Cancer 110:2457\u20132467","journal-title":"Cancer"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12105-017-0860-8","volume":"12","author":"JK Wasserman","year":"2018","unstructured":"Wasserman JK, Gravel D, Purgina B (2018) Chordoma of the head and neck: a review. Head Neck Pathol 12:261\u2013268","journal-title":"Head Neck Pathol"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s40134-018-0275-7","volume":"6","author":"RGC Santegoeds","year":"2018","unstructured":"Santegoeds RGC, Temel Y, Beckervordersandforth JC, Van Overbeeke JJ, Hoeberigs CM (2018) State-of-the-art imaging in human chordoma of the skull base. Curr Radiol Rep 6:16","journal-title":"Curr Radiol Rep"},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3171\/JNS-07\/08\/0319","volume":"107","author":"A Samii","year":"2007","unstructured":"Samii A, Gerganov VM, Herold C, Hayashi N, Naka T, Mirzayan MJ, Ostertag H, Samii M (2007) Chordomas of the skull base: surgical management and outcome. J Neurosurg 107:319\u2013324","journal-title":"J Neurosurg"},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jocn.2018.04.008","volume":"53","author":"P Leah","year":"2018","unstructured":"Leah P, Dower A, Vescovi C, Mulcahy M, Al Khawaja D (2018) Clinical experience of intracranial chordoma\u2014a systematic review and meta-analysis of the literature. J Clin Neurosci 53:6\u201312","journal-title":"J Clin Neurosci"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/annonc\/mdx054","volume":"28","author":"S Stacchiotti","year":"2017","unstructured":"Stacchiotti S, Gronchi A, Fossati P, Akiyama T, Alapetite C, Baumann M, Blay JY, Bolle S, Boriani S, Bruzzi P, Capanna R, Caraceni A, Casadei R, Colia V, Debus J, Delaney T, Desai A, Dileo P, Dijkstra S, Doglietto F, Flanagan A, Froelich S, Gardner PA, Gelderblom H, Gokaslan ZL, Haas R, Heery C, Hindi N, Hohenberger P, Hornicek F, Imai R, Jeys L, Jones RL, Kasper B, Kawai A, Krengli M, Leithner A, Logowska I, Martin Broto J, Mazzatenta D, Morosi C, Nicolai P, Norum OJ, Patel S, Penel N, Picci P, Pilotti S, Radaelli S, Ricchini F, Rutkowski P, Scheipl S, Sen C, Tamborini E, Thornton KA, Timmermann B, Torri V, Tunn PU, Uhl M, Yamada Y, Weber DC, Vanel D, Varga PP, Vleggeert-Lankamp CLA, Casali PG, Sommer J (2017) Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group. Ann Oncol 28:1230\u20131242","journal-title":"Ann Oncol"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00701-009-0535-7","volume":"152","author":"E Ito","year":"2010","unstructured":"Ito E, Saito K, Okada T, Nagatani T, Nagasaka T (2010) Long-term control of clival chordoma with initial aggressive surgical resection and gamma knife radiosurgery for recurrence. Acta Neurochir 152:57\u201367","journal-title":"Acta Neurochir"},{"key":"7_CR21","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3171\/jns.2001.95.6.0933","volume":"95","author":"B Colli","year":"2001","unstructured":"Colli B, Al-Mefty O (2001) Chordomas of the craniocervical junction: follow-up review and prognostic factors. J Neurosurg 95:933\u2013943","journal-title":"J Neurosurg"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11060-009-9846-z","volume":"94","author":"K Dassoulas","year":"2009","unstructured":"Dassoulas K, Schlesinger D, Yen CP, Sheehan J (2009) The role of gamma knife surgery in the treatment of skull base chordomas. J Neurooncol 94:243\u2013248","journal-title":"J Neurooncol"},{"key":"7_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1227\/01.NEU.0000223441.51012.9D","volume":"59","author":"F Tzortzidis","year":"2006","unstructured":"Tzortzidis F, Elahi F, Wright D, Natarajan SK, Sekhar LN (2006) Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery 59:230\u2013237","journal-title":"Neurosurgery"},{"key":"7_CR24","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00701-009-0383-5","volume":"151","author":"S Takahashi","year":"2009","unstructured":"Takahashi S, Kawase T, Yoshida K, Hasegawa A, Mizoe JE (2009) Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy. Acta Neurochir 151:759\u2013769","journal-title":"Acta Neurochir"},{"key":"7_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5435\/00124635-200409000-00005","volume":"12","author":"SG Parekh","year":"2004","unstructured":"Parekh SG, Donthineni-Rao R, Ricchetti E, Lackman RD (2004) Fibrous dysplasia. J Am Acad Orthop Surg 12:305\u2013313","journal-title":"J Am Acad Orthop Surg"},{"issue":"12","key":"7_CR26","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1002\/jbmr.2894","volume":"31","author":"J Benhamou","year":"2016","unstructured":"Benhamou J, Gensburger D, Messiaen C, Chapurlat R (2016) Prognostic factors from an epidemiologic evaluation of fibrous dysplasia of bone in a modern cohort: the FRANCEDYS study. J Bone Miner Res 31(12):2167\u20132172","journal-title":"J Bone Miner Res"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/00006534-199011000-00002","volume":"86","author":"YR Chen","year":"1990","unstructured":"Chen YR, Noordhoff MS (1990) Treatment of craniomaxillofacial fibrous dysplasia: how early and how extensive? Plast Reconstr Surg 86:835\u2013842","journal-title":"Plast Reconstr Surg"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/rheumatology\/keh243","volume":"43","author":"AL Langston","year":"2004","unstructured":"Langston AL, Ralston SH (2004) Management of Paget\u2019s disease of bone. Rheumatology (Oxford) 43:955\u2013959","journal-title":"Rheumatology (Oxford)"},{"key":"7_CR29","first-page":"1503","volume-title":"Neurosurgery","author":"HB Hamilton","year":"2004","unstructured":"Hamilton HB, Voorhies RM (2004) Tumors of the skull. In: Wilkins RH, Rengechary SS (eds) Neurosurgery. McGraw-Hill, New York, pp 1503\u20131528"},{"key":"7_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1212\/WNL.25.2.99","volume":"25","author":"JE Thomas","year":"1975","unstructured":"Thomas JE, Baker HL Jr (1975) Assessment of roentgeno-graphic lucencies of the skull: a systematic approach. Neurology 25:99\u2013106","journal-title":"Neurology"},{"key":"7_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3171\/2017.2.PEDS16701","volume":"20","author":"S Khalid","year":"2016","unstructured":"Khalid S, Ruge J (2016) Considerations in the management of congenital cranial dermoid cysts. J Neurosurg Pediatr 20:30\u201334","journal-title":"J Neurosurg Pediatr"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10195-016-0434-7","volume":"18","author":"A Angelini","year":"2017","unstructured":"Angelini A, Mavrogenis AF, Rimondi E, Rossi G, Ruggieri P (2017) Current concepts for the diagnosis and management of eosinophilic granuloma of bone. J Orthop Traumatol 18:83\u201390","journal-title":"J Orthop Traumatol"},{"key":"7_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/00006534-199701000-00004","volume":"99","author":"YR Chen","year":"1997","unstructured":"Chen YR, Breidahl A, Chang CN (1997) Optic nerve decompression in fibrous dysplasia: indications, efficacy, and safety. Plast Reconstr Surg 99:22\u201330","journal-title":"Plast Reconstr Surg"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1053\/joms.2001.20487","volume":"59","author":"P Ricalde","year":"2001","unstructured":"Ricalde P, Horswell BB (2001) Craniofacial fibrous dysplasia of the fronto-orbital region: a case series and literature review. J Oral Maxillofac Surg 59:157\u2013167","journal-title":"J Oral Maxillofac Surg"},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/jso.24368","volume":"114","author":"K Amorim Bernstein De","year":"2016","unstructured":"De Amorim Bernstein K, DeLaney T (2016) Chordomas and chondrosarcomas\u2014the role of radiation therapy. J Surg Oncol 114:564\u2013569","journal-title":"J Surg Oncol"},{"key":"7_CR36","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3171\/JNS-07\/10\/0758","volume":"107","author":"JJ Martin","year":"2007","unstructured":"Martin JJ, Niranjan A, Kondziolka D, Flickinger JC, Lozanne KA, Lunsford LD (2007) Radiosurgery for chordomas and chondrosarcomas of the skull base. J Neurosurg 107:758\u2013764","journal-title":"J Neurosurg"},{"key":"7_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF00149375","volume":"7","author":"A Mortensen","year":"1989","unstructured":"Mortensen A, Bojsen-Moller M, Rasmussen P (1989) Fibrous dysplasia of the skull with acromegaly and sarcomatous transformation. Two cases with a review of the literature. J Neurooncol 7:25\u201329","journal-title":"J Neurooncol"},{"key":"7_CR38","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S1052-5149(03)00047-9","volume":"13","author":"B Turowski","year":"2003","unstructured":"Turowski B, Zanella FE (2003) Interventional neuroradiology of the head and neck. Neuroimaging Clin N Am 13:619\u2013645","journal-title":"Neuroimaging Clin N Am"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00234-003-1005-1","volume":"45","author":"M Bendszus","year":"2003","unstructured":"Bendszus M, Martin-Schrader I, Schlake HP, Solymosi L (2003) Embolisation of intracranial meningiomas without subsequent surgery. Neuroradiology 45:451\u2013455","journal-title":"Neuroradiology"},{"key":"7_CR40","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s11912-008-0052-5","volume":"10","author":"QN Nguyen","year":"2008","unstructured":"Nguyen QN, Chang EL (2008) Emerging role of proton beam radiation therapy for chordoma and chondrosarcoma of the skull base. Curr Oncol Rep 10:338\u2013343","journal-title":"Curr Oncol Rep"},{"key":"7_CR41","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ijrobp.2003.09.041","volume":"58","author":"D Schulz-Ertner","year":"2004","unstructured":"Schulz-Ertner D, Nikoghosyan A, Thilmann C, Haberer T, Jakel O, Karger C, Kraft G, Wannenmacher M, Debus J (2004) Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys 58:631\u2013640","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Oncology of CNS Tumors"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-04152-6_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T16:39:27Z","timestamp":1570120767000},"score":24.131882,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-04152-6_7"}},"issued":{"date-parts":[[2019]]},"ISBN":["9783030041519","9783030041526"],"references-count":41,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-04152-6_7","published":{"date-parts":[[2019]]},"assertion":[{"value":"1 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}],"items-per-page":20,"query":{"start-index":0,"search-terms":"Neoplasms.+Tumors.+Oncology.+Including+cancer+and+carcinogens"}}}